The Fate of Incompetent Perforation Veins After Surgery For Primary Varicose Veins. by Kianifard, Babak.
The fate of incompetent perforating 
veins after surgery for primary 
varicose veins
by
Babak Kianifard FRCS
Submitted for the degree of Doctorate of Medicine 
Postgraduate Medical School 
University of Surrey
JULY 2005
© Babak Kianifard 2005
ProQuest Number: 27610175
All rights reserved
INFORMATION TO ALL USERS 
The quality of this reproduction is dependent upon the quality of the copy submitted.
In the unlikely event that the author did not send a com p le te  manuscript 
and there are missing pages, these will be noted. Also, if material had to be removed,
a note will indicate the deletion.
uest
ProQuest 27610175
Published by ProQuest LLO (2019). Copyright of the Dissertation is held by the Author.
All rights reserved.
This work is protected against unauthorized copying under Title 17, United States C ode
Microform Edition © ProQuest LLO.
ProQuest LLO.
789 East Eisenhower Parkway 
P.Q. Box 1346 
Ann Arbor, Ml 48106- 1346
ABSTRACT
Background: Studies have suggested that Incompetent Perforator Veins (IPV)
become competent following High Saphenous Tie and Stripping (HST&S) of the 
Great Saphenous Vein (GSV). Other studies show an association between IPV and 
both primary and recurrent varicose veins. The role of Incompetent perforator veins 
(IPV) in primary non-ulcerated varicose veins has not been established. The aim of 
this randomised trial was to assess the fate of IPV after HST&S with or without 
Subfascial Endoscopic Perforator Surgery (SEPS). Also as secondary outcome 
measures photoplethysmography, quality of life and visual analogue scores were 
assessed over a 12 month period following surgery.
Materials and Methods:
Local ethical committee approval was obtained. Inclusion criteria consisted of 
patients with duplex proven GSV reflux and IPV (reflux > 0.5 s). Those with deep 
venous reflux, sapheno-popliteal vein reflux, ulceration and recurrent varicose veins 
were excluded. Patients were randomly allocated to HST&S alone (NSEPSG) or 
HST&S plus SEPS (SEPSG). Standardised operations were performed by one of two 
consultant vascular surgeons. Each patient completed a post-operative diary for 2 
weeks (VAS for pain, and mobility, number of pain-killers taken and the amount of 
daily assistance required). Follow-up assessments were made at I week, 6 weeks, 6 
months and I year. As part of the assessment each subject had repeat Duplex 
Ultrasound (DU) performed by a single senior vascular technologist. They also filled 
QOL questionnaires (SF-36 and Aberdeen Questionnaires), underwent 
Photoplethysmography (PPG), were timed walking a fixed distance, and completed 
VAS sheets for pain mobility and cosmesis (all also performed pre-operatively). 
Other data such as risk factors, CEAP classification, body mass index (BMI), family
history and number of hours standing were also assessed. The end point of the study 
was 1 year from the operation.
Results: Seventy two patients were recruited (powered to 0.95). Thirty-two were 
randomised to the NSEPSG (M:F 13:19, mean age 53.4), 38 to SEPSG (M:F=23:15, 
mean age 53.4). Two patients were excluded, one withdrew and the other was 
excluded due to undergoing the wrong treatment.
The patients in the two groups were similar with respect to the grade of their varicose 
veins and risk factors. The SEPSG had a significant increase in operative time of 16 
minutes which was due to the SEPS procedure. There were no differences in the post­
operative diaries filled by the patients. During the follow-up period there were no 
differences in the two groups with respect to the VAS, QOL assessments, or PPG 
times. In the NSEPSG there was a significant increase in the number of patients with 
IPV as assessed by DU at one year (25/32 vs. 12/38 in the SEPSG, P<0.001). Also the 
majority of these perforators were the same ones seen on the pre-operative DU (37/46 
(80%) vs. 5/19 (26%) in SEPSG).
Conclusions: IPV do not remain closed following HST and stripping. The addition of 
SEPS to HST&S increases operative time by an average of 16 minutes and is not 
associated with increases pain, immobility or cosmetic deterioration. SEPS is 
effective in treating IPV.
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1 CHAPTER 1
1.1 INTRODUCTION 
BACKGROUND
The first depiction of varicose veins is thought to be a tablet found at the foot of the 
Acropolis dating from 4th century B.C. (Browse et al., 1999). Browse outlines a 
thorough history of varicose veins and states the first publication on varicose veins is 
thought to be the Ebers Papyrus written in 1550 BC. A section in this text describes 
Tumps’ and that some types can be treated surgically, although ‘certain serpentine 
windings are not to be operated upon because that would be head down’, presumably 
from shock.
There are many references to veins in Hippocrates’ works who is thought to be the 
first to encourage debridement and pressure dressings for the treatment of venous 
ulcers. The first physicians to ligate blood vessels to control bleeding were Herophilos 
and Erasistratos from the Alexandrian School of Medicine in Egypt in 270 B.C. They 
also recognised that the valves of the heart stopped retrograde blood flow. 
Unfortunately their works were lost when the great library in Alexandria was 
destroyed.
Indian medicine developed in the same era. The main textbook, Sushruta Samhita 
describes debridement of ulcers with maggots, ulcer curettage and dressing. Celsus, 
the great Roman physician during the Emperorship of Tiberius (AD 14-37), 
distinguished between wounds and ulcers and described ligation of veins which were 
bleeding, division of veins in between ligatures and treatment of varicose veins by
15
avulsion and cauterization. He also used antiseptics on wounds and described the four 
cardinal signs of inflammation. Later, Galen of Pergamum (AD 130-200) began the 
description of varicose vein surgery by performing venesection for ulcers, using silk 
sutures and advising the incision and tearing out of varicose veins with a blunt hook. 
During the coming years multiple methods of treatment of varicose veins have been 
documented along with anatomical depiction of the venous system, most famously by 
Leonardo da Vinci in the sixteenth century. During this period Canano and Amatus 
first described valves within veins and in 1585 Saloman Alberti published the first 
drawings of valves. William Harvey’s publication of “De Motu Cordis” in 1628 
began the present physiological understanding of venous function. The first 
description of the term venous tone was used shortly after by Richard Lower in his 
book “De Corde” (1669), and in his next publication he described the effects of limb 
muscles on blood flow.
In the 18th century Reverend Stephen Hale first measured arterial and venous 
pressures in live animals and Sharp in his book “A Treatise on the Operations of 
Surgery”, recognised the role of gravity in venous ulcer formation. Hale went on to 
describe the oedema resulting from ligation or obstruction of the major veins and 
Baillie described stasis as a cause of thrombosis. The nineteenth century was a 
productive period with respect to surgical knowledge. In 1822 Davis described 
phlegmasia alba dolens with respect to deep venous thrombosis. Later that century 
Astley Cooper stated that compression of varicose veins restored the valvular 
competence and Brodie described reflux down the Greater Saphenous Vein (GSV) 
and its prevention by direct pressure. Rokitansky reported the occurrence of 
thrombosis at wound and inflamed sites and came close to describing Virchow’s triad 
described by Virchow some eight years later. In 1854 Unna described the plaster
16
dressing for treatment of ulcers (Unna Boot). Vemeuil in his book in 1855 outlined 
detailed anatomy of the veins of the leg and stated that varicose veins were caused by 
incompetence of the deep veins. He also observed the valves existed in the 
communicating veins which stopped blood from flowing from the deep to the 
superficial system. Hilton showed that venous ulcers frequently occurred around the 
medial malleolus and that rest helps healing. In 1866 John Gay in his series of 
drawing from cadavers showed post thrombotic damage and mature thrombi within 
the deep veins.
The modem era of varicose vein surgery began in 1891 with Trendelenberg 
describing the ligation of the GSV in the upper third of the thigh to prevent reflux, 
and later in the early twentieth century, Keller and Mayo described the technique of 
stripping of the GSV. Homan in 1916 was the first to classify varicose veins as 
primary if the deep vein was normal and secondary if the deep veins showed post 
thrombotic changes.
In 1923 Berberich and Hirsch described their first attempt at phlebography using 
strontium bromide and later Ratchow introduced the first water soluble contrast 
medium. By 1938 Dos Santos described a clinically applicable technique of 
phlebology. In 1940 Bauer used these techniques to define the state of the deep veins 
in patients with Deep Venous Insufficiency (DVT). He later went on to show that the 
use of heparin prevented further progression of thrombosis, and described the sequel 
of DVT known as post thrombotic syndrome.
Linton in 1938 described the operation of subfascial ligation of perforator veins on the 
medial lower leg communicating veins. By measuring pressures in the GSV at the 
ankle Pollack and Wood showed the differences in lying and standing as well as the 
drop in pressure during exercise. Cockett & Elgan Jones (1953) described ‘Ankle
17
blow-out syndrome’ and the role of the incompetent perforating veins in the 
pathogenesis of this process. He also went on to outline the treatment by extra-fascial 
ligation of the incompetent veins (Cockett 1955). Later in 1956, along with Dodd, 
Cockett went on to publish “The Pathology and Surgery of the Veins of the Lower 
Limb” which became the standard textbook at the time.
The modem treatment of varicose veins, as will be outlined later, has evolved as a 
continuing process in the quest for its cure. It becomes apparent that varicose veins as 
a pathological entity have been with the human race since the beginning of medical 
history and continue to be a burden despite leaps in medical technology and 
knowledge.
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1.2 ANATOMY
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Figure 1 Figure showing the superficial venous anatomy (reproduced courtesy o f Mr B Price)
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A thorough understanding of venous anatomy is essential in the treatment and 
investigation of varicose veins. Although there are a large number of variations, the 
venous systems within the lower limbs can broadly be divided into two, namely the 
deep and the superficial system of veins. The deep fascia is a thickened fibrous layer 
which forms a complete investment in the muscles and fuses with the periosteum over 
subcutaneous bony points of the lower limb. The superficial system runs in the layer 
superficial to the deep fascia, whereas the deep venous system lies deep to the deep 
fascia of the leg. Veins which traverse this fascia and join these two systems of veins 
are called Perforator Veins (PV) or communicating veins. These are also subdivided 
into direct perforators, connecting the superficial veins to the deep axial veins, and 
indirect perforators connecting the superficial veins to the veins and sinuses of the leg 
muscles. The superficial, deep and perforator system of veins contain valves which 
only allow uni-directional flow of blood. In the superficial and deep system the flow 
is caudal, and in the perforating system, from the superficial to the deep veins. As will 
be seen later by the use of the muscle pump and valves the veins transport blood from 
the foot towards the heart.
1.2.1 Superficial Venous System of the Lower Limb
The toes on each foot are drained via dorsal digital veins which receive tributaries 
from the plantar digital veins and form the dorsal metatarsal veins. These in turn unite 
across the proximal metatarsal bones to form the dorsal and planter venous arch. The 
medial marginal vein drains the medial aspect of the dorsal venous arch and continues 
as the GSV ascending anterior to the medial malleolus. The lateral marginal vein 
drains the lateral aspect of the arch and continues as the Small Saphenous Vein (SSV) 
ascending posterior to the lateral malleolus (fig. 2).
20
In the sole of the foot, the superficial veins form the plantar cutaneous arch across the 
root of the toes and also drain into the marginal veins. Proximal to this arch there is 
the plantar cutaneous venous plexus within the fat of the heel, which also drain into 
the marginal veins as well as the plantar cutaneous arch.
1.2.2 The Greater Saphenous Vein (GSV)
The GSV ascends anterior to the medial malleolus, along the postero-medial border of 
tibia and within the superficial fascia accompanied by the saphenous nerve. It is at 
this level that the saphenous nerve (supplying sensory fibres to the medial aspect of 
the calf and the foot) can be damaged as a result of stripping of the GSV or avulsions 
of varicosities. At the level of the knee the GSV arches posterior to medial plateau of 
the tibia and medial condyle of femur. It then runs proximally along the medial aspect 
of the thigh to join the Common Femoral Vein (CFV) at the Sapheno-Femoral 
Junction (SFJ) by piercing the deep fascia of the thigh at the saphenous opening (fig 
1). This aperture in the deep fascia is approximately 3cm infero-lateral to the pubic 
tubercle and is called the cribriform fascia.
The GSV contains 10-20 valves (Tibbs et a l. 1992) allowing uni-directional flow of 
blood towards the heart. It has important but variable number of tributaries just before 
its union with the CFV, namely the superficial (and often the deep) external pudendal, 
superficial epigastric vein and superficial circumflex iliac veins (Mcminn 1990). 
Within the thigh the antero-lateral and postero-medial cutaneous veins drain into the 
GSV.
The posterior arch vein drains a fine network around the medial malleolus and 
ascends along the postero-medial aspect of the calf to join the GSV distal to the knee 
joint. There are major perforating veins connecting this tributary to the posterior tibial
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veins (PTV) lying deep to the fascia. An anterior tributary ascends along the dorsum 
o f  the foot often joins the GSV at the knee.
C om m unication 
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Figure 2 Figure depicting venous anatomy (reproduced by permission of Mr B Price)
1.2.3 Small saphenous vein (SSV)
The lateral marginal vein continues as the SSV behind the lateral malleolus. It ascends 
lateral to the tendo-calcaneus. It then pierces the deep fascia and ascends medially 
within the calf to lie in the midline ascending on the gastrocnemius muscle. It 
emerges between the two heads o f  gastrocnemius to terminate in the popliteal vein 
typically 3-7 cm above the knee joint within the popliteal fossa. Its termination is
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often variable and can join the popliteal vein below the knee, GSV via the antero­
lateral or postero-medial veins of the thigh or more rarely it may drain into the 
femoral vein, the common femoral vein or even tributaries of the internal iliac veins. 
Within the calf it ascends in proximity with the sural nerve (Gray 1995). The 
Giacomini vein, is a superficial vein which, when present, connects the GSV and SSV 
along the posterior aspect of the thigh.
1.2.4 Deep Venous System of the Lower Limb
The deep veins of the lower extremities, accompany the corresponding arteries (fig. 
3). The plantar plexus in the planter region of the toes, give rise to the plantar digital 
veins. These unite with the dorsal digital veins giving rise to the four plantar 
metatarsal veins. These veins connect, via perforators, with the dorsal veins and 
continue to form the plantar venous arch. Medial and lateral plantar veins 
communicate with the GSV and SSV and form the PTV behind the medial malleolus. 
PTVs accompany the posterior tibial artery and receive tributaries from the muscle 
compartments; in particular the soleus venous plexus, the superficial veins and the 
peroneal veins.
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Figure 3 Deep venous anatomy (reproduced by permission o f Mr B Price)
On the Dorsum o f  the foot the dorsalis pedis veins accompany the corresponding 
artery, and form the paired anterior tibial veins (ATV) at the ankle. At the distal 
boarder o f  the popliteus muscle the ATV and PTV unite to form the popliteal vein
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(POV). Medial and lateral Gastrocnemius veins usually drain directly into the POV. 
The POV is at first medial then posterior and finally postero-lateral to the popliteal 
artery as it ascends with in the popliteal fossa to the aperture within the adductor 
magnus where it becomes the femoral vein (FV). This vein accompanies the 
corresponding artery and travels from the postero-lateral aspect of the artery to its 
medial aspect as it ascends within the adductor and femoral triangles. It receives 
profunda femoris vein (PFV) to become the common femoral vein (CFV). This vein 
lies within the medial compartment of the femoral sheath (in between the artery and 
the femoral canal). It receives tributaries (a variable number which may also drain 
into the GSV), including the GSV itself just before ascending behind the inguinal 
canal as the external iliac vein.
1.2.5 Perforating Veins
There are four groups of perforating veins within the leg, namely those within the 
foot, medial and lateral calf and those within the thigh (Gloviczki & Bergman, 1997, 
fig. 1 & 2).
Within the foot most of the perforators have no valves and connect the superficial 
veins such as the dorsal venous arch, the greater and small saphenous veins to the 
dorsalis pedis or medial and lateral planter veins.
Cockett Perforators
The most important perforators are located on the medial aspect of the calf, and are 
named after Cockett:
Cockett I -  behind medial malleolus
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Cockett II -  7-9cm proximal from the medial malleolus, 2-4cm from the medial edge 
of the tibia.
Cockett III -  10-12cm proximal from the medial malleolus, 2-4cm from the medial 
edge of the tibia (Golviczki & Bergan et a l ) .
The Cockett perforators connect the posterior arch veins (or a tributary of the GSV) 
with the PTV.
Paratibial perforating veins are usually within 1 cm of medial edge of the tibia. 3 
independent clusters usually exist lying 18-22cm, 23-27cm and 28-32cm from the 
medial malleolus. The majority of these connect the tributaries of the GSV to the deep 
veins.
Boyds perforator lies 35cm from the medial malleolus and 2cm from the tibial edge, 
connecting the GSV or its tributaries to the PTV or POV.
Indirect perforators are randomly distributed mostly in the proximal calf. On the 
postero-medial side of the calf indirect perforators arise from the SSV and connect 
with muscular sinuses or veins which drain the gastrocnemius and soleus muscles into 
the deep veins.
Peroneal perforator is a direct perforator connecting the tributaries of the SSV and 
the peroneal vein (include Bassi perforator, 5-7 cm from lateral malleolus and the 12 
cm perforator).
On the antero-lateral side of the calf direct perforators connect the anterior tributaries 
of the GSV with the paired ATV.
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Within the thigh there are many perforators joining the deep system to the GSV. Two 
of note are groups on the medial side, the Dodd’s perforators and the Hunterian 
perforators connecting the GSV with the proximal POV or the FV.
1.3 PHYSIOLOGY
The function of the venous system in the leg is to return the blood from the lower 
limb to the heart. In the supine position the pressure at the level of the right atrium is 
0-2 mm Hg and 15 mmHg within the foot veins. Hence there is a pressure difference 
of 13-15 mmHg driving the blood back towards the heart (Browse et al..).
In the erect posture the column of blood between the heart and the foot exerts a 
gravitational force which increases the pressure within the veins of the foot. This 
increase in pressure is proportional to the column of blood between the right atrium 
and the foot (hpg, h = height of column of fluid, p = density of the fluid and g = 
gravitational acceleration). In order for the blood to return to the heart in the erect 
position a “pump” is required to overcome the increased pressure on the venous side 
of the leg circulation. Such physiological pumps exist and are discussed below.
Venous blood flow is directed by valves within the walls of the vein. These are 
bicuspid valves made from collagen covered by endothelium. They prevent blood 
from flowing away from the heart. The valves within the PV and communicating 
veins prevent blood from flowing from the deep to the superficial system of veins. 
This is reversed in the foot where PV valves prevent blood from draining from the 
superficial veins into the deep veins within the muscles of the sole of the foot.
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1.3.1 The Venous Wall
The wall of the veins like those of the arteries comprise of three layers (Gray 1985): 
Tunica Intima - Containing a layer of endothelium, a subendothelial layer of fine 
connective tissue and an elastic or fenestrated layer which forms the main bulk of this 
layer.
Tunica Media - Transverse muscle layer. The thickness of arteries are mainly due to 
this layer. The nervous supply to these muscles is chiefly from the sympathetic system 
which form a fine plexus around the larger vessels.
Tunica Adventitia - External connective tissue coat. Vasa vasorum (nutrient vessels 
arising from a branch of the artery or neighbouring vessels) penetrate this layer and 
provide the vessels with a blood supply. Minute venous systems accompany these 
vessels along with lymphatics and nerves.
The main difference between these layers in the arteries and veins is that there is a 
comparative lack of the muscle layer and a much smaller amount of elastic tissue 
within the vein walls. The veins also function as a reservoir of blood with two thirds 
of the circulating blood volume within the system at rest. This volume can readily be 
reduced by rapid cardiovascular reflexes, metabolites and circulating vasoactive 
substances which can result in an increase in venous and arterial muscle tone. The 
vein walls also have the ability to collapse when not filled with blood. In this manor 
venous tone plays an important role in the distribution of blood volume, control of 
body temperature and blood pressure.
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1.3.2 Valves
The valves present in the venous system function to direct the flow of blood and are 
bicuspid in structure. They comprise of reduplication of the inner coat reinforced by 
connective tissue and elastic fibres and are covered by endothelium on both surfaces. 
The valves are attached to the vein wall at the convex edge of their semi lunar valves. 
The concave end is free and lies in close opposition to the vein wall during the correct 
flow of blood. Once regurgitation occurs the valve cusps become distended their 
edges are brought into contact and regurgitation interrupted (Gray 1985).
The position of these valves in the lower limbs is inconsistent. There is invariably a 
valve at the proximal end of the GSV which is thought by some to be important in the 
development of venous reflux (Basmajian 1952, Cotton 1961, Eger 1943). The valves 
in the perforating veins of the leg (excluding the foot) are arranged to allow blood 
flow from the superficial to the deep system.
1.3.3 Venous Pump
The veins within the lower limbs act as reservoir chambers whose content is pump 
towards the heart by the contraction of the surrounding muscles within the lower limb. 
The valves with in the veins direct the blood caudally and prevent it from falling 
down towards the leg. The pumping mechanism comprises of:
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1.3.3.1 The Foot, Calf, Thigh, Abdominal and Thoracic Pumps
The foot pump acts to expel blood with in the venous vessels within the foot. The 
tightening of the plantar aponeurosis and coordinated contraction of the foot muscles 
in conjunction with slight changes in the position of the foot arches result in ejection 
of venous blood proximally into the leg, via the superficial and deep system of veins. 
The soleal sinuses and gastrocnemius veins are intra-muscular venous sinuses and the 
posterior tibial, anterior tibial and the peroneal veins lie in between these muscles 
(inter-muscular). These inter-muscular veins are not subjected to as higher pressures 
as the intra-muscular veins and hence act as the outflow tract for the foot veins during 
walking. All these veins join up to form the main exit point of the calf pump, the 
popliteal vein. As this vein ascends within the subsartorial canal in the thigh it is 
protected from pressure produced by thigh muscle contraction. It then ascends into the 
abdomen and later the thorax, and is subjected to intermittent positive and negative 
pressures produced by respiration.
The superficial system does contribute to the pumping mechanism as it is squeezed 
against the skin during muscular contractions. As these pressures are lower than the 
deep compartments, the valves ensure that blood within this system flows up the GSV 
veins into the femoral and popliteal veins or directed into the deep system via the PV. 
As well as the named communicating veins there are many unnamed vessels which 
drain blood into the veins deep to the fascia. The valves within these veins are 
arranged so that flow from the deep to the superficial system is not permitted under 
normal conditions.
When the muscles within the deep compartment of the leg contract the pressure 
within the intramuscular veins reaches in the region of 200-300 mmHg. The pressure
within the intermuscular veins rises to 100-150mmHg (Browse et al. 1999). The flow 
from the deep to the superficial veins is prevented by closure of the valves and blood 
is hence directed towards the outflow tract.
During the phase of relaxation of the calf muscles blood then flows from the 
superficial to the deep system (Bjordal 1970). At the moment when the calf muscles 
begin to relax the deep veins are collapsed and unfilled by the arterial flow. The 
superficial veins meanwhile are full and subject to hydrostatic pressure plus the 
remnant of cardiac generated pressure, the ‘vis a tergo’. The pressure difference 
between the two systems is hence in the order of 100-110 mmHg, enabling flow from 
the superficial to the deep system. This reduction in volume in the superficial system 
is associated with a reduction in pressure within these veins (Beecher et a l. 1936) and 
the venous pressure of the foot which is essential for preservation of healthy skin and 
subcutaneous tissues. The absence of this mechanism is thought to be responsible for 
venous pathology.
During inspiration the diaphragm is flattened and the intrabdominal pressure is 
increased and obstructs venous return. Simultaneously the intrathoracic pressure 
decreases encouraging venous return from abdomen into the thorax. Once the 
inspiration phase is over the intrabdominal pressure decreases and the venous return 
from the limbs recommences.
Changes in the volume of the limb during exercise (venous pump function) can be 
assessed, by a variety of investigations (Photoplethysmography (PPG), air and strain 
gauge plethysmography and foot Volumetry) and an assessment of the efficacy of the 
pump function made. The ‘gold standard’ in the assessment of calf pump function is 
foot vein pressure monitoring or ambulatory venous pressure monitoring (Nicolaides 
et a l. 1981). This is an invasive procedure and is not used as a diagnostic tool.
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However it has been used to validate other non invasive tests mentioned above as will 
be discussed below.
1.3.4 Failure of Pump
The failure of the venous pump can arise as a result of two broad factors which can 
co-exist. Musculo-skeletal failure results from pathology affecting the contraction of 
the muscles and movement of the joints of the lower limb. The normal articulation 
and contraction of these muscles and joints are essential to the normal function of the 
venous pump and their failure can result in venous hypertension and Chronic Venous 
Hypertension (CVI) (e.g. disuse atrophy, neurological damage, vascular insufficiency, 
joint disease etc).
The failure of the venous valves, be it primary or secondary, is the other factor which 
in the long run can lead to venous hypertension, as a result of continuous reflux of 
blood.
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1.4 AETIOLOGY
Venous insufficiency has been broadly divided into three types, i.e. Congenital, 
Primary and Secondary. The fundamental deficiency in all of these however is that of 
failure of venous valves.
1.4.1 Congenital Venous Insufficiency
These are very rare conditions ranging from aplasia to rudimentary non functioning 
valves.
1.4.2 Primary Venous Insufficiency
The aetiology of primary venous insufficiency remains an area of intense research and 
discussion. It has not as yet been conclusively proven whether it is the valves which 
primarily fail leading to vein wall failure or primary vein wall failure leading to 
secondary valve failure. Trendelenburg suggested that the venous valves protect the 
distal vein wall from the hydrostatic pressure of the veins above. He believed that 
varicose veins began when the highest valve in the GSV became incompetent. 
However this suggestion is now disputed due to the discovery of varicosities within 
the tributaries of the GSV without evidence of GSV incompetence (Abu-own et al.
1994) leading to the ascending theory discussed later in this chapter. Also the early 
dilations seen in varicosities were found to be distal to the valves as opposed to 
proximal making their position difficult to explain by the theory of ‘back pressure’ 
(King 1950, Cotton 1961).
There are many predisposing factors associated with varicose veins. These include 
age, sex, race, weight, height, pregnancy, diet, bowel habits, occupation, heredity,
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alcohol, clothing and erect stance. The Basle study (Widmer 1978) showed a steady 
increase in prevalence with age in apparently healthy people. Other studies have 
confirmed these finding (Coon et al 1973). With regards to gender, Callam (1994) in 
his review of epidemiology of varicose veins found there to be a clear female 
predominance in the prevalence of varicose veins with a female to male ratio of 
between 1.5:1 and 3.5:1, depending on the definition of varicose veins used.
With respect to race and geographic location there is limited good evidence to make a 
conclusion. However Callam cites the first direct comparison in the United States 
National Health Survey of 1961, which states that 24.1% of the whites complained of 
varicose veins versus 10.4 of the blacks. This was a questionnaire survey and may be 
very subjective. In another study (Mekky et al 1969), questionnaires were sent to 500 
women cotton wool workers in Egypt and England who were also examined. Of the 
English women, 32.1% varicose veins versus 5.8% of the Egyptian women. Callam 
also quotes a more recent study performed by Maffei in Brazil (Maffei et al 1986). 
This also showed a higher prevalence of varicose veins in the white (49%) versus the 
non-white (36%) race.
Pregnancy has also been shown to have an impact on the development of varicose 
veins. This was seen by Beaglehole etal. (1976) looking at Maoris and Pakehas in a 
New Zealand population and also by Maffei looking at the Brazilian population. 
Beaglehole found that females with varicose veins had a greater parity than those 
without varicose veins and also the severity of the varicose veins increased with 
parity. Maffei found a clear correlation between prevalence of varicose veins and 
number of pregnancies. However Coon’s and also the Basle study failed to show the 
same findings. It is thought that the changing hormonal milieu is causing venous 
distension of veins, as well as the compression of the iliac vessels by the enlarging
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uterus, may be responsible for increased incidence of Varicose veins (VV) after 
pregnancy.
Obesity has been consistently shown to be a risk factor in the development of varicose 
veins (Sadick 1992, Abramson etal. 1992). A high body mass index (BMI) is found to 
be a more important risk factor in Women than in Men. A strong case for genetic 
predisposition can also be made. The risk of developing varicose veins was found to 
be higher in those with affected first degree relatives. Gundersen and Hague (1969) 
showed that the proportion of patients with varicose veins that had a relative with 
varicose veins was higher than the general population (females 43%, males 19%). 
Comu-Thenard etal. (1994) examined the first degree relatives of patients with 
varicose veins and compared them to a control group. He found a 90% risk of 
developing the condition if both parents had varicose veins, 25% for males and 62% 
for females if one parent was affected. Browse et a l. (1999) considers occupation, 
posture and clothing as secondary aetiological factors and sites papers by Santler et 
al, who studied policemen with varicose veins, and Lake et al who surveyed a 
department store in New York, as two epidemiological studies which found a higher 
incidence of varicose veins in occupations which involved standing.
1.4.3 Secondary Venous Insufficiency
Secondary varicose veins are due to post-thrombotic damage, pelvic tumours, 
pregnancy, and acquired or congenital arterio-venous fistulae. In the post-thrombotic 
syndrome the sequel of thrombosis in the deep or superficial system may manifest as 
persistent venous hypertension (persistent exposure of the veins of the leg to increased 
pressures as a result of venous pump failure, Belcarogr al. 1995). This may be due to
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continued chronic reflux or obstruction to the venous outflow. This is commonly also 
referred to as Secondary venous insufficiency.
1.4.4 CEAP Classification
In 1995, under the auspices of the American venous forum, the International 
Consensus Conference on chronic venous disease developed the C (Cause) E 
(Aetiology) A (Anatomical Distribution) P (Pathophysiological dysfunction) 
classification of venous disease (Reporting standards in venous disease: an update
1995). This largely replaced the clinical class 0-3 (Reporting standards in venous 
disease 1988).The later classification concentrated on anatomy and clinical severity as 
follows:
Class 0 Asymptomatic
Class 1 Mild CVI with mild to moderate ankle oedema, mild discomfort,
usually superficial veins only.
Class2 Moderate CVI with hyper-pigmentation of gaiter area, moderate
fibrosis, without ulceration.
Class 3 Severe CVI with chronic leg pain, pre-ulcerative skin changes, eczema,
severe oedema, usual involvement of deep venous system.
The CEAP classification was designed in order for there to be a means by which to 
standardise patients with varicose veins and accurately compare limbs involved in 
medical and surgical trials.
Clinical Classification (CO-6)
There are seven categories in this aspect of classifying each limb. These are 
Class 0 No visible or palpable signs of venous disease
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Class 1 Telangiectases, reticular veins, malleolar flare.
Class 2 Varicose veins
Class 3 Oedema without skin changes
Class 4 Skin changes due to venous disease (Pigmentation, venous eczema,
lipodermatosclerosis)
Class 5 Skin changes as per class 4 plus healed ulcer
Class 6 As per class 5 plus active ulceration
Aetiological Classification (Ec, Ep, Es)
As described earlier venous dysfunction can be Primary (Ep), Secondary (Es) or 
Congenital (Ec).
Anatomical Classification (As, Ad, Ap)
The anatomical classification involves the division of sight of reflux into Superficial 
(As), Deep ( Ad)  and Perforator ( Ap).
Pathophysiological Classification (Pr,Po)
The pathological cause of venous disease may be as a result of obstruction to outflow, 
reflux disease or both. A multitude of tests exist to distinguish between these two 
pathological process (Porter et al. 1995).
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1.5 PATHOGENESIS
The number of theories put forward to explain the development of varicose veins and 
their consequences such as fascio-cutaneous changes, goes some way to show that 
varicose veins are probably multifactorial in origin.
1.5.1 Primary Varicose veins
There are two opposing schools of thoughts with regard to pathogenesis of varicose 
veins. The first is that the primary failure is that of the vein wall leading to valvular 
failure. The second is that primary vein valve failure leads to secondary wall changes 
and failure.
With the failure of the vein wall the valve cusps become disturbed and incompetent. 
Cotton (1961) and King (1950) have shown that the dilation of the vein wall starts 
distal to valves and hence unlikely to be as a result of backpressure from failing 
valves. There is also evidence showing that the elasticity of vein walls are reduced in 
varicose vein walls compared to normal limbs. Clark et al. used simultaneous 
measurement of calf volume changes (using occlusive plethysmography) and dorsal 
foot pressures to calculate and elastic modulus (K):
AP
K= -----------
AVWo
There also appears to be reduced elasticity within the vein walls of patients at high 
risk of developing varicose veins (history of factors strongly associated with varicose 
veins such as family history, standing occupation etc.) than normal legs (Clark et al
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1989, Clarke et al 1992). Clarke et al. go on to suggest that this loss in elasticity 
precedes the development of varicose veins and has a role in its development.
Rose and Ahmed (1986) noted an increase in amount of abnormal collagen fibres in 
the structure of varicose vein walls. They have suggested that what happens at a 
cellular level in the development of varicose veins, is an imbalance between collagen, 
muscle cell and elastic fibre, resulting in a loss of contractility. Venturi et al. (1996) 
using markers for collagen and elastin found that the dilations of varicose veins were 
directly related to the decrease in elastin content of the vein wall in these areas. They 
also found that non-dilated areas of the same veins had normal structure within their 
walls. They however did not find a significant difference in the collagen content of 
varicose veins as compared to normal vein walls. They concluded that the dilation of 
the veins were related to a reduced synthesis or accelerated catabolism of elastin. 
Further support for the hypothesis that biochemical and functional abnormalities 
develop with in the vein wall came from Lowell et al. (1992) and Barber et al (1997). 
Lowell et al submerged venous rings in organ chambers and observed their 
contractility in response to various stimulants (potassium chloride, endothelin 
(endothelium derived contraction factor) and noradrenaline). They found reduced 
contractility of rings of varicose vein removed from patients with varicose veins when 
compared against normal vein segments (normal excess segments used in bypass 
surgery). Barber et al supported this by showing that varicose vein walls had reduced 
contraction to endothelin-1 as opposed to normal vein wall. They also found a 
reduction in the number of endothelin-B receptors (receptor for an endothelial derived 
contracting factor) on varicose vein endothelium, corresponding to the reduced 
contractile response. They suggest that the increase in levels of endothelin-1 could 
account for the down regulation of the endothelin-B receptors.
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Primary valvular defects are thought to be due to abnormalities in the structure of the 
venous valves. Ludbrook (1986) suggested the failure of one valve owing to high 
pressure from above may cause the valve to become overloaded and damaged with 
continued damage of the valves below. He had already shown that proximal 
incompetence of valves preceded the changes seen in varicose veins (Ludbrook 1963). 
However he was unable to ascertain whether it was the inherent defect in the vein 
wall that led to the valves becoming incompetent or a primary defect within the 
valves.
Corcos et a lls  (2000) histological work into defective valves showed that the 
development of primary venous insufficiency was due to structural changed in the 
valves which included dilation of the annulus and hypertrophy of the cusps.
Boisseau (1997) in his paper explains that valvular sinuses allow vortices to be 
created with in them. The blood moves slowly here and under normal condition of 
movement these empty rapidly. Conditions of hyper-viscosity and stasis result in 
deposition of red cell aggregates and leukocytes. These are hypoxic areas which cause 
endothelium activation and damage and the adherence fibrin-leukocyte nidus and 
thickening of the sub-endothelial layers which become thrombogenic. Subsequently 
the coagulation system is activated resulting in thrombin formation and ultimately 
incompetent valves which cause skin venous hypertension. This role is important in 
deep vein thrombosis but its role in Chronic Venous Insufficiency (CVI, prolonged 
venous hypertension) is uncertain.
1.5.2 Descending Theory
Trendelenburg having introduced high saphenous tie as the surgical treatment of 
varicose veins, suggested that the venous valves served to protect the vein wall below
40
it from the hydrostatic pressures of the column of blood proximal to it. He believed 
that once the highest valve in the GSV gave way, the increased pressure burden led to 
varicosities, and hence suggested ligation of the SFJ.
Ludbrook (1963) measured static and dynamic venous pressure at different levels 
within the GSV in patients with severe varicose veins, mild varicose veins and normal 
subjects. He found that valvular incompetence preceded the changes associated with 
varicose veins. He concluded from this that the incompetence of the SFJ preceded 
development of distal varicosities.
1.5.3 Ascending Theory
The descending theory of valvular incompetence in the pathogenesis of varicose veins 
began to be questioned as a result of high recurrences following high saphenous tie as 
suggested by Trendelenburg. Furthermore, cadaveric anatomical studies in non- 
varicose vein subjects have shown that in 20-40% there is an absence of valve in and 
above the common femoral vein and yet no varicose veins had developed. Further 
work has shown there to be no correlation between the absence of this valve and GSV 
incompetence (Basmajian 1952, Eger & Casper 1943, Powell & Lynn 1951).
Cotton (1961) in his anatomical study of normal cadaveric GSV veins and veins 
stripped at surgery, found that varicosities did not occur below the terminal valve 
(Most proximal valve nearest to SFJ), but most commonly found below the sub 
terminal valve. He also noted the presence of varicosities further down the leg in 
some 9 out of 40 of operated patients in the absence of a saphenous varix. He found 
difficulty in explaining the lack of varices below the terminal valve in the early stages 
of varicose veins but does suggest that the development of varicose veins may not be
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solely due to the effect of increased pressure on the wall or that if the sapheno- 
femoral valve is the last to become incompetent it appears to have been affected least. 
Alexander’s (1972) stated that analytical study which reviewed the evidence for the 
descending theory left him wanting, as the evidence which he submitted was 
inconsistent or opposed the basis on which the descending theory was based.
A large series of patients (500 limbs) referred for cosmetic leg veins were scanned by
Thibault et al. (1990). They were divided into four groups on clinical assessment:
-Spider veins only
-Varicose veins only
-A combination of above
-Clinically normal
They found the incidence of below knee GSV reflux to be the highest and the 
incidence of SFJ incompetence to be the lowest in all four groups, which stands 
against the descending theory.
In order for the descending theory to be acceptable the ligation of incompetent SFJ 
must result in abolition of reflux within the GSV or prevention of further varices from 
developing. However Mcmullin Etal (1991) showed that ligation of the SFJ without 
stripping of the GSV failed to control reflux in the GSV in just over 50% of their 
patients (24/52). Lofgren et al. (1957) published their operative findings in 510 
recurrent varicose veins. Of the 488 recurrence associated with the GSV, 197 of them 
had had adequate ligation of the SFJ previously and yet in all of these patients reflux 
persisted in the remaining GSV. As the GSV had been treated by sclerotherapy 
following the original ligation, the GSV was found to have recanalized up to the 
upper third of the thigh or higher. They found that despite SFJ ligation the 
recanalisation progressed from distal to proximal. In patients with inadequate SFJ
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ligation at the first operation the recanalisation was observed in both proximal and 
distal directions.
Further more, a number of studies have shown a refluxing GSV in the absence of SFJ 
incompetence (Abu-Own etal 1994, Labropoulos et al. 1994, 1997). Abu-Own et al. 
having noted the relatively common occurrence of this finding performed Duplex 
Ultrasound (DU) on 167 consecutive patients referred to them. They found that in a 
third of patients with GSV reflux the SFJ was competent. In most cases they could not 
attribute this to Incompetent Perforator Vein (IPV) as only 5 limbs showed IPV. They 
have surmised that the function of the valves may be to protect the capillary and 
venuole systems from large fluctuations in pressure and that valvular failure may start 
distally and progress proximally.
Jutley et al. (2001) reviewed their Duplex Ultrasound (DU) results on 223 limbs 
referred to their vascular laboratory with primary uncomplicated varicose veins. They 
found 30% of these patients to have an intact SFJ despite signs of varicosities. The 
majority of these were caused by IPV with in the thigh and the calf. These findings 
have also been shown by Singh et al. (1997, 52% with varicosities and competent 
SFJ) and Somjen (1995, 34% with segmental reflux in GSV with competent SFJ). 
Labropoulus et al (1994) correlated the anatomical extent of reflux with clinical signs 
of patients with superficial venous insufficiency. He also found that in 123 patients 
with reflux confined to the GSV, 40% had an intact SFJ. The group also found that 
patients with segmental below knee reflux were symptomatic of disease with 
significantly higher rates of aching swelling and skin changes. The group went on in 
1997 to perform DU on three groups of patients which they felt represented the 
progressive nature of the disease. These groups were those with no symptoms, with 
prominent veins but no varicosity, and those with varicose veins. They found reflux in
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the below knee GSV to be the most common finding (68%) in all three groups, and 
only a third of the limbs with above Knee GSV reflux had SFJ incompetence.
They also showed multi-segmental reflux within the limbs of the lower limb which is 
not explained by the descending valve failure theory and the fact that distal reflux was 
more common in all groups again pointed towards an ascending progression of 
disease. They also suggest that the calf pump function, duration of symptoms, extent 
of disease, pattern and amount of reflux to be influencing factors in disease 
progression since the prevalence of distal reflux was similar in all three groups. They 
go on to site functional, morphological and biochemical studies which show 
segmental venous wall damage irrespective of position of the valves. Seidle et al. 
(2004) also suggested that Labropoulos’s theory had some merit since in a group of 
1712 patients attending a clinical for mostly cosmetic varicose veins, 43% (735) had a 
competent saphenous system.
Descending valvular failure, as suggested by Trendelenburg, does not account for 
many cases of varicose veins. Also the recurrence rate following a high tie negates the 
descending valvular theory. There appears to be other mechanisms at work which 
may account for surgical failure and recurrence following treatment based descending 
theory of pathogenesis.
1.5.4 Fascio-cutaneous Changes
Fascio-cutaneous changes are seen in CVI with severe calf pump dysfunction. The 
changes seen within the legs range from dermatitis, venous ‘stars’ and dilation, hyper­
pigmentation, oedema, lipodermatosclerosis, skin atrophy and finally ulceration. 
These changes are more commonly seen within the gaiter area of the legs. Intra- 
dermal venules become dilated under increased pressure and become fine dilated
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veins prone to localised thrombosis. They are most commonly found around the 
medial malleolus where they are referred to as ankle flare (Browse 1983). 
Pigmentation around the gaiter region is as a result of haemosiderin laid down by red 
blood cells which have been extruded through the inter-endothelial pores. 
Lipodermatosclerosis describes the progressive fibrosis of the skin and subcutaneous 
tissues induced by the high venous pressures (Browse 1983). In its chronic state the 
skin around the gaiter area becomes contracted with oedema above it and is refereed 
to as the ‘Inverted champagne bottle shape. All the signs described occur as a result of 
impaired tissue nutrition and oxygenation, which ultimately may lead to ulceration, 
often following innocent trauma to the gaiter area.
1.6 EPIDEMIOLOGY
The true epidemiology of venous disorders cannot be accurately assessed. This is due 
to the wide variation of the disease and a lack of uniformity of definitions, 
classification, and investigation along with lack of standardised diagnostic criteria. 
Callam (1994) in his review of the epidemiology of varicose veins attempts to pay 
particular attention to these variables and points out the differing variables of the 
studies which he reviews.
1.6.1 Varicose Veins
Galium estimates the prevalence of visible tortuous varicose veins in an unselected 
population of westerners over the age of 15 to be 10-15% in the male, and 20-25% in 
the female. In the Framingham study, 1720 men and 2106 women free of varicose
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veins were followed up for a 16 year period. The two year incidence was on average 
39/1000 in men and 52/1000 in females. The incidence was higher in women than 
men in all age groups except 80-89 (Brand et al 1988, Debacker 1977). Age had no 
significance effect on the incidence in each sex, unlike the community survey carried 
out by Abramson et al. (1981). He found the incidence of varicose veins in a 
community in western Jerusalem to be 10% for men and 29% in women and they both 
rose with increasing age.
In Basle Study III, the prevalence of all grades of varicosity in a sub-population of 
healthy Swiss workers was 56% in men and 55% in women. Twenty percent of the 
men and eleven percent of the women had trunk varices (Widmer 1978).
In a study by Maffei et al. (1986) the prevalence of varicose veins in a population of 
1755 Brazilians, was 47.6%. He also showed a female preponderance. Beaglehole 
(1976) found the prevalence of varicose veins to be 36.3 % in the male and 47.4 % in 
the female Maoris in New Zealand, and 21.6% and 40.4 % in the Pekehas race.
The Edinburgh Vein study is a cross sectional survey with a target population of 18- 
64 years old. The participants were an age stratified random sample selected from the 
computerised age-sex register of 12 general practices. Of the 1566 people examined, 
age adjusted prevalence of trunk varices in this Edinburgh population was found to be 
39.7% in Men and 32.2% in women in the age group of 18 to 64. In contrast to the 
Widmer, they found trunk varices to be more common in men than women (33.3 % 
versus 26.2 %). They also found that 80% of the 1566 of the random sample of people 
they examined, had hyphen web and reticular varices (Evans 1999).
Overall it would appear that varicose veins are more prevalent in females than males 
in most studies. The incidence with increasing age increased in one study and the
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Framingham study found the incidence of varicose veins to be 39/1000 in men and 
52/100 in women.
1.6.2 Fascio-cutaneous Changes
Fascio-cutaneous changes are seen most commonly around the gaiter region and are 
the long term sequel of CVI. These changes include oedema, hyper-pigmentation, 
dermatitis and weeping eczema, lipodermatosclerosis and ultimately ulceration.
Most of the published studies do not quote the prevalence of fascio-cutaneous 
changes. Callam (1992) in his review of prevalence of leg ulceration concludes that 
approximately 1% of the population are likely to have had leg ulceration but only 0.1- 
0.2% are open ulcers at a single point in time. Coon et al. (1973) found the incidence 
of these leg changes in the Tecumseh community to be 3% in men and 3.7% in 
women, rising to as high as 20% in the over 70 year olds. In the Brazilian study by 
Maffei, the prevalence of active or healed ulcer was 3.2% in men and 4% in women. 
In the Basle III study, 15% of subjects had CVI with no prevalence for men over 
women. However the age adjusted prevalence of CVI was 9.4% in men and 6.6% in 
women in the Edinburgh vein study. In this study gender differences were not found 
to be statistically significant when the grades of severity were analysed individually.
1.6.3 Primary and Chronic Venous Insufficiency
In all the studies carried out on the epidemiology of varicose veins, none differentiates 
between primary and secondary varicose veins. Therefore no accurate data exists with 
respect to quantify the relative contributions of the two pathologies.
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1.7 INVESTIGATIONS OF VEINS
Accurate investigation and diagnosis are the basis of medical treatment. Confirming 
the correct clinical suspicion is essential in planning treatment of venous disorders. 
Venous examination alone is unreliable in accurately diagnosing venous reflux and 
anatomy (Hoar et al. 1984, Singh et al. 1997). The correct anatomical mapping of the 
vascular system is vital to these treatments and a number of different investigations 
fulfil this need. The available modes of investigation provide functional as well as 
anatomical information which help to confirm the clinical suspicion and plan 
treatment. However none of the available diagnostic tools provide complete 
information. It is important to know for each test which part of the venous anatomy 
and function it measures and its accuracy.
The ideal investigation must have a high accuracy, sensitivity, specificity and positive 
and negative predictive values. It should be non-invasive, reproducible and practical, 
enabling it to give the maximum amount of information with regards to anatomy and 
function of the venous system. This information would allow a clinician to plan his 
treatment effectively. Since no such tests exist at present, one often has to rely on 
more than one investigation for the accurate picture.
1.7.1 Investigation of Venous Anatomy
Not all the investigations mentioned here have stood the test of time or are in 
everyday use but they are included for completeness.
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1.7.1.1 Phlebography
1.7.1.1,1 Ascending Phlebography
Investigators in the past have thought ascending phlebography to be the best standard 
against which other new method of investigation of lower limb venous reflux should 
be measured (Baker et al. 1993, Lea Thomas & Bowles 1986).
This process involves the use of x-ray contrast medium to delineate the area of 
interest. It is an invasive form of investigation which has become safer by the 
introduction of low osmolality contrast medium (Browse et al. 1999).
In the lower limb, a vein within the foot is cannulated and a tourniquet applied 
proximally depending on the area of interest. In order to observe the deep venous 
system the tourniquet is often used to occlude the superficial venous system at the 
ankle and also above the knee, without disrupting the arterial flow. If the superficial 
system is not occluded by a tourniquet, a confusing picture may ensue making any 
interpretation difficult. Under screening, contrast medium is then injected in to the 
foot vein. Films from various angles are taken from the foot to lower inferior vena 
cava. Valsalva manoeuvres distend the veins and assist in assessing valve function. 
Manual calf compression, simulate the calf pump and assessment of outflow can be 
made as well as outlining IPV. Tilting beds and valsalva manoeuvres are also used to 
delay venous emptying allowing better visualisation and assessment of deep vein 
incompetent valves. By placing a radiopaque ruler on the table, an assessment of the 
position of the perforator can be made. However with the advent of duplex 
ultrasonography deficiencies in this test have been shown, in particular with respect to 
identification of segmental reflux.
49
1.7.1.1.2 Varicography
The direct injection of contrast media into a varicosity can outline the superficial 
system involved as well as communication of the varicosity with the deep system. 
With the examining table in the foot down position, the contrast is injected. The dense 
contrast medium then enters the leg and any incompetent perforators lower down. The 
table is then flattened and radiographs taken of the superficial system before the table 
is placed in head down position. This allows the contrast medium to travel to the groin 
and images are taken of the SFJ. Again by the use of a radiopaque ruler one can 
estimate the position of these communications. However, due to the fact that the 
contrast is travelling from the superficial system into the deep, no assessment of the 
valvular function is usually possible. Therefore an assessment is made as to whether 
the communications seen are abnormal in architecture (tortuous, dilated veins, usually 
> 3mm, which do not taper distally. Browse et al. 1999, Lea Thomas & Keeling 
1986).
This invasive investigation is dependent on the pathway taken by contrast media and 
may possibly miss abnormal communications, such as IPV.
1,7.1.1.3 Saphenography
Saphenography is used to outline the GSV and SSV usually before use as grafts in 
cardiac bypass procedure. The procedure is similar to ascending phlebography, but 
the GSV is cannulated if possible and no tourniquets are applied. By manual 
compression of the popliteal vein along with tilting of the table the whole of the GSV 
can be visualised. This test has now been replaced by non invasive duplex ultrasound
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mapping, which is non-invasive, does not involve ionizing radiation and can clearly 
show defects with in the walls of the vessels.
1.7,1.1.4 Descending Phlebography
This procedure is used to assess retrograde flow within the lower limbs. The femoral 
vein is cannulated and contrast injected in the supine position while the patient 
performs valsalva manoeuvres. The contrast will be seen descending down 
incompetent valves, and the lowest level of reflux can be used to grade the reflux (0- 
4). An assessment of the sapheno femoral incompetence and the GSV can also be 
made since any reflux of medium into this vein is abnormal. However as has been 
discussed in ascending theory of varicose veins (Pathogenesis), the SFJ and proximal 
valves in legs affected by varicose veins may be competent with reflux and 
malfunctioning valves more distally. Clearly this procedure has its deficiencies and 
has been replaced by DU.
1.7.1.1.5 Complications of Phlebography
Phlebography is an invasive technique and carries complications related to the 
contrast medium used:
The use of non-ionic low osmolar contrast medium has reduced the systemic and 
idiosyncratic reactions observed with earlier contrast media. According to Browse et 
al. up to 5% do suffer with mild systemic upsets such as nausea and vomiting. Severe 
reactions such as bronchospasm, and severe systemic anaphylaxis are rare and require 
intensive resuscitation. Local complications of the effect of the contrast media include
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local pain, thrombophlebitis, chemical cellulites in cases of extravasation of the 
media.
Non contrast related complications concern the technique used. This includes air 
embolus pulmonary embolus and arterio-venous fistula. Also the radiation exposure 
of the patient during the procedure needs to be considered.
The complications and disadvantages noted above are all overcome by colour duplex 
imaging, which is non invasive with no side affects and gives both an anatomical map 
and a functional assessment of the venous system.
1.7.1.2 Ultrasound (US)
Ultrasound allows non invasive assessment of patients with venous and arterial 
disease. Austrian physicist Christian Doppler (1805-1853) described the Doppler 
effect of sound waves. Essentially he showed that the frequency of sound emitted by a 
moving object increases on approaching a subject and decreases on moving away. 
This principle is applied to observation of moving blood within a vessel and the 
changes in frequency converted to audible or visual outputs of choice (sound or 
graphical). The frequency shift is expressed as:
2Fo X V X COS0 
AF = -----------------
Where:
F = Frequency shift
C/Fo = Wavelength of ultrasound
V Cos0 = Closing speed between the erythrocytes and the Doppler probe.
(Bernstein 1993)
The US apparatus fundamentally consists of a piezoelectric crystal which acts as the 
source of the sound wave, and a second crystal which acts as receptor of sound waves
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reflected off the surface of blood vessels. These crystals convert pressure waves into 
electric signals, and electric signals into mechanical vibrations. In this way they act as 
both transmitter and receptor of ultrasonic sound. The frequency of the sound waves 
emitted by the crystal within the probe is determined by the number of oscillations per 
second of the source. Diagnostic ultrasound for medical purposes uses frequencies in 
the 1-20 MHz range, which can be varied depending on the indication for the test.
The velocity of ultrasound in tissue determines the travel time between the transducer 
and the moving blood vessels. Continuous wave ultrasound isonates everything with 
in the path of the beam and does not determine the site of moving cells. However 
when the sound is transmitted in bursts (pulsed, or gated) the site of from which sound 
is reflected can be determined since the speed of sound in the tissue is known and the 
time interval can be calculated:
PRF = C/2d
Where:
PRF = Pulse repetition frequency 
C = velocity of sound in tissue 
d = distant to reflector
Greyscale or B-mode US is another application of the use of US. This does not look at 
moving particles with in the tissue but provides a virtual image of the region under 
examination by analysis of the backscatter or echoes from the interfaces in the tissues 
of differing echogenecity (different amplitudes of reflected sound). These reflected 
waves are of differing intensity and are transformed in to images; black representing 
absent signals, white strong signals and shades of grey for the intermediate signals. In 
this way an virtual two dimensional image can be created. Real-time applications of 
B-mode (real time US or two dimensional echo) allows assessment of both anatomy
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and motion by rapid generation of static images (15-60 per second) which produces 
the impression of motion.
1.7.1.2.1 Real Time Ultrasound (two dimensional echo)
This system produces a virtual image of the region under examination. This type of 
probe (2 MHz) enables analysis of the structure of the tissues of differing 
echogenicity. Augmented by the use of colour, it can produce virtual images of 
interested areas.
1.7.1.2.2 Duplex Ultrasound
In this system a pulse wave Doppler system is combined with a B-mode system to 
produce real time images and motion in combination (fig. 4, 5). This allows study of 
the vessels and haemodynamic properties using Doppler and visualisation of the 
vessels and anatomy by the B-mode. This examination is improved by the use of 
colour to represent the blood moving away or towards the probe (Doppler shifts for 
each pixel represented as red and blue depending on whether the shift is due to the 
blood moving away or towards the probe). Also the intensity of the colour represents 
the velocity of the moving blood. This form of imaging is known as colour duplex or 
Triplex.
Colour duplex does have its limitations. The simultaneous two dimensional images 
produced are of a poorer quality than echography mode alone. The optimal angle of 
the beams differ for that of echography and Doppler and rapid movement of the probe 
can cause colour interference. A further development. Power colour duplex which
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assesses the perfusion and not direction of flow (usually depicted as orange colour) 
and is also particularly useful in outlining lesions with the vessel wall.
1.7.1,2.3 Choice of Frequency
The probes used in us examinations contain different piezoelectric crystals which emit 
differing frequencies of ultrasound. The frequency used in each examination is 
determined by the depth and diameter of the vessel to be studied along with the 
experience of the examiner. Low frequency probes (2 MHz) are used for deeper 
vessels e.g. Large abdominal vessels, but are also useful in obese patients. Higher 
frequency probes (5-7.5 MHz) are used to study veins with a diameter of 2 mm. The 
large frequency probes (up to 12MHz) enable very superficial and smaller vessels to 
be studied. Larger frequencies are used to study reticular veins within the skin 
(20MHz).
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MATERIAL REDACTED AT REQUEST OF UNIVERSITY
1.7.1.3 Investigation of Choice
Despite its shortcomings, Venography had been the investigation of choice and the 
gold standard to which other modalities are compared (Baker et al. 1993, Lea Thomas 
& Bowles 1985, Hanrahan et al. 1991, Herman RJ et al. 1980, Meyer et al. 2000, 
Neglen & Raju 1992).
With the advent of improving technology and development of US, phlebography has 
been displaced as the investigation of choice due to its invasive nature and its 
shortcomings. However in order for US investigation to be useful it has to be accurate 
and reproducible and compare well with established ‘Gold standards’, however poor 
this method of assessment may be. A number of studies have compared the different
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modalities as well as comparing their findings with operative findings which have 
been used as the gold standard in some studies.
Valentin et a l  (1993) in their prospective study compared the venographic (ascending 
and descending phlebography) findings with DU finding in 23 limbs with CVI. These 
findings were assessed against the patient’s clinical findings. They found DU to be 
more accurate in explaining the clinical findings than venography. Descending 
venography only showed venous disease in 39% (increased to 94% with the addition 
of Ascending venography) of patients with obvious varices and venous ulceration, 
whereas DU had a sensitivity of 95%. Other studies have confirmed such poor finding 
with descending venography (Ackroyd et a/.(1986) 31% in proven post thrombotic 
damage and 19% of patients with lipodermatosclerosis, Herman et al. (1980) 36% and 
38% respectively, Neglen & Raju (1992) 17% and 21% with corresponding DU 
findings being 56% and 79%). An explanation for these findings may be the presence 
of a competent valve in the proximal part of the femoral vein making evaluation of 
the distal part of the vein difficult.
Baker et al. (1993) compared DU with descending phlebography in 79 limbs with 
venous abnormality on ascending Phlebography (23 with post thrombotic changes) as 
well as foot volume plethysmography. They found good agreement between the DU 
and ascending venography with respect to deep vein reflux. The half refilling time 
correlated well with the DU findings but not with descending phlebography. As 
descending phlebography can only detect refiux distal to the first competent valve, it 
did not detect segmental refiux below a competent valve in 12 patients which were 
detected duplex scanning. Since 11 out of these twelve patients had post-thrombotic 
damage on ascending venography or abnormal foot volumetry, these were assumed to 
be pathological refluxes missed by descending phlebography. Duplex was also found
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to be more sensitive in detecting reflux in the deep and superficial system below the 
knee.
Phillips et al. (1995) showed DU to be as accurate as ascending venography and 
Varicography in assessment of sapheno-femoral and sapheno-popliteal junctions, but 
did cast a doubt on the ability of duplex to assess IPV (Phillips & cheng 1996) as will 
be discussed below.
In 1989 Van Bemmelen et al. described the quantitative segmental evaluation of 
venous reflux with duplex ultrasound scanning. They used rapidly deflating 
pneumatic cuffs to simulate venous haemodynamics and measured venous reflux 
times and velocities in normal subjects. They found the deflation of the distal cuff 
(calf) was the only method that allowed reproducible quantitative measure of reflux to 
be assessed in all segments of lower limb. Neglen & Raju et al. used this method to 
compare DU finding with phlebography and compared these test to the clinical 
severity stage of the patient (Reporting standards in venous disease 1988). They found 
duplex findings to directly reflect the clinical severity stage of the limbs. Descending 
phlebography failed to identify reflux in 8 limbs in which DU had indicated severe 
reflux. Haemodynamic testing in all 8 limbs were consistent with venous disease as 
was their clinical findings. This may be explained by the presence of a proximal 
competent valve or obstruction within the venous system of these legs which prevents 
reflux being shown distally.
Also in nine limbs the opposite occurred, i.e. no reflux on DU but severe reflux on 
phlebography. Haemodynamic tests on these patients were normal with only slight 
clinical signs of venous disease. This may be explained by the trickling effect of the 
heavier contrast medium, or alternatively that phlebography is more sensitive to
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minimal reflux, however these do not correlate well with the objective functional 
assessments in the same way as DU.
Quantification of venous reflux by means of DU has also been shown to correlate well 
with fascio-cutaneous changes. Vasdekis et al. (1989) found that the venous reflux 
(measured in millilitres per second) was associated with skin changes if reflux was 
greater than lOml/s irrespective of site of reflux.
Overall DU appears to be an accurate non invasive technique which compares well 
with phlebography and in some studies surpasses venography in the assessment of 
patients with venous disease and is now becoming the gold standard for venous 
investigations (Mqcqx et al. 1998, Renton etal. 1991 ordered, Singh et al. 1997, Welch 
et al. 1996.)
1.7.1.4 Assessment of Incompetent Perforator Veins
With respect to incompetent perforator veins (IPV), ascending phlebography is 
thought to be able to localise 81% of IPV (Lea Thomas et al 1972), which can be 
increased to 90% by the addition of varicography (Lea Thomas & Bowles 1985). 
Clinical examination and continuous wave ultrasound correlate poorly to presence of 
IPV as assessed by duplex ultrasound (Schultheiss et al. 1997).
Phillips & Cheng in their paper cast doubt on the ability of DU to detect IPV when 
compared against ascending phlebography, as they found that they could only identify 
40-60% of IPV. However they had no means of confirming the IPV found on DU and 
venography (their gold standard) since exploration of the calf was not performed in 
any of these subjects.
A comparison of Colour duplex ultrasound, ascending phlebography and clinical 
examination was the basis of a paper by Antoch et al. (2002). They used these
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modalities to look specifically at IPV within the calf which were then confirmed at 
operation by retrograde blood flow in the perforator on calf compression. They found 
the sensitivity of DU to be superior to that of ascending phlebography with a 
sensitivity of 80%. This figure was improved if combined with clinical examination 
but the addition of ascending phlebography yielded no advantage.
Hanrahan et a l (1991) found 35 IPV at operation ( Rob operation) in 19 patients. The 
criteria for inclusion was based purely on the diameter (>4 mm) of these vessels at 
operation. The same number of IPV were found by ascending venography, which also 
used the diameter of the IPV as the basis of inclusion of IPV. Only 26 (74%) of these 
IPV were found on DU. Duplex did show a larger number of perforators than 
venography, some of which were of a larger diameter than the limit used for surgery 
and venography. However these perforators did not exhibit reflux and were hence 
assigned as competent. The group concluded that DU may be more accurate in 
assessing functional assessment of perforator veins than venography and hence a 
higher number of IPV were found on venography which may not have been 
incompetent despite their diameter.
The confirmation of DU finding with respect to IPV is perhaps best done at surgery 
although no definitions exist with respect to IPV found at surgery. Steigler et al
(1994) found the accuracy of DU in localising IPV to be 95.8% when compared to 
operative findings. This was confirmed by Dixon et al. who compared operative 
findings with DU findings and found DU to be 100% sensitive and 93% specific with 
respect to position of the IPV. Pierik et al. (1995) in their prospective study of 20 
consecutive patients found the sensitivity and specificity of DU in predicting the site 
of perforating veins on the medial side of the calf to be 79.2% and 100% respectively 
for IPV and 82.5% and 100% for competent perforating veins. Meyer et al. (2000)
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carried out a similar study in 89 legs looked at Cockett’s perforators. They found an 
excellent correlation between IPV perforators found by DU (n=76) and ascending 
phlebography (n=76) as compared with operative findings of the perforators at 
surgery (SEPS, n=83).
Overall it would appear that DU is an accurate and non invasive method of imaging 
IPV and correlation with ascending phlebography and surgical findings are good.
PeiToraU)!' \^ in .
Figure 5 Colour DU showing flow within a perforator vein crossing the fascia
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1.7.2 Investigation of Venous Function
These tests identify correct and incorrect function of the veins. Of special importance 
with respect to varicose veins is the function of the venous valves. These techniques 
include:
Tourniquet Tests
Continuous Wave Doppler Ultrasound 
Descending Venography 
Foot Volumetry
Ambulatory Venous Pressure Measurement
Plethysmography
Doppler Colour Flow Imaging
1.7.2.1 Tourniquet Test (Trendelenburg Test)
These are a series of clinical tests aimed at delineating sites of venous incompetence. 
The venous system of the leg is emptied by elevation of the leg above the level of the 
heart with the patient in supine position. A tourniquet is applied across variable 
positions on the lower limb, tight enough to occlude the superficial venous system. 
The patient is then asked to stand again and if the veins above the level of the 
tourniquet fill, whilst those below it stay collapsed the incompetence must lie above 
the level of the tourniquet. However if the veins below the tourniquet fill rapidly there 
must be an incompetent communicating vein below it. The tourniquet can be applied 
at differing levels in order to more accuracy locate the point of incompetence.
There are several problems with this assessment that makes it fallible and operator 
dependent. The position of valves within the venous system are estimated and the
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tourniquet applied accordingly. Also this examination is not able to detect reflux 
below a competent valve since it is dependent of gravity for refilling of the veins.
1.7.2.2 Continuous Wave Doppler Ultrasound
These are the simplest Doppler ultrasound machines used and are usually in hand held 
portable sizes. They use two piezoelectric elements which act as transmitter and 
receiver. They emit continuous waves which reflect off particles and result in a 
change in the frequency of the waves (refer to ultrasound previously). These reflected 
sounds are then received and the alteration in the frequencies (Doppler shift) are 
converted to audible or visible outputs which allow assessment of movement of 
blood. Due to the continuous and simultaneous emission and reflection of the sound 
no specific information can be given with regards to depth and position of the veins.
i. 7.2.2.1 Gated or Pulsed Doppler
Pulsed Doppler allows detection of blood flow at a specific defined depth (refer to 
ultrasound above). This system has a single piezoelectric crystal which alternatively 
acts as source and receiver for the sound waves. By selecting the time interval 
between these two processes it is possible to localise signals emitted from specific 
depths.
Multi-channels systems now exist which allow simultaneous measurement of 
velocities in various neighbouring vessels and using an algorithm calculate a flow 
volume quantity.
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1.7.2.3 Foot Volumetry
This method uses an open water filled plethysmograph. The patient stands, ankle deep 
in the temperature controlled water, and exercises (e.g. heel raises). As the blood is 
pumped out of the foot, the volume of water drops which can be measured accurately 
by the use a calibrated pressure manometer. On resting, the refilling of the veins 
results in an increase in the volume. The refilling time is an indication of the severity 
of the reflux. Superficial reflux can be distinguished from deep venous reflux by 
occlusion of the superficial system by application of a tourniquet.
1.7.2.4 Ambulatory Venous Pressure Measurements (AVP)
As discussed earlier (physiology, venous pump), AVP monitoring is the most accurate 
method of assessing calf pump function and assessment of venous insufficiency 
(Nicolaides et al 1981, Bjordal 1970). However due to its invasive nature it is not in 
common use. Mean ambulatory venous pressure during the relaxation phase of muscle 
pump cycle is found to correlate well with the severity of venous disease as well as 
being a prognostic indicator of venous ulceration (Nicolaides et al. 1986).
The process itself involves the cannulation of a vein on the dorsum of the patient’s 
foot (Browse et al 1999). The needle is connected to a calibrated strain gauge. Once 
stable pressure readings are reached, the patient begins a suitable number of 
predetermined leg exercises, followed by relaxation whilst holding onto a support 
frame. Recordings are taken throughout and displayed in the form of a graph 
depicting foot vein pressure against time. The process can then be repeated with the 
application of a thigh tourniquet which is moved up and down the leg to determine the
64
contribution of the superficial system and the lowest level of abnormal 
communication.
1.7.2.5 Plethysmography
Plethysmography measure changes in the volume of structures, in this case the lower 
limb, brought about by the movement of venous blood during calf muscle pump 
action. The variety of different types of plethysmography follow this principle the 
only difference being the method by which they measure this change in volume. In 
this way a quantitative assessment of venous outflow, venous reflux and venous 
volume and outflow obstruction can be made.
The earliest instruments used were water-filled plethysmographs which consisted of a 
water-filled, watertight container in which the body part is immersed. Changes in calf 
dimensions, for example, will displace an equal volume of water which can be 
measured in a variety of ways (e.g. the displaced water is collected into a separate 
chamber where it compresses air that activates an attached spirometer or a sensitive 
pressure transducer, which in turn writes a record on a kymograph). Calibration of 
such systems are easily done by adding a known volume of water and due to the 
variation of volume with temperature the container is maintained at a constant 
temperature.
In principle the process involves raising the lower limb above the atrium to an angle 
of approximately 25° in order to empty the veins. A transducer is placed at the calf 
and pneumatic cuff inflated at the level of the thigh, so as to occlude the superficial 
veins (40-50 mmHg). This results in an increase in calf volume which stabilises 
within a few minutes (Venous volume). The cuff is then deflated and the rate of drop 
in the calf volume measured by the use of the plethysmograph. Maximum outflow and
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2s emptying are the commonest indices used to assess outflow obstruction. The rate of 
venous emptying is proportional to patency of the deep veins although no distinction 
can be made with regards to the position of these occluded veins.
The rate of refilling on standing (Venous refilling time) and variations during exercise 
(heel raises, ejection volume, ejection fraction) with and without superficial vein 
occlusion by a pneumatic tourniquet, can be performed and give rise to a number of 
important indices and can also be used to assess venous reflux and the contribution of 
the superficial system.
Other types of Plethysmography are:
1.7.2.5.1 Strain-gauge Plethysmography
The strain gauge plethysmography is essentially a mercury filled rubber tube which is 
wrapped around the limb. The changed in the volume in the leg causes changes in the 
length of this rubber tube is then reflected by changes in electric resistance of the 
strain gauge.
1.7.2.5.2 Air Plethysmography
Air Plethysmography uses a plastic sleeve surrounding the calf, which can be inflated 
to low pressures (6-8 mmHg). Changes in calf volume are then detected as a function 
of changes in the pressure within the cuff once it has been calibrated.
1.7.2.5.3 Impedance Plethysmography
Impedance plethysmography measures the change in tissue impedance (electrical 
resistance) associated with calf volume change. A high frequency low strength current 
is passed through two electrodes on a limb. Changes in voltage are recorded via two 
other electrodes placed inside the first two. The tissue resistance is related to the
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volume of blood within the limb and hence these changes during exercise can easily 
be measured.
1.7.2.5.4 Photoplethysmography (PPG)
PPG is a non-invasive technique used to detect alteration in blood in the dermal 
circulation. In 1938, Hertzman described a method of using reflected light from the 
skin circulation and correlating it to skin blood content (Hafner et al. 1999, Vermaart 
et al. 1994). Since then PPG has been developed to measure changes in skin 
circulation during exercise. PPG contains an infra-red light source and a photoelectric 
cell which measures reflected light and converts it into graphical representation which 
correlate well with venous refilling times (fig. 7).
This test relates to alteration in the skin blood volumes in response to limb 
compression or exercise. These methods have been used in the lower limb where 
venous emptying and recovery times have been found to correlate with venous 
insufficiency (Abramowitz 1979, Nicolaides and Miles 1987, Rosfors 1990, lafrati et 
al. 1994). Norris et al. (1983) used in vivo calibration of PPG and found good 
correlations between AVP measured invasively and PPG estimations (fig. 7). They 
suggested that this technique if validated by other centres would be a useful non 
invasive method to assess CVI. However, with the advent of ultrasound this line of 
thought was not pursued in to common clinical use.
Contraction of muscles leads to the compression of veins and return of blood toward 
the heart. During the ensuing rest, the blood returns to the lower limb mainly through 
the arterial circulation. If the superficial or deep veins are incompetent, blood will 
reflux down into the limb and hence the refilling time is shortened. By the use of 
tourniquets placed at the ankle and thigh, it is possible to distinguish superficial 
venous reflux from deep venous reflux in the sitting position (Nicholaides & Miles
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1987). This venous refilling time (RT or 90% of refilling time (90%RT)) has been 
shown to be reproducible and correlate well with foot vein pressure recovery time 
(Abramowitz 1979, Nicholaides & Miles 1987, Norris et al. 1988), although there is 
no correlation with mean AVP. It is also important to note that PPG does not give any 
measure of venous blood volume but is used to measure venous refilling time 
following exercise.
The position of the PPG on the limb is important since refilling times can vary by as 
much as 20% depending on the position of the probe (Rosfors 1990). Usually a fixed 
point above the medial malleolus is chosen (fig. 6)
Figure 6 PPG probe in position on the medial aspect of the lower calf.
Nicolaides et al. in their study showed that based on PPG refilling times (90% of 
Refilling Time (RT) used in this study) patients can be divided into three groups: 
Normal valvular function RT = >18s
Superficial venous refiux only RT <18s (increases to more than 18s by obstruction of 
the superficial system by means of a tourniquet)
Deep venous refiux RT < 18s (remains <18s with superficial veins occluded with a 
tourniquet).
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However a linear relationship does not exist between PPG refilling time and mean 
ambulatory venous pressure (a good indicator of venous insufficiency), and hence 
PPG cannot grade the insufficiency but can only detect it.
Photoplethysmography has been used to assess the results of venous surgery and 
improvement in the refilling times following surgery have been shown (Pearce et al. 
1983).
100
AVP
(mmHg)
0
PPG
(tracing)
Figure 7 Figure showing the observed changes with simultaneous PPG and ambulatory venous 
pressure (AVP) monitoring (After Norris et a/. 1983).
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1.8 VARICOSE VEIN SURGERY
1.8.1 Great Saphenous Vein Surgery
Ligation of the GSV near its termination in to the femoral vein has been the main stay 
of surgical treatment of superficial varicose veins. As cited by Browse (1999), 
Trendelenburg (1891) was the first to ligate the great saphenous vein in the treatment 
of GSV incompetence. Keller (1905) and Mayo (1906) went on to describe stripping 
of the GSV and Homans (1916, 1917) published two papers on the treatment and 
classification of varicose veins. He was the first to suggest that the GSV and its 
tributaries should undergo flush ligation at their junction with the femoral vein.
There is now no longer any doubt that stripping of the great saphenous vein is 
significantly superior to ligation alone. It produces a better immediate result and also 
a lower long term recurrence rate (Jakobsen 1979, Logfren et al. 1958, Munn et al. 
1981). However the stripping of the GSV to the ankle was associated with an 
unacceptable high rate of saphenous nerve damage (up to 60%) due to the proximity 
of the nerve to the GSV in the lower calf (Cox et al. 1974, Munn et al 1981, Negus 
1986). Rivlin went on to suggest that if the stripping is halted at a level just below the 
knee, there is less chance of damaging the saphenous nerve and majority of important 
perforators are still avulsed. Dissection of 60 cadaveric legs has outlined the anatomy 
in the region and suggests that stripping the GSV to below knee level would minimize 
the risk of saphenous nerve damage (Holme et al. 1988). Negus using this method 
reduced the post-operative neurological complication to 4.2% in his series of 71 
patients. Sarin et al. (1992 & 1994) undertook a randomised trial in order to compare 
stripping to upper calf against ligation of the GSV alone. They showed there to be no 
significant difference in the incidence of saphenous nerve damage in the stripped
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group (4%), versus the ligation only group (7%). They also showed that post 
operatively (within 3 months) the ligation group had a higher incidence of residual 
GSV reflux and IPV within the calf. The longer term follow up (median 21 months) 
of these subjects with duplex ultrasound and assessment showed a far higher clinical 
recurrence in the ligation group as compared to the stripped group. Jones et al. (1996) 
went on to confirm these findings in their randomised trial and showed a two third 
reduction in the risk of re-operation at 5 years following stripping as opposed to 
ligation alone (Dwerryhouse et al 1999).
There are many variations in the surgical technique of High Saphenous Tie and 
Stripping and multiple avulsions (HST&S). Below is a brief description of one 
technique. An oblique incision is made about I cm or so below the groin crease. 
Dissection is deepened within the subcutaneous tissue to outline the GSV. The trunk 
of the vein is traced caudally to its junction with the femoral vein after piercing the 
cribriform fascia. The junction is clearly dissected out along with all tributaries in the 
region outlined previously (anatomy). These are then doubly ligated and divided with 
non absorbable sutures. The GSV itself is then ligated and divided flush with the 
femoral vein. A small venotomy allows the introduction of a flexible vein stripper 
which is fed down within the vein to just below the level of the knee. An incision is 
made over the lower end of the stripper and the stripper and vein delivered into the 
wound. The vein is divided with the distal end being tied off. The stripper head is 
applied to the distal end of the stripper and a ligature tied around the vein containing 
the stripper just proximal to the head. The stripper can then be removed by steady 
traction, towards the groin.
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1.8.2 Perforator Vein Surgery and Subfascial Endoscopic 
Perforator Surgery (SEPS)
Trendelenburg in 1891, suggested the developed of incompetence of the highest valve 
in the great saphenous vein -  the concept of descending valvular incompetence. The 
failure of these valves means blood can reflux back down the veins, both stretching 
the veins (varicosity), and causing inflammation (eczema and ulceration).
In the 1930s it was found that perforator veins lower down the leg, could also fail, and 
allow blood to leak out of the deep veins, causing excess blood in the superficial 
veins. Linton (1938) began to realise the importance of interruption of the IPV in the 
treatment of varicose ulcers. He began open ligation of perforator veins in the belief 
that they were responsible for venous ulceration and hence their ligation would heal 
chronic venous ulcers. In 1953 Linton began to use a single medial incision, rather 
than the three longitudinal incisions he initially used. Through this he was able to 
access most IPV. Although successful in healing most ulcers (Cockett 1955, Fields & 
Van Boxel 1971, Haeger 1966) this technique was plagued by delayed wound healing, 
flap necrosis and wound infections in up to 58% of the cases (Stuart et al. 1997, Puts 
& Gruwez 1993). Puts et al. confirmed the complications with skin necrosis. However 
they managed to reduce the rate of skin necrosis by 6.7 times in non ulcerated patients 
and 4.2 times in ulcerated patients by the use of a combination of low molecular 
weight heparin and piracetam. Cockett (1955) advised extrafascial ligation of the IPV 
(Subcutaneous) as he felt that the integrity of the deep fascia around the distal soleus 
muscle was important in calf pump function. Dodd (1964) described a postero-medial 
subfascial approach in order to avoid dissection of unhealthy tissue. The Rob 
Procedure described by Healy (1979) used a long “stocking seem incision” to perform 
posterior subfascial ligation and Depalma (1974) used multiple parallel incisions in
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the Danger’s line along the medial aspect of the calf. Unfortunately these procedures 
were found to have very high morbidity (Cockett 1955, Fields & Van Boxel 1971, 
Haeger 1966, Puts & Gruwez 1993, Stuart et al. 1997) and have since been 
abandoned as routine procedure for perforator ligation. Pierik et al. (1997) in their 
randomised trial compared SEPS to modified Linton procedure and had to halt the 
trial at 15m follow-up. An unplanned interim analysis carried out due to perceived 
complication rate in the open technique revealed an unacceptable high rate of wound 
complication in the modified Linton group (53%). They however went on to follow- 
up these patients and found that in both groups the venous ulcer healing rate was 
good. The recurrence rate in the modified Linton group was 22% and in the SEPS 
group 12%. They concluded the long term follow up results of SEPS to be as good as 
the modified Linton procedure (Sybrandy 2001).
Subfascial shearing, a technique described by Albanese (1965, 1969), was probably 
the forerunner to SEPS. An incision is made on the medial side of the upper thigh and 
the subfascial space found. Shearers (blunt instruments invented for the procedure), 
were then introduced into this space and pushed down towards the medial malleolus. 
By manipulating the instrument in this space all the communicating veins were thus 
divided, which often resulted in considerable bleeding from the incision.
Subfascial Endoscopic Perforating Surgery was described by Hauer in 1985 (as sited 
by Browse 1999) and introduced to the UK in the early 1990s. Other European 
surgeons described their experience and improvements on the technique (Couto & 
Bapista 1991, Jugenheimer & Junginger 1992, Pierk 1995, Wittens 1995).
Conrad et al. (1994) in Australia, simultaneously with Golviczki et al. (1996) 
described carbon dioxide insufflation in the subfascial compartment in order to 
improve subfascial visibility and to expand the working space. After exsanguination
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of the limb using an Esmarch bandage, a pneumatic tourniquet is inflated to a pressure 
of 300 mm Hg. At approximately 8 cm distal to the tibial tuberosity and 3cm from the 
tibial edge, a 15mm incision is made and the first 10mm port inserted into the 
subfascial space. Carbon dioxide insufflation is then commenced to a compartment 
pressure of 30 mm Hg. A laparoscope is then inserted in the first port and a second 
10mm port is inserted under direct vision. After the IPV are identified two 10mm 
clips are placed across the vein and which is then divided by the use of endoscopic 
scissors (fig. 8,9,10).
The use of SEPS in primary non ulcerated varicose veins in the UK is undertaken 
selectively (Whiteley 1998) and to date no published randomised trials have assessed 
their use in treatment of primary and recurrent non ulcerated varicose veins. Published 
experiences with SEPS show acceptable results (Conrad 1994, Gloviczki et al 1996, 
1997, 1998, Hauer et al 1988, Pierik et al. 1995, 1997, Rhodes 1998, Stuart et al. 
1997,). In one retrospective study (Jugenheimer and Juginger 1992) post-operative 
wound healing delay was seen in 2.9%, 2 (1.9%) patients complained of dysaesthesia 
in the distribution of the sural nerve and 9.7% in the region supplied by the saphenous 
nerve (they also had stripping of the GSV). Other complications included 
subcutaneous haematoma in 5.8%. New or persisting IPV were found in 2 patients 
after a 27 month follow-up.
At our centre, as will be described in the methods, we use a modified scope and no 
carbon dioxide insufflation. The entire medial aspect of the calf can be visualised and 
accessed by the use of a single specialised 16mm SEPS scope. The IPV are clipped 
but not divided since division of such veins may lead to an increased incidence of 
haematoma which may be mistaken for deep venous thrombosis Kianifard {et al. 
2002).
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Figure 8 IPV as first seen during the operation
Figure 9 IPV dissected out
Figure 10 SEPS clips across an IPV which is divided in this case.
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1.8.3 Perforator Vein Surgery in Primary Non Ulcerated Varicose 
Veins
The place of SEPS in the management of primary non ulcerated varicose veins has 
not been established (Browse etal 1999). The management of patients with IPV in the 
presence of symptomatic non ulcerated legs with and without CSV reflux is unclear. 
Despite an extensive literature search no meaningful studies were found to answer this 
question.
In almost all studies on the subject the pathological IPV were most often seen on the 
medial side of the calf with the lateral aspects almost invariably spared. It is also clear 
that the number of IPV increases with increasing grades of chronic venous disease 
(Delis et al. 1998, Jiang et al. 1999, Labropoulos et al 1995,1999, Nelzen 2000). 
Some studies have also examined the size of the perforator in order to assess a 
correlation with significant reflux. Labropoulos et al (1999) found that the size of 
both incompetent and competent perforators increased with severity of the disease 
with the largest being found in the middle and lower calf. In this study the best cut off 
diameter for prediction of incompetence with in the perforator was >3.9mm in 
diameter. However this only gave a sensitivity of 73% which was in line with other 
studies. Phillips and Cheng (1996) performed US scans on legs of 50 healthy and 90 
symptomatic patients and compared the perforator veins which they found. In the 
control group they found perforator veins in 36% of the subjects, 83% of which were 
< 3mm, non of which exhibited reflux. Of the remaining 17% all were between 3 and 
4mm and again no reflux was seen within these perforators. In the symptomatic group 
78% of the patients had perforator veins, with 18% being < 3mm and 25% of which 
exhibited reflux. Of the remaining 82%, all were >3mm and 54% of which exhibited 
reflux. They recommended that due to missed perforators (lack of sufficient
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retrograde flow of blood) on DU all perforators >4mm should be regarded as 
incompetent regardless of demonstration of reflux. Yamamoto et al. (2002) compared 
pre-operative perforator vein diameters as assessed by DU with intra-operative 
diagnosis of IPV as assessed by bleed-back test. They found that IPV had a larger 
diameter than competent perforator veins and that perforator veins with a diameter of 
>3mm were 80.4% predictive of incompetence and recommended surgery for all 
perforators >3mm. Similar results were found by Sandri et al. (1999) who showed 
that 90% of IPV >3.5mm were incompetent after assessing 500 perforators in 78 
patients.
Labropoulos et al. (1999) compared the duplex finding of healthy volunteers to those 
of patients with chronic venous disease. In the 30 normal limbs which they examined 
they found 106 perforator veins all of which were competent. In those with venous 
disease 581 perforator veins were found in 103 limbs, 28% of which were 
incompetent. They also found 74% of IPV were associated with superficial vein 
reflux alone and the combination of superficial and perforator vein surgery has been 
shown to have a haemodynamic benefit to these patients (Bradbury et al. 1993, 
Padberg et al. 1996, Rhodes et al. 1998). Padberg et al. and Sales et al. (1996) 
showed that segmental deep venous reflux was reversed in patients following such 
procedure. However following stripping of the CSV alone Walsh et al. (1994) found 
segmental deep venous reflux to also be abolished.
The isolated pathological haemodynamic contribution of IPV to chronic venous 
disease has been a questionable one. Some authors have cast doubt on the significance 
of this contribution (Bjord 1988, Bumand et al. 1977, Stacey et al. 1988), whereas 
others have found IPV to be important in the pathogenesis of chronic venous disease
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(Cockett & Elgan Jones 1953, Zukowski et al. 1991, Pierik et al. 1995, Gloviczki et 
al. 1997b).
Zukowski et «/. (1991) measured ambulatory venous pressures in patients with patent 
deep veins. They studied 180 patients with superficial venous disease only. They 
showed a significant contribution by the IPV to the abnormal haemodynamics (as 
measured by the time required for post exercise pressures to return to 90% of normal), 
of primary varicose veins especially in the presence of segmental deep venous reflux. 
Thirty five percent of these perforators were found to be of major haemodynamic 
significance and 35% of moderate haemodynamic significance.
In order to study the isolated haemodynamic contribution of deep, superficial and 
perforating veins McMullin et al. performed ascending phlebography, duplex scans 
and A VP measurements in 90 patients. Seventeen of these patients were found to have 
no deep or superficial abnormality on duplex scanning and phlebography showed all 
of these limbs to have an average of 2 IPV. This group of patients were symptomatic 
and were found to have a Venous Sufficiency Indexes (VSI, a measure of refilling 
time and drop in pressure on exercising) which was significantly lower than those 
with no venous abnormality with in their limbs. They concluded that the 
haemodynamic abnormalities and symptoms were due to the IPV. They also found 
that the VSI of those patients with deep venous insufficiency to be significantly lower 
than those with IPV only. From this they concluded that IPV did not develop as a 
result of Deep venous insufficiency (DVI) and may occur as a primary abnormality. 
Goldman et al. (1994) in their review of varicose veins state that IPV can exist 
independently and cause an increase in deep venous pressure.
The single randomised trial looking at haemodynamic contribution of IPV was 
performed by Fitridge et al. (1999). They randomised 38 uncomplicated limbs to
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superficial surgery with and without flush ligation of the IPV. The patients were 
assessed using air plethysmography pre-operatively and 3 months post-operatively. 
They found no differences between the two groups at 3 months and concluded that 
further follow up is required to assess the impact of perforator surgery in the long 
term.
A much quoted study by Campbell and West (1995) found that 80% of IPV were 
closed at 6 weeks following HST&S. This was a retrospective audit study to assess 
operative treatment for varicose veins and included patients with all manner of 
superficial reflux disease. At their follow up DU assessment (between 2 and 6 weeks 
post operatively) they found that 80% of the previously IPV had become competent or 
showed no flow, despite undergoing no direct intervention. However there was no 
follow up data beyond six weeks to assess the patency of these IPV in the longer term. 
There is evidence of IPV being directly responsible for varicose veins. Jutley et al. 
(2001) reviewed their DU results on 223 limbs referred for symptomatic 
uncomplicated primary varicose veins. They found 30% of the patients to have a 
competent SFJ. In 29% of these, varicosities could be explained by IPV in the thigh 
(47%) and calf (53%). Seidel et al. (2004) found IPV to be responsible for 17% of 
primary varicose veins in 735 patients they scanned with an intact saphenous trunk. 
Their selected group of patients attended their private clinical with mostly cosmetic 
complaints. In a study of 500 consecutive patients awaiting surgery 56.4% of them 
were found to have IPV on DU. (Sandri et al. 1999).
Certainly the association of IPV with recurrent varicose veins has been established. 
Duplex based studies on varicose veins, carried out at our centre have shown an 
increase incidence of IPV in recurrent varicose veins than in primary varicose veins
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(63% vs. 44%, Rutherford et al 2001). Jiang et al. (1999) in their series of 172 
patients with recurrence also found 2/3 to have an IPV.
Labropoulus et al. (1996) reviewed their duplex results of 134 limbs with recurrent 
varicose veins. They found IPV in the thigh and calf to be directly responsible for 
recurrence in up to 50% of their series. One third of all patients who had had previous 
stripping of the GSV had IPV in the calf. Interestingly the same proportion of patients 
were found to have IPV following ligation of the SFJ. This negates the notion put 
forward by Campbell & West that 80% of IPV become competent following HST&S, 
and stripping does not appear to protect against development of IPV.
Similar high rates of recurrence have been quoted by Thibault & Lewis (1992) as the 
cause for recurrent varicose veins (61.5% recurrent limbs with IPV). Tong & Royal
(1995) in their duplex study on 244 recurrent limbs found 25.8% of them to have IPV 
involved in the recurrence and England (1996) in a similar study found IPV present in 
69.2% of his series of 267 recurrent limbs. Other studies quote a much lower rates of 
recurrence as a result of IPV (Corbett et al. 1984, Dwerryhouse et al. 1999, Gamer et 
al. 2003, Redwood & Lamber 1994).
Over all the majority of the studies carried out do not answer the question of treatment 
of IPV in primary non ulcerated varicose veins. Certainly there appears to be 
improvement in the haemodynamics of the limb when perforator surgery is combined 
with superficial reflux ablation, although this is questioned by Fitridge et al (1999). 
Other studies have shown a significant haemodynamic contribution by the IPV to 
venous hypertension. The majority of these studies look at a mixed group of patients 
which include those with SSV, deep vein perforator vein reflux as well as presence of 
ulceration and the contribution of each system to the overall picture is impossible to 
assess. The constant finding of increased number of IPV in primary VV as compared
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to normal legs, and the increase in number of IPV in legs with recurrent varicose 
veins as compared to legs with primary varicose veins, along with the correlation of 
number of IPV with grade of venous deficiency does implicate these perforators in the 
pathogenesis of varicose veins.
1.9 RECURRENT VARICOSE VEINS
Recurrence after varicose vein surgery for primary or recurrent varicose veins, is 
unfortunately common. The reported incidence of recurrence varies widely depending 
on means of assessment and diagnosis, type of procedure undertaken and time of 
assessment after the primary procedure, case mix and clinical classification. However 
the incidence is thought to be in the region of 7 to 80% at 3-10 years (Royle 1986, 
Jones et al. 1996, Darke 1992, Jiang et al. 1999, Campbell et al. 2003, Rivlin 1975). 
The aetiology of such recurrences is probably multifactorial and the numerous studies 
detailing recurrences use differing definitions and methods of investigating (Perrin et 
al. 2000). The common reasons for these recurrences are:
1.9.1 Inadequate or Inappropriate Surgery
1.9.1.1 Failure of Sapheno-Femoral Ligation Or Missed Branches 
at the Junction
Rivlin (1966, 1975) found that 72% of his series operated on for recurrent varicose 
vein had inadequate surgery at their primary procedure. This was also noted by other 
investigators and is thought to be one of the commonest reasons for recurrence 
(Bradbury et al. 1993, Englund R 1996, Glass 1989, Lofgren & Lofrgen 1971, Haeger 
1961, Negus 1993, Stonebridge et al. 1995, Gamer et al. 2003). The recurrences were 
shown in one paper to be more commonly seen in patients operated on by junior
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trainees (Lees et al. 1997), hence emphasising the need for correct training and 
supervision in order to improve the recurrence rates. Turton et al. (1997) found this 
to be remediable by proper supervision of juniors by consultant surgeons and 
sufficient attention to ligation of the junction and the tributaries.
Defining the anatomy of sites of recurrence is imperative in planning surgery. Duplex 
ultrasonography outweighs all other modes of investigation for assessing recurrent 
varicose veins providing a non invasive technique which accurately provides both 
anatomical and functional information (Benabou et al. 1998, Englund 1996, Jiang etal 
1999, Perrin et al. 2000, Tong & Royle 1995). There have been many publications on 
this topic. Redwood & Lambert (1994) found 58% of their 99 patients with recurrent 
varicose veins to have incompetence at the SFJ but they do not distinguish between 
neo-vascularisation and an intact system. Jiang et al. in their paper scanned a series of 
264 limbs all of which had previously undergone sapheno-femoral ligation or 
stripping. Overall 65.2% of this group had a recurrence at the SFJ. These included:
-Pristine SFJ indistinguishable from primary varicose veins with the GSV 
intact ( 17.4%)
-Narrow SFJ - refiuxing into an intact GSV (15.2%),
- refiuxing into local varicosities (11.7%),
- refiuxing into an intact GSV and groin tributaries (6.4%)
-A cluster of small veins communicating with an intact GSV or varicosities 
(11.4%)
-No reflux at the SFJ, but from epigastric or perineal veins (5.7%).
82
Out of 143 patients who had their GSV stripped, 43.3% (62/143) had a GSV or a 
similar vein present in that position. This figure was increase to 73.6% in those who 
were not stripped. Labropoulos et al. (1996), in their retrospective study found 35% of 
their series had SFJ incompetence. Englund in his series of 267 recurrent limbs found 
44.6% of them to have an intact SFJ and GSV.
1.9.1.2 Aberrant Anatomy
At surgery anatomical variations at the SFJ can lead to incorrect surgery performed as 
a result of mistaking the SFJ or the GSV. Browse et al (1999) say that the large 
medial and lateral superficial thigh veins can be mistaken for the GSV and can 
presumably be stripped instead of the GSV. In their experience duplication of the 
GSV occurred in 5% of their patients which again may be a source of erroneous 
surgery. Also they suggest that the numerous anatomical variations of SFJ exist (e.g. 
direct entry of one or more tributaries into the femoral vein) which may cause 
mistakes at operation if the SFJ in not properly exposed.
Jutley et al. (2001) in their retrospective study of uncomplicated symptomatic primary 
varicose veins found an anatomical variation in 24% (53 limbs) of their patients 
which would not have been detected clinically or by hand held Doppler. Fifty nine 
percent of these comprised of splitting of the GSV into two or more within the thigh 
with at least one of these branches eliciting reflux. In 19% the origin of the GSV was 
found to be bifid.
Corrales et al. (2002) suggest that the incidence of duplication of the GSV to be far 
higher than this. They reviewed 109 saphenograms undertaken in preparation for 
peripheral bypass surgery. In almost fifty percent of these they found evidence of 
duplication of the GSV, most being in the form of a closed loop in the thigh. Thomas
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(1979) in his cadavaric study found true duplication of the GSV (i.e. splitting within 
the superficial fascia proximally and rejoining into one channel) to be uncommon 
(8%). This area of error can by enlarge be overcome by pre-operative DU of all 
patients.
1.9.1.3 Incompetent Thigh or Calf Perforators
Work performed at our unit (Rutherford et al. 2001) has shown 44% of patients with 
primary varicose veins have incompetent perforator veins, (0.55 and 0.14 per leg 
associated with great saphenous and small saphenous veins respectively), where as 
63% of patients with recurrent varicose veins have incompetent perforating veins, 
(0.84 and 0.37 per leg associated with great saphenous and small saphenous veins 
respectively). The incidence of IPV in recurrent veins are similar to findings from 
other studies out lined previously (Englund 1996, Jiang et al. 1999, Labropoulus et al. 
1996, Thibault & Lewis 1992, Tong & Royal 1995). Thus there is a significant 
association between both the presence of and the number of IPV, and recurrence of 
varicose veins.
Although 80% of incompetent perforating veins associated with great saphenous 
reflux are thought to become competent in the short term surgery (follow up of 6 
weeks), 20% do not (Campbell & West 1995) and the long term position of these 
perforator veins is unknown. This coupled with the high number of recurrences 
following surgery and the number of incompetent perforators associated with varicose 
veins, suggests that our understanding of pathogenesis of varicose veins is incomplete 
and may implicate a more important role for incompetent perforating veins. Hence 
SEPS used in conjunction with traditional surgery should reduce the rate of recurrence 
in primary and recurrent varicose veins in patients with proven perforator vein
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incompetence. However despite a thorough search of the literature no meaningful 
studies were found to answer this question.
1.9.2 Regeneration I  Neo-vascularization
Glass (1987a) did much to put the idea of neo-vascularisation on the map of recurrent 
varicose veins. He cites work by Langenbeck, and Perthes in the late 19th century as 
the first to note regeneration of new veins following ligation of the SFJ. Later 
Homan’s went on to state that recurrent veins were either as a result of opening of 
collateral vessels in the region or new vessels with in the scar tissue (neo- 
vascularisation). Thereafter the theory of inadequate surgery and missed collaterals 
became more popular and took over as the explanation for such recurrences (Lofgren 
& Lofrgen 1971, Rivlin (1966, 1975), Negus 1993, Lees et al. 1997). Glass performed 
ligation of the SFJ under local anaesthetics aimed at healing venous ulcers. These 
patients then underwent HST & S and multiple avulsions once the ulcer had healed. In 
10 of these patients, he performed insitu phlebography examination and radiographic 
and histological examination of the excised vessels. He showed a fine anastamotic 
network which had developed within the scar tissue between the proximal and distal 
ends of the ligated veins. Histological studies revealed this to be a step by step 
progression of development. At 2 weeks, an organised blood clot occupied the gap 
between the two ends of the veins with blood vessels extending into the area from 
surrounding tissues. At six weeks the thrombus was adherent to the vessel wall with 
evidence of recanalisation with numerous small abnormal vessels extending in 
parallel arrangement into the connective tissue. At 12 weeks muscular walls were 
observed in the wall of these veins, and at 40 weeks the thrombus had resolved 
completely with large thin walled vessels joining the two ends of the veins. By 64
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weeks the walls of the vessels were thicker and contained abundant muscle and elastic 
tissue resembling that of mature recurrent veins. These findings were equivalent to his 
findings in rat models which had undergone surgical interruption of their iliac or 
femoral veins (Glass 1987b). He concluded that a large pressure difference in a vein 
proximal and distal to the site of transection appeared to be necessary for the 
restoration of its continuity. In 1989 Glass published his data and concluded that 
recurrence can be reduced by closure of the cribriform fascia and or covering of the 
SFJ with synthetic mesh.
Since then many studies have shown neovascularisation to be the principle cause of 
recurrence following diligent surgery ( Darke 1992, Van Rij etal 2003, Jones et al 
1996), . Jones et al. (1996) found neovascularisation (serpentine tributaries arising 
from the ligated SFJ) to be the principle cause of recurrence in their study. Fifty two 
percent of their patients followed up by duplex ultrasound as part of randomised trial 
(stripping versus ligation of the GSV) were found to have neovascularisation at the 
SFJ (24/53 in stripped, 35/60 ligated) 2 years post-operatively. All patients with 
tributaries >3 mm were found to have clinical recurrence as did 55% of those with 
tributaries <3mm. Nyamekye et al. (1998) re-explored 28 legs with recurrence at the 
SFJ. They took block dissections of the region which were histologically examined 
for neovascularisation. Twenty seven of the 28 groins showed evidence of 
neovascularisation and it was found to be the commonest cause of recurrence. Of 
particular note was the complete lack of mural nerves (stained with SI00) in these 
immature veins. De Maeseneer et al. (1997) prospectively followed up a consecutive 
group of new patients following surgery. They performed duplex scans at 2 months 
and 12 months post-operatively. All of these patients had pre-operative duplex scans 
and 122 patients underwent HST&S. At the 2 month follow-up scan 2% of the total
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had a small communication (<4mm) at the sapheno-femoral junction. At the 12 month 
scan out of the 122 patients who had undergone stripping 12 had mild neo­
vascularisation (<4mm) and 2 had moderate neovascularisation at the SFJ (>4mm). It 
would seem that with the advent of correct surgery, neovascularisation appears to be 
the commonest cause of recurrence. This finding was confirmed by Van Rij et al. 
(2004). They performed HST&S on 42 patients (49 SFJ) with recurrent varicose 
veins. All but three of these patients (94%) showed neo-vascularisation at the SFJ. 
Histological specimens of these junctions taken during procedure, showed all to have 
abnormal architecture inconsistent with that of a normal SFJ, i.e. neo-vascularisation. 
They further suggest that neo-vascularisation may be as a result of angiogenic stimuli 
from surgery, which is not a general feature of venous surgery since neo­
vascularisation is not observed at sites of GSV harvesting for bypass surgery. This 
implies that the underlying venous abnormality may persist in these recurrent patients. 
They suggest that the endovascular procedures for varicose veins may in this way 
reduce the rates of recurrence since they do not induce a vigorous angiogenic 
response. This has been shown by our comparative study looking at 
neovascularisation following radio-frequency ablation and HST&S (Kianifard et al. 
2005 in press).
1.9.3 De novo Reflux
As outlined by the Framingham study the two year incidence of varicose veins was 
39/1000 in males and 52/1000 in females in a longitudinal study. This implies that 
patients may develop varicose veins following surgery, in the remaining previously 
competent veins of the leg due to thus far undetermined factors.
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1.10 QUALITY OF LIFE ASSESSMENT
The assessment of treatment outcome from the perspective of the patient has gained 
more importance in the modem era of medicine. This enables measurement of the 
effects of treatment on the quality of life of the patients. In order to use instruments to 
evaluate such factors, the tests must be reliable, valid, responsive and practical. 
Attempts to produce such instruments have been in the form of questionnaires which 
have undergone large scale use and modification to become important tools in 
assessment of treatments and quality of life. Broadly these questionnaires can be 
divided into two groups. The first is the generic form of the questionnaires aimed at 
evaluation of the quality of life and health related maters. These questionnaires, such 
as the short form 36 (SF 36) are broad tests which are non specific and aim to 
evaluate the overall health status. The second type of questionnaire is a specific 
instrument which focuses on a particular disease (e.g. Aberdeen questionnaire (AQ) 
for varicose veins). Many investigators in this field advise the concurrent use of these 
questionnaires (Garratt et al 1993a, Patrie & Dayo 1989, Ware et al. 2000).
In order for a questionnaire and the scoring system to be useful, it has to be reliable 
and valid. Reliability is the extent to which measures give consistent or accurate 
results. This entails an estimation of how much of the variation in score is due to the 
truth as apposed to chance random errors. The tests carried out need to examine the 
consistency of the questionnaire by evaluating and comparing the different measures 
designed to measure the same variable (internal consistency).
The stability of the questionnaire i.e. the correlation of the scores on re-testing the 
subjects can also be tested to assess reliability. An important factor in test re-test
procedures is that the time gap between tests must be taken into account with respect 
to the condition, since physical changes noted by the questionnaire may be real ones. 
An alternative method of assessment would be to compare findings with an alternate 
method of measuring the same criteria and comparing the results.
The split-half correlation is a more commonly used method to assess the reliability 
and internal consistency. This compares 2 halves of a test designed to assess the same 
characteristic i.e. scores from questions in the same questionnaire which measure the 
same characteristics. Both halves of the results should produce similar results as 
expressed by coefficient a, the average of the possible split-half reliabilities adjusted 
for the original number of items. Alpha values of > 0.7 are thought to correspond to 
good internal consistency (Cronbach 1951, Jenkins et al. 1993).
Validity, the extent to which the results relate directly to the characteristics being 
evaluated (i.e. testing the underlying theory), can be divided into:
Content validation - Once the internal structure of the questionnaire is 
established, theoretical relationships between the various domains and external 
criteria are outlined based on theoretical knowledge of the criteria being measured, or 
by alternate established tests. One example would be to test the difference in two 
groups known to differ in some way (e.g. patients with complicated medical histories 
should score lower than those with no medical history).
Convergent validity - is supported when different methods of measuring the 
same criteria produce similar result (e.g. physical function and mobility).
Discriminatory validity - tests whether one aspect of the questionnaire can be 
differentiated from another, (e.g. physical function and measure of loneliness)
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Criterion validity - shows that the test scores are systematically related to 
some outcome criteria and requires a known external factor against which the scores 
can be assessed.
1.10.1 Short Form 36 (SF36)
“Psychometrics” is the use of standardised scales or tests to measure the attributes of 
an object. This theory has been used to interpret patient ratings into scales and 
numbers to measure health. One of the most extensive applications of psychometric 
analysis took place during the Health Insurance Experiment (HIE), which attempted 
to devise a scale to measure a wide spectrum of functional status in a broad age group. 
These techniques involved the construction of scales based upon questions asked in an 
attempt to analyse the health status of subjects. The HIE found such tests to be valid 
and reliable, but their application, in the form of long self administered surveys were 
cumbersome due to the number of questions asked. Also their application in disease 
was not as yet established. Subsequently several short form scales based on the 
original questionnaires were devised and used successfully. The Medical Outcome 
Study (MGS) was a further development from HIE, where 40 physical and mental 
health scores were tested in the form of self administered questionnaire to assess the 
impact of components of American health service on the outcome of care. The SF36 
was developed from eight of the most important health concepts included in the MGS 
which best described the overall health status of the individual (Ware et al. 2002). 
These eight attributes are measured using multi-item scales containing 2 to 10 items 
each.
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These are:
Physical function 
Role-physical 
Bodily pain 
General health 
Vitality
Social functioning 
Role-emotional 
Mental health 
Reported health transition
The attributes in the questionnaire are each scored and are summed up to give a total 
out of 100 with higher scores representing better states of health (Ware et al. 2002). 
This scoring system has been used in a number of studies and has been found to 
correlate well with the health of the individuals (Brazier et al 1992, Garrett et al. 
1993a, Jenkinson et al. 1993). Brazier et al. (1992) conducted a survey in 1980 British 
patients using the SF36 questionnaire (anglicised version) and found a Cronbach’s a  
coefficient of > 0.85 and a reliability coefficient of 0.75 for all dimensions of the 
questionnaire except for social function. Very similar coefficients were found by 
Jenkins in his survey of 13042 of the population in the U.K.
Ruta et al. (1994) showed the SF 36 to be reliable as tested on two groups of patients. 
Group 1 included 1787 patients which were divided into 4 groups, back pain, 
menorrhagia, varicose veins and suspected peptic ulcer. These were sub-divided into 
patients referred to hospital and those treated by the General Practitioner. Group 2 
consisted of 573 patients attending the gastroenterology clinic. They tested the
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internal consistency of the device by using Cronbach alpha which was > 0.8 for all 
sections of the SF36 in both groups. The test re-test consistency was expressed as 
correlation coefficients which were 0.66 - 0.93 in group 1 and 0.79 - 0.94 in group 2.
A review of the studies (n=14) undertaken in estimating the reliability of each scale of 
the SF36 questionnaire found a reliability coefficient of 0.8 or more in each scale 
(Ware et al. 2000).
Validity is the extent to which the score pertains to what it is supposed to mean, i.e. if 
it represents the intended interpretation. Content validity requires a pre-existing 
standard measure or sound theoretical basis along which a comparison of results 
found can be made. Construct validation examines both the test and the underlying 
theory by creating a domain of variables with in the questionnaire and establishing an 
internal structure of the observed variables and verifying the theoretical relationships 
between the scale scores and observed criteria. An example of this would be patients 
with known mild conditions should score higher (i.e. better) than patients with 
moderate to severe conditions. The foundations of construct validation are 
convergence and discriminatory validity. Convergent validity is fulfilled when 
different methods of measuring the same object provide similar results. 
Discriminatory validity determines whether one underlying construct can be 
differentiated from another, (e.g. one would not expect a measure of loneliness to 
correlate with physical function).
Criterion validity shows that test scores can systematically be shown to represent one 
or more outcome criteria. In order for this technique to be used the evaluator must 
know what the anticipated result should be by means of comparison with external 
validated evidence. These correlations may be negative (e.g. age and physical health) 
or positively (e.g. physical and mental health scores against general health).
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Garratt et a l  (1993a) was one of the first to validate the SF36 form in the UK. He 
performed a postal survey on 1787 patients which were broadly divided into four 
groups (with back pain, varicose veins, menorrhagia and suspected peptic ulcer 
disease). The source of these patients were identified from referrals from General 
Practitioners or those being treated by the practitioners without a referral to a 
specialist. The response rate was over 75%, reliability was found to be high 
(Cronbach s a  exceeding 0.8) and correlation between items and remainder of their 
own scale was also higher than those with other scales, providing further evidence of 
internal consistency. In this study two methods of validation were used. The first was 
the psychometric test which showed a ‘eigen value’ (statistical measure to explain the 
variations between patients are not by chance), above 1.1 for all sections in the 
questionnaire. Construct validity was confirmed by assuming patient referred by the 
General Practitioners were likely to score lower than those which were not referred, 
and the greatest difference in the scores from the general population were expected to 
be the back pain group and the lowest the varicose veins group. These were by 
enlarge confirmed and correlated well. Although the varicose veins group showed the 
smallest difference from the normal population, the study showed that such patients 
can be distinguished from the general population. Jenkins et a l  1993 also validated 
the SF36 in his large survey of population picked at random fi-om general practices. 
He found patients who had reported a long illness or had attended their General 
Practitioners, consistently and significantly scored lower than the rest. He also found 
good correlation between the items and the variable to which they contribute. Brazier 
et a l  in their study compared the SF36 to the Nottingham Health Profile and were 
able to find the weak points associated with the Nottingham Health Profile. In this 
study 1980 randomly selected patients from General practices were surveyed. They
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found the SF36 to be reliable and valid as their distribution of the scores corresponded 
with what might have been expected, (e.g. higher age and physical function, lower 
social class and health, consultation with GP in last 2 weeks and perceived health).
By its extensive use in clinical settings SF36 has emerged as a reliable and valid tool 
for measuring outcome of health.
1.10.2 Aberdeen Questionnaire
Having assessed the use of SF36 in patients with varicose veins, Garrett et al. went on 
to develop a specific questionnaire for varicose veins based on questions deemed 
relevant by 2 consultant vascular surgeons (Garrat et al. 1993b). The surgeons went 
on to score possible responses to each question allocating zero for normal and a score 
to all other categories in proportion to their perceived contribution to severity. The 
two scores were then summed, averaged and rescaled to produce total scores ranging 
from 0 to 100 (normal to the worst, i.e. the opposite to that of SF36). This 
questionnaire along with the SF36 was distributed to 373 patients with varicose veins 
(287 referred by General Practitioner, and 86 who had just attended the practitioner), 
and 900 random sample of the population. The questionnaire was validated against 
the SF36 scores for each patient. Two out of the fifteen questions they started with 
were discarded since they were found not to correlate with the 4 specific and 
important clinical factors confirmed by the vascular surgeons. This achieved a 
Cronbach’s alpha value of 0.72. All scales of the SF36 were found to correlate well 
with the varicose vein score apart from mental health and general health perception 
(correlation of 0.31 and 0.25 respectively). Garratt et al. (1996) go on to further test 
the use of this tool with respect to the reliability, validity and responsiveness to 
changes in health by following up these groups with a repeat survey at twelve months.
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Further validation for the specific instrument was shown by the correlation of the 
individual items with in the instrument and the SF36 score. Both instruments were 
validated by good correlation with both the practitioners rating of the disease and the 
known complications associated with the condition. Only a few of these results were 
however statistically significant but the majority were in the direction hypothesised by 
the researchers. Patients surveyed at 12 months were divided into those who had been 
admitted to hospital in that period and those who had not. Their score in both 
questionnaires were compared to the health transition question in the SF36 
(‘compared to one year ago, how would you rate your health now?’), and the strong 
relationship between these factors further validates both questionnaires. The largest 
improvement over the 12 months was found in the group admitted to hospital for 
surgery. The health profile at one year in this group was better than the mean found in 
the general population. The profile for the group not admitted to hospital improved 
very little. The sensitivity of these instruments for changes in health was also 
investigated by means of Standardised Response Mean (SRM, the mean change in 
score for a scale divided by the standard deviation of the change). As would be 
expected in patients with varicose veins, the specific questionnaire was far more 
responsive than the SF36. The largest SRMs were found in patients admitted to 
hospital.
This specific questionnaire went on to be called the Aberdeen questionnaire (AQ) and 
in conjunction with SF36 further work in its assessment of varicose veins before and 
after surgery has been carried out. In a prospective study, 137 patients filled out the 
AQ, SF36 and patients symptoms and concern tick box form before and 6 weeks after 
surgery for varicose veins (Smith et a l  1999). The AQ was found to be reliable 
(Cronbach’s alpha > 0.7). Highly significant correlations were found with the patient
95
symptoms and concerns form which further validates the AQ in this setting. Overall 
there appears to be sufficient evidence in support of AQ as a specific tool in the 
assessment of patients with varicose veins.
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2 CHAPTER 2
2.1 METHODS AND MATERIALS
2.1.1 Proposal and Ethical Approval
The lack of scientific evidence in support of, and against the use of subfascial 
perforator vein surgery (SEPS) in primary varicose vein, has led us to the construction 
of this randomised control trial to investigate the use of SEPS in this area. The fate of 
these Incompetent Perforator Vein (IPV) following surgery for primary varicose veins 
is unknown. The prime objective of this study was to assess the effects of varicose 
vein surgery on these IPV as assessed by DU (primary outcome).
In order to assess the effects of SEPS on the fate of IPV we devised a randomised 
clinical trial with one arm of the study undergoing SEPS as part of their surgery. Our 
hypothesis was that the addition of SEPS to HST&S, would reduce the number of IPV 
seen to be refiuxing at one year. Also as secondary outcome measures 
photoplethysmography, quality of life and visual analogue scores, analgesic use, 
operative times, and walking speeds were assessed over a 12 month period following 
surgery.
A proposal for the trial was drawn up along with standard pro forma (appendix 1) in 
relation to the different aspect of the trial. Patient information sheets (appendix 1) and 
consent forms (appendix 1) were also constructed and the trial was approved by the 
Local Ethical Committee (South West Surrey Local Research Ethics Committee).
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2.1.2 Sample Size
From Campbell (1995), 20% of patients will have incompetent perforators after high 
tie and strip versus approximately 5% (P2) to allow for missed perforator ligation at 
SEPS. However clinical experience shows that the number of refiuxing veins is likely 
to increase and an estimation of 40% (PI) at one year seems reasonable. Assuming 
that there will be a difference between these groups that will be apparent on duplex 
ultrasonography (DU):
The expected proportions are 0.40 (PI) and 0.05 (P2).
P1-P2
Hence the standard difference = voa-w)
Where = (PI- P2) / 2
Therefore the standard difference = 0.84
A nomogram (Altman 1999) was used to calculate the sample size with the study 
being power set at 0.95. The sample size for the study was 72 patients to be 
randomised into two groups.
2.1.3 Patient Groups
List of suitable patients were compiled from a thorough and systematic search of 
duplex ultrasound reports and waiting list databases for varicose vein surgery. A 
further source of patients with venous disease was the one stop varicose vein clinic at 
which all newly referred patients with varicose veins were assessed by the vascular
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nurse specialist. If symptoms and signs of varicose veins existed, DU assessment was 
performed at the same clinical appointment.
Prior to inclusion on to the waiting list, all patients had been reviewed by the same
consultant vascular surgeon and had a pre-operative duplex ultrasound scan of their
legs. The duplex scans were individually reviewed and all patients with Small 
Saphenous Vein (SSV) reflux, deep venous incompetence, recurrent Varicose Veins 
(VV), venous ulceration or lack of incompetent calf perforator veins were excluded. 
The exclusion and inclusion criteria used were as follows:
Inclusion Criteria (all of the following need to be present)
-Duplex proven incompetent perforating veins on medial or posterior aspect of 
lower leg.
-Isolated great saphenous reflux in patients with primary varicose veins. 
-Patient able to give fully informed consent.
(In bilateral cases, one leg was randomised to one group with the other leg 
automatically entered in to the other group).
Exclusion Criteria (presence of any of the following would exclude the patient) 
Patients unable to give fully informed consent.
Patients with Duplex proven deep venous reflux or occlusion.
Venous ulceration.
SSV reflux
Essentially all patients with Sapheno-Femoral Junction (SFJ) incompetence. Great 
Saphenous Vein (GSV) reflux and IPV in the calf were considered for the trial. All 
such patients received a postal patient information sheet (appendix 1) outlining the
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trial and its risks. Each patient was also sent a stamp addressed envelope to return 
stating whether they would like to take part or arrange an appointment for further 
information (appendix 1). Those who responded positively were then contacted and 
individual appointments made to discuss the project. All questions were answered at 
these meetings and a consent form signed. The patient’s waiting list card was then 
marked as a trial patient. A pro-forma (appendix 1) was completed for each patient 
and base line tests were performed. These tests were performed in a standard fashion 
and a pro forma completed for each aspect. The tests were as follows:
-Repeat duplex ultrasound (if >6m since last scan or performed by other 
technologists)
-Photoplethysmography PPG 
-Assessment of gait
-Quality of life questionnaires (SF 36 and Aberdeen questionnaire (AQ))
-Visual analogue score
As well as the above, information was collected with respect to:
-CEAP classification for each patient 
-Duration of symptoms 
-Risk factors including BMI
These patients were monitored as they moved up the waiting list. On the day of their 
admission for surgery, each patient was randomised to High Saphenous Tie and Strip 
and multiple avulsions (HST&S) alone or HST&S plus SEPS. A random number 
table was used to assign each leg to the appropriate group (Altman 1999). Both 
groups also had multiple avulsions as appropriate. A consent form was then signed
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and a standardised surgical procedure carried out. It was denied inappropriate for the 
patients to be blinded as they had to consent to the procedure. Also it although the 
assessors were blinded to whether or not the the patients had undergone SEPS, the 
ragiographer was not since the SEPS clips are easily visible on DU.
2.1.4 Operative Intervention
Interventions were randomised into:
Either:
A -  High saphenous tie, strip to below knee and multiple avulsions of visible veins.
Or:
B -  High saphenous tie, strip to below knee and multiple avulsions of visible veins 
and SEPS using the coordinates of the IPV as found on pre-operative DU.
On the day of the operation each patient was consented for the procedure and 
underwent a standard general anaesthetic as preferred by the attending anaesthetist. 
The patients were positioned supine with their legs abducted and resting on a venous 
board. The legs were prepped and draped in the usual manor.
Surgery was performed using standardised methods described below. Post-operative 
bandaging consisted of a layer of cotton wool and a layer of firmly applied panelast, 
which remained undisturbed until the one week follow-up.
2.1.4.1 High Tie and Strip
A transverse skin crease incision was made medial to the femoral pulse. The 
dissection is deepened and the GSV identified and pursued until the SFJ. The 
common femoral vein is then identified and all its tributaries around the SFJ ligated in
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continuity with 3/0 prolene. The tributaries at the sapheno-femoral junction are then 
dissected out and severed and tied in a similar manor.
The SFJ is then divided between two clips and the proximal SFJ is suture ligated with 
3/0 prolene.
The cribriform fascia is then closed with 3/0 prolene and a flexible stripper introduced 
into the proximal end of the GSV. The stripper is fed down to the level just below the 
knee and the proximal end is ligated to the stripper with a long length of vicryl. The 
GSV is then stripped via a small distal incision below the knee thereby insuring the 
inversion of the vein during the stripping process. If the vein were to snap during 
stripping, the vicryl suture is used to re-introduce the stripper and the vein stripped, 
this time with the appropriate head attached to the stripper.
The groin incision is then closed with 3/0 vicryl and the skin incision with sub­
cuticular 3/0 prolene.
2.1.4.2 SEPS
If SEPS was requires a pneumatic tourniquet (Boazul or Ludquvist, fig 11) was rolled 
up to the thigh and inflated to a pressure of 120 mmHg, thereby acting as an arterial 
and venous tourniquet.
The coordination of the perforators were marked on the calf and a vertical 2 cm 
incision made in a suitable position to access the perforators (usually 2 cm posterior to 
the tibial edge). The SEPS scope (Olympus/Keymed), is then inserted into the 
subfascial plane developed by the operator’s finger (fig 12). Two self closing 5mm 
Allport clips (Ethicon Endosurgery), are applied in continuity to each IPV (refer to 
fig. 8, 9 and 10) and the vein is not divided. On completion the skin was closed with 
sub-cuticular 3/0 prolene.
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Figure 11 SEPS procedure
Figure 12 SEPS procedure
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2.1.4.3 Avulsions:
Incisions near the varicosities were made with a beaver blade and phlebectomy hooks 
were used to avulse the dilated veins. All incisions were closed with steristrips. 
Anticoagulation: 5000 iu subcutaneous heparin (unfractionated) at end of
operation.
Post-operative bandaging: Cotton Panalast for one week.
Variables measured during the operation:
1. Time of operation -  HST time, SEPS time and Total time.
2. Blood loss -  weighing of swabs.
3. Number of avulsions performed.
Patient recovery
The factors measured to assess patient recovery were:
-Analgesia requirement.
-Visual analogue score for pain and mobility.
-Return to work/normal and personal diary to assess patient “cost” of the procedure.
All patients were given a diary (appendix 1) to complete on each post operative day 
for 14 days. On a daily basis, they were asked to document the number and type of 
pain relief taken along with the number of episodes of assistance they required to 
carry out their normal daily work, which would otherwise not be needed. They also 
completed a visual analogue score for pain and mobility on each day. At the 6 week 
follow-up appointment each patient was asked the number of days they had taken off 
work or before they could resume normal activity.
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2.1.5 Outcome
All patients were followed up with appointments made for 1 week, 6 weeks, 6 months 
and 1 year post operatively. At each follow up visit a proforma was completed for 
each patient following repetition of the tests undertaken pre-operatively.
Criteria measured:
-Presence of any venous reflux measured by duplex ultrasonography
-Improvement in function measured by refill time by means of
Photoplethysmography.
-Time to walk a fixed distance
-Patients opinion on cosmetic results (Visual analogue score)
-Patients opinion on pain (Visual analogue score)
-Patient opinion on mobility (Visual analogue score)
-Quality of life questionnaires (SF36 and Aberdeen questionnaires)
End point:
Follow up at one year from date of operation.
2.1.6 Assessment
Once the patients had agreed to partake in the trial, a standard form was completed for 
each patient (appendix 1). Included on this form were patient characteristics and 
contact details, history of their VV and their general health, assessment of their risk 
factors and symptoms, CEAP classification, gait assessment, DU findings and 
Photoplethysmography assessment (appendix 1). Patients also completed visual 
analogue score forms as well as quality of life questionnaires (Aberdeen and SF36 
Questionnaire).
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2.1.6.1 Visual Analogue Score (VAS)
The visual analogue score took the form of a 10 cm line along which the patients were 
invited to make a mark corresponding to the aspect of the affected leg being tested on 
the scale. The three VAS were with respect to pain, mobility and cosmetics.
PAIN
No Pain 
At All
The Most Severe 
Pain I’ve Ever Felt
MOBILITY
Full Mobility 
Without Restriction
I am Unable to 
Move At All
COSMETIC VIEW OF LEG
I am perfectly happy 
with the Cosmetic 
Appearance of my Leg
My Leg Could 
Not Look Worse 
Than It Does Now
Visual Analogue Scores
Pain % Mobility % Cosmetic View %
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The VAS was completed by each patient at each visit to the hospital (recruitment 
meeting, 1 week, 6 weeks, 6 months and 12 months). Also the Pain and Mobility 
scores were assigned by each patient for the 14 days following surgery (patient diary 
appendix 1).
2.1.6.2 Gait
A segment of corridor in the outpatients department was measured out (30 meters) 
and each patient was invited to walk this distance at a leisurely pace. They were timed 
performing this task at each visit. An objective assessment of their gate was initially 
made however this was found to be irreproducible and subjective between the 3 
investigators collecting the data.
2.1.6.3 QOL
Each subject completed a self-completed anglicised SF36 form (Baker et al. 1995, 
Brazier et al. 1992), and an Aberdeen questionnaire at each visit. The Aberdeen 
questionnaire was used in this study since at time of conception, it was the only 
questionnaire validated fo use in the UK with respect to Varicose veins.
Subjects with bilateral legs in each trial were asked to complete a separate Aberdeen 
questionnaire for each leg. The participants were advised on how to complete the 
form and asked to complete it fully. Any queries from the patients were answered 
generally without leading the patient towards a specific answer but enabling an 
informed answer.
Each dimension of the SF36 questionnaire was scored separately and out of 100. On 
all scales, the higher scores represent a better health. The questions on the Aberdeen
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questionnaire were weighted and scored by a consultant vascular surgeon who 
assessed the contribution of the content to the severity of the disease. In this respect 
high scores represent worst symptoms.
2.1.6.4 Duplex Ultrasound
All duplex ultrasounds (Siemens Sonoline Antare, Version 3, Siemens Medical 
solutions, Berkshire, UK) performed throughout this study were performed by the 
same senior vascular technologist following a standard protocol. A pro forma was 
completed for each patient on each visit (appendix 1). All patients who had not been 
scanned by our vascular technologist, or who had had a DU study longer than six 
months previous to recruitment, were re re-scanned.
With the patient erect the SFJ is scanned in cross section using colour flow duplex. 
The probe is applied to the skin and the angle and Doppler gate adjusted to gain 
optimum pictures from the system. Standardised Valsalva manoeuvre (Baker et a l  
1993) along with sequential manual thigh and calf compression (Sarin et a l  1994) are 
performed to assess reflux in the deep and superficial systems along the axial veins of 
the leg. Reflux is defined as abnormal flow of blood which lasts longer than 0.5sec in 
all veins (Sarin et a l  1994, Van Bemmelen et a l  1989).
The patient is asked to perform a val salva manoeuvre or a calf squeeze test is 
perform to exhibit reflux at the SFJ. If a doubt exists regarding the outcome spectral 
Doppler settings are used. Using the above manoeuvres the length of the GSV is 
scanned and all other dominant and refluxing tributaries which arise from the groin 
and the GSV. Deep venous competence is then looked for by scanning the deep veins 
in turn.
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The SSV is found in proximal calf in transverse views and the probe rotated 
longitudinally and checked for reflux. The SSV may be of a Giacomini variant and is 
scanned through out its course. With the patient in the sitting position on the edge of 
an elevated examination bed, the calves are then examined for IPV. In the transverse 
section the deep fascia is followed up and down the leg, looking for veins which cross 
this fascia. Each is then examined for reflux (blood flowing from the deep system in 
to the superficial system which lasts >0.5s). The IP Vs are marked and distance 
measured from above the medial and lateral malleolus and the anterior subcutaneous 
boarder of Tibia. All anatomical variations are noted throughout the examination.
The specific segments scanned for reflux are outlined in appendix 1.
2.1.6.5 Photoplethysmography (PPG)
All PPG were performed in a standard fashion in a sitting position (Abramowitz et al. 
1979, Norgren 1988, Pearce et al. 1983, Rosfors 1990) with the legs in a non weight 
bearing position. The patient was asked to sit on the front edge of the seat and lean 
back in to the back support of the seat. The knees are positioned at 45 degrees to the 
horizontal, so that the feet are comfortably rested on the floor.
The PPG sensor (The Dopplex, Assist Range, Huntleigh Diagnostics) was attached a 
distance of 5 cm above the medial malleolus of the affected limb by means of a 
transparent adhesive film. Once the test is started, a base line steady trace is first 
achieved during which the patient is asked to remain as relaxed as possible. When a 
steady trace is reached the 10 second period of exercise begins with a bell emitted 
from the machine which is repeated at intervals of one second. Simultaneously with 
each bell, the patient performed toe raises. At the end of this period the patient is
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asked to completely relax all muscles and sit still within the chair with the foot resting 
on the ground. The tracing is continued until the baseline is reached once again.
This data was recorded on the memory of the machine and was connected to a simple 
printer for hard copies of the graphs representing the changes observe. Each graph had 
a time scale axis using which a value of RT90 (90% of refilling time) for each test 
was calculated and recorded (Nicholaides & Miles 1987, fig. 7)
2.1.6.6 Data Collection
All data for each patient was tabulated and compiled into an Excel spreadsheet. Once 
completed, ten random subjects were chosen and the data input double checked to 
ensure there were no mistakes during the data input process. The differing aspects of 
the data were then divided into smaller spreadsheet and the results of the NSEPSG 
(non SEPS group) and SEPSG (SEPS Group) compared.
The patients were all recruited and had their pre-operative assessment and consenting 
performed by the investigator. The bulk of the follow-up data was collected by myself 
with the help of two additional colleagues who were trained to carry out the 
assessments and data collection (vascular nurse specialist and senior vascular 
technologist).
2.1.6.7 Statistical Analysis
All the data collected in the pro-forma were entered into a Microsoft Excel database 
(Microsoft Corporation, USA). The data were exported into SPSS (Statistical Package 
for the Social Sciences, Version 2003, SPSS Incorporated, Chicago) and analysed.
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The significance of the differences between the two groups with respect to parametric 
quantitative data (e.g. Age, BMI, Surgical time, pregnancy, days off work) was 
analysed using unpaired t-test. Chi-square test was used to assess non parametric 
qualitative data (categorical data e.g. family history, standing, hospital stay, presence 
of IPV) and Mann-Whitney U test was used for ordinal and ranked non parametric 
data ( VAS, QOL, PPG). One way analysis of variance was also used to test these 
data, and displayed in separate tables.
Wilcoxon Signed Ranks Test was used to assess significance of changes observed in 
each group over the 1 year follow-up period. One sample t-test was used to compare 
the pre-operative SF36 scores with the mean population score (Baker et al. 1995, 
Brazier et al. 1992). For all analysis P values calculated were considered to be 
significant if below 0.05 in a two sided test.
During the course of the study two subjects in the NSEPSG were excluded. One 
withdrew from the study and the other underwent SEPS even though she was 
randomised to the NSEPSG. As these two patients (both from the NSEPSG) were the 
only drop outs in the study, it was decided to exclude them rather than treat them as 
intention to treat, as they would have little significance due to the small numbers.
I l l
2.1.6.8 Summary of Outcome Measures
Pre-operatively:
Duplex Ultrasonography
Photography of leg in standard position and in standard lighting. 
Photoplethysmography (PPG)
SF 36 and Aberdeen quality of life questionnaires 
Visual analogue score -  Pain, mobility, cosmetic view of leg 
Observation of gait and time to walk 30metres at own pace
Operatively
Length of operation -  Split into SEPS and total procedure.
Total time in theatre
Blood loss -  weighing of swabs
Number of avulsions performed
Hospital Stay
Patient diary for 14 days, includes:
Visual analogue score -  Pain and mobility 
Analgesia use
Length of hospital stay -  Time and date medically able to leave
Time and date actually left 
Reason for any difference
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1 week post-op 
Duplex ultrasound
Photography of leg in standard position and in standard lighting. 
Photoplethysmography (PPG)
SF 36 and Aberdeen quality of life questionnaires 
Visual analogue score -  Pain, mobility, cosmetic view of leg 
Observation of gait and time to walk 50 metres at own pace
6 week post-op 
Time to return to work.
Diary of home assistance required after discharge.
Duplex ultrasound
Photography of leg in standard position and in standard lighting. 
Photoplethysmography (PPG)
SF 36 and Aberdeen quality of life questionnaires 
Visual analogue score -  Pain, mobility, cosmetic view of leg 
Observation of gait and time to walk 50 metres at own pace
6 months
Duplex ultrasound
Photography of leg in standard position and in standard lighting. 
Photoplethysmography (PPG)
SF 36 and Aberdeen quality of life questionnaires 
Visual analogue score -  Pain, mobility, cosmetic view of leg 
Observation of gait and time to walk 50 metres at own pace
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1 year
Duplex ultrasound
Photography of leg in standard position and in standard lighting. 
Photoplethysmography (PPG)
SF 36 and Aberdeen quality of life questionnaires 
Visual analogue score -  Pain, mobility, cosmetic view of leg 
Observation of gait and time to walk 50 metres at own pace
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3 CHAPTERS
3.1 RESULTS
N=38 DU 
at 1 year
223 PATIENTS 
CONTACTED
SEPSG
N=38
N= 32 DU at 1 
year
NSEPSG
N=34
23 DID NOT 
RESPOND
41 DECLINED TO 
TAKE PART
159 AGREED TO 
TAKE PART
2 Excluded 
(I wrong procedure 
I declined surgery)
N=89 
72 RECRUITED 
DEPENDING ON 
ORDER ON 
WAITING LIST
N=70
42 HAD OPERATION 
7 NO IPV 
6 RECURRENT W  
6 NOSFI
4 SSV INCOMPETENCE 
3 ULCERATION 
2 LATER DECLINED
Table 1 Consort table showing flow o f participants.
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3.1.1 Patients
A total of 223 patients who fitted our inclusion criteria were contacted. Three patients 
were recruited directly from our one stop varicose vein clinic and took part in the trial. 
In all 220 patients were contacted by mail, of which 90% replied. Approximately 10% 
(23) did not respond. These 23 patients were written to a second time with no effect. 
Forty one patients responded negatively and were not considered further.
Of the 156 patients who responded positively:
-42 had already had the procedure
-7 had no perforators on repeat scans
-6 were recurrent varicose veins
-6 had no sapheno-femoral incompetence on repeat scans
-4 had developed small saphenous vein incompetence on repeat scans
-3 had developed ulceration
-2 decided not to proceed to operation
-86 deemed suitable for trial of which 69 proceeded to be included. These and the 
other 3 patients recruited from the one stop varicose vein clinic made a total number 
of 72 patients. Random number tables were used to assign these patients to undergo 
High Saphenous Tie and Strip and multiple avulsions (HST&S) with subfascial 
endoscopic perforator surgery (SEPSG) or without SEPS (NSEPSG) as their operative 
intervention. The patients were recruited from July 2000 and the I year follow up was 
completed in April 2004.
All 100 % of patients completed their follow-up. Two patients in the NSEPSG were 
excluded:
-One patient withdrew just before the operation
116
-One patient underwent the wrong procedure. It was felt that due to being the only 
patient in the study to have been excluded for this reason, it would make little 
statistical difference if the patient was treated as intention to treat.
The characteristics of the patients in each group are summarised in table 2. The 
SEPSG contained 38 patients with a mean age of 51.1 years old and a male to female 
ratio of 1.7. The corresponding figures in the NSEPSG were 32, 49.9 years and 0.8. 
The difference for the varied distribution of the males and females in each group is 
unaccounted for as the procedure of allocation was random.
Table 2 Demographics o f the two groups (SEPSG -  Subfascial Endoscopic Perforator Surgery Group, 
N S E P S G -N on  Subfaseial Endoseopie Perforator Surgery Group, SD one standard deviation, t-test 
performed for the P values indieated below, non were signifieant)
SEPSG NSEPSG P VALUE
Age (SD) 53.4(15.0) 50.4(15.1) 0.87
Male 23 13
Female 15 19
Mean no. of pregnancies 2.6 2.3 0.529
BMI female (SD) 27.9(4.1) 27.9 (6.4) 0.994
BMI male (SD) 28.5 (15.0) 29.0(15.1) 0.747
Duration of symptoms in yeas 
(SD) 17.6 (12.3) 18.2 (18.2) 0.86
3.1.2 Data Collection
The over all response rates and data collection rate was good with the exception of the 
VAS collected at one week, which were mostly uncompleted. This may be due to the 
fact that the patients were already completing their diaries during this period and may
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have felt this to be duplication. All the collected data were compiled into spreadsheets 
for assessment. Table 3 shows a summary of the completed data available on the 
databases.
Table 3 Response rate and completion rate of data eollection
Data collected Response rate in SEPSG Response rate in NSEPSG
BMI 31/38 (82%) 27/32 (84%)
CEAP Classification 38/38 (100%) 32/32 (100%)
Days off 27/38 (71%) 22/32 (69%)
Diary 38/38 (100%) 32/32 (100%)
Duration of symptoms 38/38 (100%) 32/32 (100%)
Family history 38/38 (100%) 32/32 (100%)
Photoplethysmography 38/38 (100%) 32/32 (100%)
Standing 38/38 (100%) 32/32 (100%)
VAS at Iweek 18/38 (47%) 19/32 (59%)
VAS at 6 weeks 38/38 (100%) 32/32 (100%)
VAS at 6 months 38/38 (100%) 32/32 (100%)
VAS at 1 year 37/38 (97%) 30/32 (94%)
Gait 38/38 (100%) 32/32 (100%)
Aberdeen questionnaire 
(mean of the follow-up) 35.4/38 (93.2%) 28.6/32 (96.5%)
SF 36
(mean of the follow-up) 34.6/38 (91.0) 29.6/32 (92.5%)
Surgery data 31/38 (82%) 27/32 (85%)
3.1.3 CEAP Classification
The CEAP classification was documented for each patient on their pre-operative 
assessment by means of ticking the appropriate box on the proforma (Appendix 1). 
Figure 13 is a graphical representation of the incidence of the different classifications 
in the two groups. All patients had primary varicose veins (Ep), superficial and 
perforator incompetence (Aap) and their pathology was as a result of reflux (Pr).
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SEPSG ■ NSEPSG
No. of patients
CO C1 C2 C3
C EA P C lassification
C4 C5
Figure 13 Chart depicting the distribution of clinical classification (CEAP) in SEPSG and NSEPSG.
3.1.4 Duration of Varicose Veins
Information was also collected with respect to the duration of presence of varicose 
veins. Each patient was asked to estimate the duration they had been aware of their 
varicosities. All patients had symptomatic varicose veins which were present for a 
minimum of 1 year. The duration of symptoms were divided into decades and 
depicted graphically in Fig. 14.
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No. of patients SEPSG ■ NSEPSG
1-10 yrs 11-20 yrs 21-30 yrs 31-40 y rs 41-50 yrs
No. o f yrs V V  p resent
Figure 14 Bar chart showing the distribution of number of years with varicose veins.
3.1.5 Family History
Enquiries with respect to family history of varicose veins were also made. The most 
common finding was that of first degree relatives who also had varicose veins 
(fig. 15). There was no significant difference the two groups (Chi Square test P= 
0.646) with respect to family history.
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SEPSG ■ NSEPSGNo. of patients
No Fhx First D egree  
Family history
second  d egree
Figure 15 Distribution of positive family history in the two groups of patients.
3.1.6 Standing
Each subject was asked to estimate the number of hours they would spend standing 
during the course of their average day. These were divided into 1-2 hours, 3-4 hours 
or 5-6 hours spent standing in the course of a normal day. The distribution of these 
estimations by the patients had been depicted graphically (fig.l6).The two groups 
gave comparable responses which were not significantly different (Chi Square test P= 
0.197).
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No. of patients
30
SEPSG ■ NSEPSG
1-2 Hours 3-4 Hours
No. hours stand ing
5-6 Hours
Figure 16 Estimated number of hours standing during the day by each patient in the 2 groups.
3.1.7 Surgery
Table 4 summarises the available operative data collected for each patient. This 
includes time taken for HST&S, number of avulsions, total time of the operation and 
the time taken for the SEPS procedure in the two groups (the was a large amount of 
data missing in this part of the protocol due to the researchers not being able to be 
present at all operations and the filling in of the protocol sheet was then left to the 
staff present. The times for SEPS procedure were not included since in the majority of 
the cases this data was missing). The difference in the total operating time in the two 
groups is significantly different and is assumed to be due to SEPS. There were no 
statistically significant differences in the two groups with respect to the other data 
outlined in table 4 .
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Table 4 Summarising the operative data gathered. * statistically significant, M=missing data)
No
HST TIME 
(min.)
No. Avulsions Total Time 
(min.)
Blood loss 
(ml.)
SEPSG NSEPSG SEPSG NSEPSG SEPSG NSEPSG SEPSG NSEPSG
1 33 M 22 8 41 65 540 196
2 M 15 M 16 M 33 M 296
3 24 40 80 32 105 70 200 150
4 15 M 8 7 45 M 370 139
5 M M 24 26 80 50 85 608
6 M 16 M 21 65 30 349 378
7 M M M M M M M 288
8 M M M 14 M M 288 218
9 M 30 14 15 M 55 218 162
10 18 M 19 24 48 33 167 M
11 M M M 21 M 30 M 79
12 M 30 50 11 105 50 414 340
13 M 16 57 16 120 44 185 14
14 M 21 14 31 55 41 56 150
15 30 60 4 18 45 70 16 50
16 M M 42 15 60 M 130 71
17 M 20 6 26 55 45 74 90
18 M 21 35 17 60 36 M 303
19 40 M 53 36 90 65 236 660
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No
HST TIME 
(min.)
No. Avulsions Total Time 
(min.)
Blood loss 
(ml.)
SEPSG NSEPSG SEPSG 1 NSEPSG SEPSG NSEPSG SEPSG NSEPSG
20 60 25 24 1 19 70 55 231 180
21 M 20 33 34 65 38 351 100
22 M 25 20 8 60 40 187 64
23 M 20 37 24 105 40 148 115
24 15 42 11 9 40 48 140 231
25 M M 20 16 75 M M M
26 M M 27 39 M 73 M 440
27 20 M 23 38 40 90 100 483
28 M M 29 31 90 65 129 200
29 M 20 M 29 79 45 120 215
30 10 M 8 11 28 35 M 100
31 M M 52 36 65 70 309 242
32 M 20 33 20 60 55 M 338
33 37 21 48 215
34 M M M M
35 M 27 65 177
36 M 30 60 469
37 M 16 65 126
38 M 14 M 106
Mean 27.5 25.9 27.5 21.5 66.3 50.8* 211.6 230.0
(SD)
(14.6) (11.7) (17.1) (9.6) (22.3) (15.6) (128) (160)
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There were no significant differences between the groups with respect to HST time, 
No. of avulsion and blood loss during the procedure (t-test, P = 0.764, 0.097, P = 
0.629). However on average the total time of the operation in the SEPS group was 
increased by approximately sixteen minutes (P=0.004, mean difference 15.5 95% Cl 
5.1-25.9).
The majority of patients were treated as a day case. Table 5 summarises the hospital 
stay for the patients in the study groups. All bilateral cases were kept in overnight. 
Some patients were kept in overnight due to social circumstances and 2 patients had 
difficulty controlling their pain once mobile (both bilateral). There were no significant 
differences between the two groups with respect to their hospital stay (Chi square 
test). However as noted there were a number of missing data in the SEPSG which 
were not recorded on the performa and we were unable to obtain.
Table 5 Summarising the hospital stay for the SEPS and NSEPS groups.
Day case 1 night 2 nights Missing
SEPSG 22 (58%) 8 (21%) 3(8%0 5 (13%)
NSEPSG 23 (72%) 5 (16%) 4 (13%) 0
3.1.8 Patient Diary
All patients in both groups returned a completed diary (appendix 1) at the six week 
follow-up appointment. A variety of data was documented by each patient in the two 
weeks immediately following their surgery. These include visual analogue scores for
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pain and mobility, amount of daily analgesia required for each patient and occasions 
when assistance was requires as a result of the operation.
Patient Diary (day 1-14 post-op.) SEPSG NSEPSG
*p
VALUE
VAS for Pain (/100)
Day 1 (range) 39.2 (0-80) 39.2 (0-87) 1.00
Day 14 (range) 12.9 (0-90) 9.0 (0-45) 0.71
Change over 14 days (range) 25.1(-16-73) 28.3 (-39-65) 0.48
VAS Mobility (/100)
Dayl (range) 48.0 (0-95) 44.5 (0-85) 0.74
Day 14 (range) 14.7 (0-74) 8.5 (0-31) 0.53
Change over 14 days (range) 33.8 (-15-86) 36.5 (-14-73) 0.56
Pain relief Consumption
Day 1 (range) 3.4 (0-12) 4.6 (1-9) 0.053
Day 14 (range) 0.92 (0-8) 0.75 (0-6) 0.94
Change over 14 days (range) 2.4 (-2-12) 4.1 (-1-9) 0.02**
Occasions of Assistance required
Day 1 (range) 0.8 (0-4) 0.8 (0-3) 0.99
Day 14 (range) 0.9 (0-5) 0.9 (0-3) 0.28
*Mann-whitney U, ** significance
3.1.8.1 VAS for Pain
There were no appreciable differences between the two groups with respect to day 1, 
day 14 scores or the change of the score over the 14 days (table 6). Also the pain 
score at 14 days is far lower than the pre-operative pain scores in both groups (mean 
pre-operative pain score 25.1/100 in the SEPSG and 28.3/100 in the NSEPSG). This
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reduces further to 6.3 and 4.3 respectively at 1 year (refer to Follow-up assessment 
below).
Figure 17 represents the changes in VAS for pain over the 14 post-operative days in 
the two groups. Initially the scores were, relatively high (39.2 out of 100 in both 
groups, SEPSG range 0-80, NSEPSG range 0-87) as would be expected. This quickly 
drops off to 12.9 in the SEPSG and 9 out of 100 in the NSEPSG by 2 weeks.
■ Mean diary pain score SEPSG Mean diary pain score NSEPSG
VAS for pain (/100)
45.0
40.0
35.0
30.0
25.0
20.0
15.0
10.0 
5.0 
0.0
39.2
12.9
1 2 3 4 5 6 7 8 9 10 11 12 13 14
Diary day (1-14)
Figure 17 Graphical representation of mean daily VAS for pain during 14 post-operative days as 
reeorded in the patient diary.
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3.1.8.2 VAS for Mobility
This score was also completed by each patient for 14 consecutive days following 
surgery. The mean daily values for each group are graphically represented in fig. 18. 
Once again this value tails off rapidly and is 14.7/100 for the SEPS group and 8.5/100 
in the non SEPS group at 2 weeks. These values are similar to the pre-operative scores 
for mobility (11.3/100 and 9.0/100 respectively).
VAS for mobility 
(/100)
■SEPSG -"-NSEPSG
60.0
48.0
50.0
40.0
44.5
30.0
lA Z20.0
10.0
1 2 3 4 5 6 7 8 9 10 11 12 13 14
Diary day (1-14)
Figure 18 Mean VAS for mobility as recorded in the patient diary.
3.1.8.3 Pain Relief
All patients were discharged on simple analgesia (such as non-steroidal anti­
inflammatory or codeine based tablets). As would be expected (fig. 19) the use of 
analgesia dropped off sharply within a few days of the operation and the pattern of 
consumption was similar in the two groups with no significant differences between
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them (table 6). However the reduction in the number of analgesia taken on day 14 
compared to day 1 was significantly higher in the NSEPS group (table 6).
Mean No. of Pain 
reliefe tablets taken
SEPSG NSEPSG
5.0
4.5
4.0
3.5
3.0
2.5
2.0
1.5
1.0
0.5
0.0
2 3 5 64 7 8 9 10 11 12 13 14
Diary day (1-14)
Figure 19 Mean number of daily analgesic tablets taken by each patient as recorded in the patient 
diary.
3.1.8.4 Assistance
Each patient noted the number of occasions during the first fourteen post-operative 
days, when they had required assistance, as a result of their operation which they 
would otherwise not have required (fig. 20). These varied from household chores such 
as gardening and shopping to personal care such as dressing and doing up shoelaces. 
The assistance required was similar in both groups (table 6).
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No. of times 
assisstance needed
■SEPSG NSEPSG
1.0
0.9
0.8
0.7
0.6
0.5
0.4
0.3
0.2
0.1
0.0
1 2 3 4 5 6 7 8 9 10 11 12 13 14
Diary day (1-14) 
Figure 20 Assistance required as patient diary.
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3.1.9 Follow-up Assessment
The follow-up period extended to 12 months post-operatively. Each patient had a pro­
forma completed at each visit during their follow-up appointments at 1 week, 6 
weeks, 6 months and 1 year.
3.1.9.1 Days Off
Number of days off work was noted in the pro-forma at the 6 week follow-up visit. If 
the subjects were not employed they were asked to note the number of days before 
they could resume normal activities. Figure 21 represents the distribution of the 
number of days taken off. In the SEPSG the mean number of days taken off was
20.1 (range 7-49, SD 20.0) and in the NSEPSG 20.8 days (range 6-42, SD 9.4). There 
was no significant difference in the two groups with respect to time off work (t-test P 
=0.498).
131
No. of 
patients
8
Days off SEPSG (mean 20.1) ■ Days off NSEPSG (mean 20.8)
1 1 1 1 1 1 ^ 1  1 1 1 1 1 1 11 1
1 4 7 10 13 16 19 22 25 28 31 34 37 40 43 46 49
No. of days off post-op.
Figure 21 Graph demonstrating the number of days taken off work/normal aetivity in each group.
3.1.9.2 Visual Analogue Scores (VAS)
Base line VAS were taken from each patient at the initial interview. This consisted of 
scores on pain or discomfort, cosmetic appearance and restriction of mobility. The 
VAS were repeated at each follow-up visit (1 week, 6 weeks, 6 months and 1 year).
3.1.9.2.1 Pain
There were no significant differences in the pain scores in the two groups during the 
follow-up period (Table 7,8).The mean pain score for the two groups pre-operatively 
were 25.9 (range 0-95) and 23.0 (range 0-67) out of 100 in the SEPS and NSEPS 
group respectively. The highest score during the follow-up period was at one week 
and the pain score subsided following this period (fig 22, table 7).There was good
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correlation between the available 1 week VAS for pain from the patients diaries and 1 
week follow-up appointment (SEPS 23.6/100 29.1/100, Pearson eorrelation = 0.626, 
p=0.03, NSEPSG 24.9/100 and 30.9/100, respeetively Pearson eorrelation 0.66, 
P=0.01) even though the response rate of the 1 week follow-up VAS was low (table
3).
Table 7 Mean visual analogue scores for pain in the SEPSG and NSEPSG during the follow-up period, 
*Mann-Whitney U.
Follow-up VAS (/100) SEPSG (range) NSEPSG (range) *P VALUE
PAIN
pre-op 25.9 (0-95) 23.0 (0-69) 0.96
I wk 29.1 (0-75) 30.9 (0-64) 0.64
6 wks 7.4 (0-75) 8.4 (0-75) 0.94
6 m 7.7 (0-50) 5.0 (0-31) 0.83
I year 6.3 (0-50) 4.3 (0-20) 0.79
change over 12 months 19.0 (-40-72) 19.5 (-15-67) 0.87
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Table 8 Variance analysis for VAS for pain
Sum of 
Squares df Mean Square F Sig.
VAS pain 
preop
Between
Groups
Within
Groups
Total
35.667
8762.942
8798.609
1
67
68
35.667
130.790
.273 .603
VAS pain 
1 wk
Between
Groups
Within
Groups
Total
196.908
12086.535
12283.443
1
68
69
196.908
177.743
1.108 .296
VAS pain 
6 wks
Between
Groups
Within
Groups
Total
15.645
11287.798
11303.443
1
68
69
15.645
165.997
.094 .760
VAS pain 
6m
Between
Groups
Within
Groups
Total
138.950
9550.901
9689.851
1
65
66
138.950
146.937
.946 .334
VAS pain 
ly r
Between
Groups
Within
Groups
Total
529.809
12031.496
12561.304
1
67
68
529.809
179.575
2.950 .090
M ean VA S  
(pain ) at 
fo llow -up
M ean V AS (pain) at follow-up S E P S G  
M ean V AS atfollo-up N SE P SG
35.0
30 .0
25 .0
20.0
15.0
10.0
5.0
0.0
Pre-op IWk 6W ks 6M
A ssessm ent period
Figure 22 Mean VAS for pain at follow up visits.
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At one year, the end point of the trial, the final VAS for pain compared favourably 
with the pre-operative values (table 25) and were significantly lowered in both groups 
(P <0.001 for both groups ).
3.1,9,2.2 Mobility
The mobility score, observed by VAS, was assessed at the follow-up clinic (table 9, 
10). During the follow-up period, the highest scores occurred at the 1 week follow-up 
visit (fig.23). These were substantially higher than pre-operative scores and at the 1 
year follow-up appointment these scores dropped significantly in both groups (table 
25y
Follow-up VAS (/100) SEPSG (range) NSEPSG (range) *P VALUE
Mobility
pre-op 11.1(0-86) 9.0 (0-50) 1.00
1 wk 25.7 (3-67) 30.2 (1-85) 0.66
6 wks 5.2 (0-50) 4.1 (0-50) 0 J6
6 m 6.4 (0-55) 2.8 (0-25) 0.32
1 year 6.5 (0-86) 1.8 (0-18) 0.28
change over 12 months 4.6 (40-71) 7.5 (18-48) 0.43
Table 9 Mean visual analogue scores for mobility during follow-up in the SEPSG and NSEPSG, 
Mann-Whitney U.
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Table 10 Variance analusis for VAS for mobility
Sum of 
Squares df Mean Square F Sig.
VAS Mobil, 
preop
Between
Groups
Within
Groups
Total
77.571
18456.342
18533.913
1
67
68
77.571
275.468
.282 .597
VAS Mobil 
1wk
Between
Groups
Within
Groups
Total
162.955
16178.015
16340.970
1
31
32
162.955
521.871
.312 .580
VAS Mobil 
6wk
Between
Groups
Within
Groups
Total
21.404
5361.581
5382.986
1
67
68
21.404
80.024
.267 .607
VAS Mobil. 
6m
Between
Groups
Within
Groups
Total
229.284
8042.919
8272.203
1
67
68
229.284
120.044
1.910 .172
VAS Mobil. 
1yr
Between
Groups
Within
Groups
Total
361.473
6699.800
7061.273
1
64
65
361.473
104.684
3.453 .068
Mean VAS 
(mobility) at 
follow-up
M ean VAS (mobility) a t follow-up S E P S G  
M ean VAS (mobility) a t follow-up N SEPSG
35
30
25
20
15
10
5
0
Pre-op IW k 6 W ks 6M
Assessment period
1 Yr
Figure 23 Mean VAS for mobility at follow-up visits.
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3.1.9.2.3 Cosmetic Appearance
The VAS for cosmetic appearance of patients’ legs scored much higher than pain and 
mobility. These scores appear to decline steadily during the follow-up period and 
stabilise at 6 weeks (fig. 24). There was no significant difference between the two 
groups with respect to these scores (table 11, 12) and the improvements at 1 year were 
significant in both groups (P < 0.001, table 25).
Table 11 Mean visual analogue scores for cosmetic appearance during the follow-up period in the 
SEPSG and NSEPSG, * Mann-Whitney U
Follow-up VAS (/100) SEPSG (range) NSEPSG (range) *P VALUE
Cosmesis
Pre-op 55.8 (0-100) 54.4 (0-100) 0.83
Iwk 27.5 (0-63) 38.6 (3-95) 0.22
6 wk 10.1 (0-50) 11.0 (0-52) 0.78
6 m 11.9(0-87) 9.5 (0-79) 0.73
1 year 13.6 (0-60) 9.7 (0-50) 0.44
change over 12 months 45.1 (-56-100) 46.2 (-31-10) 0.92
Table 12 Variance analysis for VAS eosmesis
Sum of Squares df Mean Square F Sig.
VAS Cosm. 
Pre-op
Between Groups
Within Groups 
Total
34.558
80934.601
80969.159
1
67
68
34.558
1207.979
.029 .866
VAS Cosm. 
1wk
Between Groups
Within Groups 
Total
954.013
26199.862
27153.875
1
30
31
954.013
873.329
1.092 .304
VAS Cosm. 
6wk
Between Groups
Within Groups 
Total
16.384
16258.862
16275.246
1
67
68
16.384
242.670
.068 .796
VAS Cosm. 
6m
Between Groups
Within Groups 
Total
97.444
23390.342
23487.786
1
68
69
97.444
343.976
.283 .596
VAS Cosm. 
1yr
Between Groups
Within Groups 
Total
254.596
16173.222
16427.818
1
64
65
254.596
252.707
1.007 .319
137
Mean VAS  
(cosm et.) at 
fo llow -up
60 
50 
40 
30 
20 
10 
0
Mean VAS (cosmet.) a t follow-up SE PSG  
Mean VAS (cosmet.) a t follow-up N SEPSG
Pre-op IWk 6 Wks 6M
A ssessm ent period
1 Yr
Figure 24 Mean visual analogue score for cosmetic appearance of legs during the follow-up period.
3.1.9.3 Walking Assessment
The gait and time to walk a measured distance of 30 meters were assessed in all 
patients during the follow-up period. Figure 25 summarises the mean walking time for 
the two groups. The walking times have remained essentially static apart from a slight 
increase at the 1 week follow-up appointment which is to be expected after an 
operation.
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M ean T im e (s) 
to w a lk  30 
m eters
3 5
3 0
2 5
20
1 5
10
5
SEPSG NSEPSG
0
Per-op 1 Wk 6 Wks 6 M
A ssessm ent period
1 Yr
Figure 25 Graph representing mean walking times over marked out distance of 30m in the two groups.
3.1.9.4 Quality of Life
The quality of life was assessed by the use of the anglicised SF-36 and Aberdeen 
questionnaire (AQ). The questionnaires were completed at the pre-operative 
assessment and at each follow-up visit in order to assess the impact of surgery on the 
patients well being.
3.1.9.5 SF-36
The patients in both groups had pre-operative scores in all dimensions of the SF-36 
which were similar to the general population scores (table 13). One sample t-tests 
were performed on all pre-operative scores and all except physical function in the 
SEPS group had P values well above 0.05 (range 0.15 -  0.73). The P value for
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physical function in the SEPS group was 0.034, indicating a significant difference 
with the general population values (Brazier et al. 1992, Baker et al. 1995, fig 26 and 
27).
There was no statistical difference between the SF36 scores in the two groups during 
the course of the follow-up period (table 13, 14). It was not possible to analyse the 
Iweek scores for physical function, role physical and role emotional due to missing 
data. This data was not fully completed by the patient as a result of missing sheet 
following photocopying of the questionnaire. This did not come to the attention of the 
researcher until completion of the trial. The Mann Whitney U test P values obtained 
for all the other scores were higher than 0.05 when comparing the two groups (table 
13). However variant analysis (table 14) did show a significant difference between the 
the two groups with respect to pre-operative physical function. There were also no 
significant differences in the improvement of the scores over the 12 month follow-up 
(P>0.05).
The changes over one year are shown in table 25. In neither group were these 
improvements significant except the score improvement for bodily pain in the SEPS 
group (P=0.002, table 25).
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Table 13 Summary o f the mean SF36 scores out o f 100, in the two groups during the follow-up period, 
(M= Missing Data, * General population data as per Baker et a l  1995, Brazier et al. 1992, $
Significant difference from the general population, all other data no significant difference seen between 
the 2 groups, Mann Whitney U test P>0.05).
SF 36 (/lOO)
* General 
population Pre- 
(/lOO) operative IWK 6WK 6M
Change 
lYR over 1 yr.
General health 71.2
SEPSG 69.0 77.5 75.6 71.3 69.8 0.8
NSEPSG 70.0 74.8 76.0 72.8 71.2 1.2
Physical function 862
SEPSG 75.8» M 792 79.8 80.7 4.9
NSEPSG 8%5 M 85 5 892 87.4 -0.1
Role Physical 822
SEPSG 79.4 M 59.0 76.4 81.1 1.7
NSEPSG 8&8 M 612 862 90.0 1.2
Role emotional 81.6
SEPSG 8&5 M 81.5 90.9 91.9 5.4
NSEPSG 86.4 M 80.0 902 91.1 4.7
Social function 87.0
SEPSG 85.4 49.0 79.5 882 87.9 2.5
NSEPSG 892 492 822 922 87.1 -2.1
Bodily pain 79.0
SEPSG 70.5 392 71.9 84.1 822 122
NSEPSG 77.0 37.5 69.4 862 852 8.3
Vitality 60.8
SEPSG 61.1 532 64.7 67.6 68.0 6.9
NSEPSG 64.5 50.6 67.0 67.8 66.9 2.4
Mental health 72.5
SEPSG 76.2 782 80.4 824 75.5 -0.7
NSEPSG 75.7 72.0 822 80.7 77.7 2.0
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Table 14 Representing the variance analysis carried out with respect to SF36 scors,* statistical 
significance
Sum of 
Squares df Mean Square F Sig.
SF36 1 PRE 
General Health
Between Groups
Within Groups 
Total
15.565
21957.500
21957.500
1
60
61
15.565
365.699
.043 .837
SF36 1 1WK 
General Health
Between Groups
Within Groups 
Total
114.249
12968.609
13082.857
1
61
62
114.249
212.600
.537 .466
SF36 1 6WK 
General Health
Between Groups
Within Groups 
Total
2.582
18320.467
18323.048
1
60
61
2.582
305.341
.008 .927
SF36 1 6M 
General Health
Between Groups
Within Groups 
Total
31.833
23320.650
23352.484
1
59
60
31.833
395.265
.081 .778
SF36 1 1YR 
General Health
Between Groups
Within Groups 
Total
27.512
33007.799 
33035.311
1
57
58
27.512
579.084
.048 .828
SF36 3 PRE 
Phys. Function
Between Groups
Within Groups 
Total
2166.130
31007.555
33173.684
1
62
63
2166.130
500.122
4.331 .042*
SF36 3 6WK 
Phys. Function
Between Groups
Within Groups 
Total
630.064
26153.936
26784.000
1
61
62
630.064
428.753
1.470 .230
SF36 3 6M 
Phys. Function
Between Groups
Within Groups 
Total
1575.837
39615.302
41191.138
1
63
64
1575.837
628.814
2.506 .118
SF36 3 1YR 
Phys. Function
Between Groups
Within Groups 
Total
703.607
28006.402
28710.009
1
61
62
703.607
459.121
1.533 .220
SF36 4 PRE 
Role Phys.
Between Groups
Within Groups 
Total
1377.419
58820.994
60198.413
1
61
62
1377.419
964.279
1.428 .237
SF36 4 6WK 
Role Phys
Between Groups
Within Groups 
Total
76.269
105923.731
106000.000
1
63
64
76.269
1681.329
.045 832
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Sum of 
Squares df Mean Square F Sig.
SF36 4 6M 
Role Phys
Between Groups
Within Groups 
Total
1785.973
109888.165
111674.138
1
63
64
1785.973
1744.257
1.024 .315
SF36 4 YR 
Role Phys
Between Groups
Within Groups 
Total
1255.772
60787.879
62043.651
1
61
62
1255.772
996.523
1.260 .266
SF36 5 PRE 
Role Emot.
Between Groups
Within Groups 
Total
.022
49152.521
49152.542
1
57
58
.022
862.325
.000 .996
SF36 5 6WK 
Role Emot
Between Groups
Within Groups 
Total
35.915
73432.099
73468.013
1
64
65
35.915
1147.377
.031 .860
SF36 5 6M 
Role Emot
Between Groups
Within Groups 
Total
.169
44820.620
44820.789
1
60
61
.169
747.010
.000 .988
SF36 5 1YR 
Role Emot
Between Groups
Within Groups 
Total
10.261
39919.192
39929.453
1
61
62
10.261
654.413
.016 .901
SF36 6 PRE 
Social func.
Between Groups
Within Groups 
Total
234.432
21943.452
22177.885
1
63
64
234.432
348.309
.673 .415
SF36 6 1WK 
Social func.
Between Groups
Within Groups 
Total
.922
55097.026
55097.948
1
65
66
.922
847.647
.001 .974
SF36 6 6WK 
Social func.
Between Groups
Within Groups 
Total
125.433
41539.679
41665.112
1
65
66
125.433
639.072
.196 .659
SF36 6 6M 
Social func.
Between Groups
Within Groups 
Total
219.848
30246.498
30466.346
1
63
64
219.848
480.103
.458 .501
SF36 6 1YR 
Social func.
Between Groups
Within Groups 
Total
9.984
22802.516
22812.500
1
61
62
9.984
373.812
.027 .871
SF36 7 PRE 
Bodily Pain
Between Groups
Within Groups 
Total
672.537
38209.710
38882.246
1
63
64
672.537
606.503
1.109 .296
SF36 7 1WK 
Bodily Pain
Between Groups
Within Groups 
Total
75.887
30556.223
30632.109
1
62
63
75.887
492.842
.154 .696
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Sum of 
Squares df Mean Square F Sig.
SF36 7 6WK 
Bodily Pain
Between Groups
Within Groups 
Total
97.152
28304.910
28402.062
1
63
64
97.152
449.284
.216 .644
SF36 7 6M 
Bodily Pain
Between Groups
Within Groups 
Total
114.603
21587.714
21702.317
1
61
62
114.603
353.897
.324 .571
SF36 7 1YR 
Bodily Pain
Between Groups
Within Groups 
Total
99.491
26415.493
26514.984
1
61
62
99.491
433.041
.230 .633
SF36 9A PRE 
Vitality
Between Groups
Within Groups 
Total
138.544
17406.071
17544.615
1
63
64
138.544
276.287
.501 .481
SF36 9A 1WK 
Vitality
Between Groups
Within Groups 
Total
114.624
22784.240
22898.864
1
64
65
114.624
356.004
.322 .572
SF36 9A 6WK 
Vitality
Between Groups
Within Groups 
Total
84.396
19577.143
19661.538
1
63
64
84.396
310.748
.272 .604
SF36 9A 6M 
Vitality
Between Groups
Within Groups 
Total
404.774
33199.165
33603.939
1
64
65
404.774
518.737
.780 .380
SF36 9A 1YR 
Vitality
Between Groups
Within Groups 
Total
19.841
21417.659
21437.500
1
60
61
19.841
356.961
.056 .814
SF36 9B PRE 
Mental Health
Between Groups
Within Groups 
Total
3.100
14352.838
14355.938
1
63
64
3.100
227.823
.014 .908
SF36 9B 1WK 
Mental Health
Between Groups
Within Groups 
Total
631.930
13391.600
14023.530
1
64
65
631.930
209.244
3.020 .087
SF36 9B 6WK 
Mental Health
Between Groups
Within Groups 
Total
95.275
9000.971
9096.246
1
63
64
95.275
142.873
.667 .417
SF36 9B 6M 
Mental Health
Between Groups
Within Groups 
Total
46.393
8712.607
8759.000
1
62
63
46.393
140.526
.330 .568
SF36 9B 1YR 
Mental Health
Between Groups
Within Groups 
Total
37.029
13792.686
13829.714
1
61
62
37.029
226.110
.164 .687
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Figure 26 Figure showing the mean scores o f the SF-36 dimensions pre-operatively and at one year for 
the SEPSG and NSEPSG as well as the mean values representing the general population.
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Figure 27 Figure showing the mean scores of the SF-36 dimensions pre-operatively and at one year for 
the SEPSG and NSEPSG as well as the mean values representing the general population.
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3.1.9.6 Aberdeen Questionnaire
Table 15 and 16 summarises the Aberdeen questionnaire score in the two groups and 
analysis of variance respectively. The mean scores during the follow-up period have 
been graphically represented in figure 28.The only significant difference between the 
two groups was observed at week one with the SEPSG mean score of 23.4 versus 18.2 
in the NSEPSG (P<0.05). This implies more perceived symptoms in the SEPS group.
ABERDEEN (/ICO) SEPSG NSEPSG *P VALUE
PRE-OP 19.1 15.5 0.108
IW EE K 23.4 18.2 **0.041
6 WEEKS 16.1 11.2 0.204
6 MONTHS 8.4 6.2 0.35
1 YEAR 9.0 5.8 0.128
CHANGE OVER lYR 10.8 9.1 0.37
Table 15 Mean Aberdeen questionnaire score for the two group, *Mann whitney U, ** significant
The scoring of the questionnaire at 1 weeks was adjusted to the conventional score as 
the diagrammatic section of the questionnaire was not completed by the patients. This 
was due to the standard post-operative care of the patients which involved bandaging 
of the operated legs for 1 week. Because of this the patients were not able to complete 
the diagrammatical part of the questionnaire. The scores for this were hence adjusted 
to exclude the scores for the diagram for all patients. There were significant 
improvements in the Aberdeen questionnaire scores over the 12 month period in each 
group (P <0.001 in both groups, table 25).
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Sum of 
Squares df Mean Square F Sig.
Aberdeen pre Between Groups 
Within Groups 
Total
215.807
4656.492
4872.299
1
65
66
215.807
71.638
3.012 .087
Aberdeen Iwk Between Groups 
Within Groups 
Total
482.407
5858.579
6340.986
1
68
69
482.407
86.156
5.599 .021*
Aberdeen 6wk Between Groups 
Within Groups 
Total
439.156
17103.929
17543.086
1
68
69
439.156
251.528
1.746 .191
Aberdeen 6m Between Groups 
Within Groups 
Total
78.808
3070.692
3149.500
1
68
69
78.808
45.157
1.745 .191
Aberdeen 1yr Between Groups 
Within Groups 
Total
165.005
3630.229
3795.234
1
62
63
165.005
58.552
2.818 .098
Aberdeen change 
overlyr
Between Groups
Within Groups 
Total
49.267
5323.323
5372.590
1
59
60
49.267
90.226
.546 .463
Table 16 Analysis o f variance for Aberdeen questionnaire,* statistical significance
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Figure 28 Figure representing the Aberdeen score for the two groups during the follow-up period.
3.1.9.7 Photoplethysmography (PPG)
The mean PPG derived RT90 (90% of refilling time on PPG) times for the two groups 
are summarised in table 17. There were no significant differences between the PPG 
times in the two groups except at 1 year. However on variant analysis this 
significance was not found (table 18). Although both the mean RT90 times were well 
within the normal limits, the NSEPSG had a significantly higher RT90 time than the 
SEPSG (P=0.04).
Considering each group individually, the mean RT90 values had increased 
significantly by 12 months after operation for both groups (P < 0.001 table 25) and 
the mean values in both groups were within normal limits (RT90 >18seconds).
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PPG (secs.) SEPSG (range) NSEPSG (range) *P VALUE
Pre-op. 13.0 (4-45) 14.5 (1-45) 0.96
1 week 31.8 (10-47) 35.2 (1-46) 0.18
6 weeks 27.0 (8-46) 28.8 (11-46) 0.52
6 months 24.9 (10-47) 27.8 (9-45) 0.29
1 year 25.2 (9-47) 30.7( 7-46) **0.04
Change over 1 
year 13.3 (-17-38) 16.3 (-20-45) 0.42
Table 17 showing the mean RT90 times in the 2 groups during the study, *Mann-Whitney U, ** 
significant
Table 18 Analysis o f variance for PPG results
Sum of 
Squares df Mean Square F Sig.
Preop Between Groups 
Within Groups 
Total
35.667
8762.942
8798.609
1
67
68
35.667
130.790
.273 .603
One wk ppg Between Groups 
Within Groups 
Total
196.908
12086.535
12283.443
1
68
69
196.908
177.743
1.108 .296
Six wk ppg Between Groups 
Within Groups 
Total
15.645
11287.798
11303.443
1
68
69
15.645
165.997
.094 .760
Six m ppg Between Groups 
Within Groups 
Total
138.950
9550.901
9689.851
1
65
66
138.950
146.937
.946 .334
One yr ppg Between Groups 
Within Groups 
Total
529.809
12031.496
12561.304
1
67
68
529.809
179.575
2.950 .090
Change over 1yr Between Groups 
Within Groups 
Total
149.660
16377.222
16526.882
1
66
67
149.660
248.140
.603 .440
Figure 29 and 30 are graphical representation of the changes in the individual RT90 
values from pre-operative time to 12 months post-operative, in the SEPS and 
NSEPSGs.
149
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Figure 29 Graphical representation of PPG derived T90 times in secs, for SEPSG (pre-op. and at one 
year).
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Figure 30 Graphical representation of PPG derived T90 times in seconds in NSEPSG (pre-op. and at 
one year).
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In all 10 patients had PPG RT90 times which were lower at 1 year than at their pre­
operative assessment (table 19, and Fig 29 and 30). Seven of these were in the SEPSG 
and 3 in the NSEPS group. Of these 10 patients, eight were found to have 
pathological reflux within the remnant below knee Great Saphenous Veins (GSV), 
one being as a result of connection with refluxing accessory GSV which was not seen 
on the pre-operative or the 1 week post-operative scan.
Two of these ten subjects (1 SEPSG, 1 NSEPSG) had PPG derived RT90 values at 
one year which were only marginally lower then the pre-operative value and were 
well within the normal limit of >18 seconds. One other patient had RT90 value at one 
year which was within normal limits, although significantly reduced from pre­
operative levels. The remaining 6 (5 SEPSG, 1 NSEPSG) all had pathological values 
of RT90 at one year (<18 seconds), and 5 (4 in SEPSG, 1 in NSEPSG) out of six had 
reflux within the remnant below knee GSV on duplex ultrasound (DU).
Patient
no.
Group Pre-op 
RT 90 
(sec.)
Iwk 
RT 90 
(sec.)
6wk
RT90
(sec.)
6m
RT 90 
(sec.)
lyr
RT 90 
(sec.)
lower 
1/2 GSV 
reflux
IPV at 
1 yr
1 SEPS 45 45 45 44 42* No Yes
2 SEPS 11 20 13 15 9 No No
3 SEPS 27 10 15 28 10 Yes yes
4 SEPS 32 32 27 22 18 Yes No
5 SEPS 17 45 43 13 15 Yes No
6 SEPS 16 44 27 16 13 Yes No
7 SEPS 29 21 29 44 16** Yes Yes
8 NSEPS 44 45 32 M 24* Yes Yes
9 NSEPS 45 45 44 20 44* Yes No
10 NSEPS 9 11 11 9 8 Yes Yes
Table 19 Summarising findings in patients with shorter RT 90 at one year compared to pre-operative 
times. (M=missing, * with in normal limits, **accessory GSV).
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3.1.9.8 Duplex Ultrasound
All DU studies were carried out by the same senior vascular sonographer throughout 
this study. We were fortunate enough to have completed DU scan follow-up in 100% 
(n=72) of our patients as per our protocol. All open perforators were noted and 
differentiated into new (not present on the pre-operative scan) or same (present on 
preoperative scan). Of note was that there were no intact SFJ in either group at 1 week 
or 6 weeks which may have represented primary failure of the surgery. In the 
NSEPSG there were 2 patients with a second refluxing LS system, one at the 1 week 
follow up the other at 6 weeks follow up. In both patients haematoma tracts along the 
striped primary LSV were visible on duplex ultrasound.
3.1.9.8.1 Subfascial Endoscopic Perforator Surgety Group (SEPS)
In the 38 patients in the SEPSG, a total of 62 Incompetent Perforator Veins (IPV) 
were found on the pre-operative scan (Table 20). At one year, 12 patients (31.5%) had 
a total of 19 open IPV (5/62 (8%) same, 14/62 (22.6%) new).
-At the one week scan 2/38 (5.2%) patients were found to have 2 same IPV open 
(Table 22). One was found not to be open during the rest of the follow-up. The other 
patient’s IPV was seen to be refluxing at 6 months with a second same perforator, 
both of which remained open at one year.
-At 6 weeks, one patient (2.6%) had 2 new IPV refluxing which remained open at 6 
months and one year.
-At the 6 month scan 8/38 (21%) of patients were found to have a total of 11 IPV 
(5/11(45.5%) same, 6/11 (54.5) new). All eight had IPV which were also present at 
the 1 year follow-up scan (table 20). Two of these eight patients had developed an 
additional new IPV each at the 12 month scan. Of the remaining 4 patients at one year
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with IPV one had 2 new and 3 others had 1 new perforator without having any other 
IPV open during the follow-up period.
Patients with 
IPV at follow- 
up (SEPSG) 
N=38 Pre-op. 1 week 6 weeks 6 months 1 year
1 1 ls,ln ls,2n
2 1 Is
3 1 In In
4 2 2n
5 4 Is 2s 2s
6 1 In
7 1 In
8 1 In
9 1 2n 2n 2n
10 3 Is Is.ln
11 1 Is Is
12 2 In 2n
13 1 In In
Total no. of 
IPVs (n=62 
pre-op.) 20 2(% ) 2(2n) 11 (5s,6n) 19 (5s,14n)
No. of patients 
with IPV 38 2 1 8 12
Table 20 summarising the ultrasound findings in SEPSG with respect to IPV. (n = new IPV not seen 
on the pre-op. DU, s = same perforators as seen on the pre-op. DU).
3.1.9.8.2 Non Subfascial Endoscopic Perforator Surgery Group (NSEPSG)
A total number of 51 IPV were found in 32 patients in the NSEPSG (table 21). IPV 
were seen in 25/32 (78.1%) of these subjects at the one year follow-up (table 22), with 
a total number of 46 IPV (37/51 (72.5%) same, 9 new)).
At the one week scan 15/32 (46.8%) patients were found to have 25 IPV (23/25 (92%) 
same, 2/25 (8%) new). All 15 patients were found to have at least one same IPV
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refluxing (eight patients had 1, six patients had 2 and one had three same IPV). Two 
of these patients had also developed one additional new IPV each.
At six weeks 17/32 (53.1%) patients were found to have 26 IPV (23/26(88.4%) same, 
3/26(11.6%) new) on DU. Four new patients had developed 1 same IPV each and one 
additional patient had 1 new IPV. In 2 patients, both with 1 same IPV at 1 week, no 
IPV were demonstrated at 6 weeks scan. Both these IPV were seen on the 6 month 
scan but not at the 12 m scan. One patient with one same and 1 new IPV at the one 
week scan had no IPV at the six week scan even though these IPV were found on the 
6 month and 12 month scans. Two patients reduced the number of same IPV from 2 to 
1 at the six week scan and one patient increased the number of IPV from 1 same to 2 
same at 6 weeks. One patient with Isame IPV at 1 week developed an additional new 
IPV at six weeks.
At six months 24/36 (58.3%) patients had a total of 37 IPV (30/37(81.1%) same, 
7/37(18.9%) new). Ten of these subjects had the same IPV pattern as at the 6 weeks 
scan. Four new patients had opened 1 same IPV each and 2 patients had developed a 
second same IPV. One of the remaining patients has 1 same IPV at 1 week, developed 
an additional new perforator at 6 weeks and a second additional new perforator at 6 
months. This pattern remained the same on the 12 month scan. Another patient with 2 
same and 1 new IPV at 1 week and 6 weeks had only one same IPV at 6 m and went 
on to have 2 same IPV at the 1 year DU. Another subject had 2 same at Iweek, 1 
same at 6 weeks and only 1 new at 6m. This patient went on to have all 3 IPV open at 
12 months. In another case 2 same IPV seen at the 1 week and 6 weeks scans were 
present at 6 months in addition to a new IPV. The one year scan in this patient showed 
all 3 pre-operative IPV to be open. One patient was also seen with 1 same IPV at 1
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week and 6 weeks scans but had developed an additional new perforator at 6m and 
went on to develop another new perforator at 1 year.
At the one year scan 25/32 (78.1%) of patients in the NSEPSG had a total number of 
46 IPV). Thirteen of these patients had the same duplex pattern as at the 6 month 
scan. Three new patients developed 1 same IPV each and one patient with 1 same IPV 
at 6 months developed an additional same perforator at 1 year. Two patients 
developed an additional 1 same IPV to add to their existing IPV at six months to bring 
their numbers to 2 and 3 same IPV. Another patient reduced the number of IPV from 
2 at 6 months to 1 at 1 year. One patient developed 1 new perforator at one year as 
well as having the existing 1 same and 1 new seen at 6 m. Another patient who had 1 
same perforator on the three previous scans developed an additional 2 new perforators 
at 1 year.
There were significant differences with respect to the number of incompetent 
perforators seen on DU post-operatively in the two groups (table 22).
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Patients with 
IPV at follow- 
up (NSEPSG) 
N=32 Pre-op 1 week 6 weeks 6 month 1 year
1 1 Is Is, In ls,2n Is, 2n
2 2 Is 2s 2s 2s
3 1 Is
4 3 2s, In 2s, In Is 2s
5 2 2s Is In 2s, In
6 2 Is 2s
7 1 Is Is
8 3 2s 2s 2s, In 3s
9 1 Is Is
10 4 Is Is
11 3 Is Is Is Is, 2n
12 1 Is Is Is Is
13 2 Is 2s 2s
14 1 Is Is
15 2 Is 2s Is
16 1 Is Is ls,ln Is, 2n
17 2 2s Is Is 2s
18 3 2s 2s 2s 3s
19 2 Is
20 2 Is Is Is
21 1 Is Is Is
22 1 In In In
23 3 Is Is
24 3 3s 3s 3s 3s
25 1 Is
26 1 ls,ln ls,ln ls,ln
27 2 2s 2s 2s 2s
Total no. of 
IPV (n=58 
pre-op.)
51
(total of 58 IPV 
pre-operatively)
25
(23s, 2n)
26
(23s, 3n)
37
(30s, 7n)
46
(37s, 9n)
No. of 
patients with 
IPV 32 15 17 24 25
Table 21 Summarising the ultrasound findings in NSEPS Group with respect to IPV. (n=new IPV i.e. 
not seen on the pre-op. DU, s = same perforators as seen on the pre-op. DU).
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Number o f perforators at duplex ultrasound scan
pre­
op. 1 week 6 weeks 6 months 1 year
IPV IN 
SEPSG 62
Total same new Total same new Total Sam new Total same New
2 2 0 2 0 2 1 1 5  6 19 5 14
No. of 
IPV
remaining 
competent 
in SEPSG 60 (97%) 62 (100%) 57(92%) 57 (92%)
IPV IN 
NSEPSG 58 :#* 23* 2 2K* 23* 3 37* 30* 7 46* 37* 9
No. of 
IPV
remaining
competent
in
NSEPSG 35 (60%) 35 (60%) 28 (48%) 21 (36%)
no. with IPV no. with IPV no. with IPV no. with IPV
No. OF
LEGS
SEPSG 38 2/38 (5.2%) 1/38 (5.2%) 8/38(21.1%) 12/38(31.6%)
No. OF
LEGS
NSEPSG 32 15/32 (50%)* 17/32 (53.1%)* 23G2(7L8%0* 25/32(78.1%)*
Table 22 Summary o f IPV found on DU in the 2 groups during the follow-up period. * Significant 
difference between the two groups (Chi square test, P<0.001)
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SEPSG
N/38
Pre-
op
1
year
**p
Value
NSEPS
Pre-
N/32 op
1
year
**p
Value
VAS
(/lOO)
Pain
Mobility
Cosmetics
36
36
36
219
11.1
5&7
6.3
6.5
13.6
0*
0.041*
0 *
32
30
30
218
9.3
55.9
4.3
1.8
9.6
0*
0 .001*
0*
SF36
(/ICO)
Gen Health
3Phys.
Function
Role
Physical
Role
Emotional
Social
Function
Bodily pain
Vitality
Mental
Health
26
33
32 
29
33 
33
32
33
69j
77.2
81.3
815
8A5
69
61.4
719
71.5
80.7 
82
94.3
87.9
82.3
67.7
74.9
0.62
0.12
0.91
120
0.34
0 .002*
0J8
0.68
26
28
29
26
29
29
29
28
617
87.1 
818 
819
818
76.1 
64.5
716
718
829
89.7
916
87.1
85.3
66.9
77.7
0.053
0.40
0.78
0.27
0.72
0.10
0.24
0 J7
Aberdeen
(/ICO)
32 19.6 15 29 15.1 6.1 0*
PPG
RT 90 (sec.) 36 12.1 25.4 0* 32 14.5 (0.7
Table 23 Table summarising the changes observed in Follow-up data in each group during the 1 year 
follow-up period., ** Wilcoxon Signed ranks tests were performed to assess changes in PPG, QOL 
and VAS over one year in each group . Those improvements which were statistically significant are 
marked (*).
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4 CHAPTER 4
4.1 VENOUS PRESSURE MONITORING
In order to assess the impact of the pressure exerted by the Incompetent Perforator 
Vein (IPV) we designed a study to measure the pressure changes observed adjacent to 
incompetent and competent perforator veins. In this way we hoped to investigate: 
Whether the IPV were associated with higher pressures in the adjacent superficial 
system.
At which phase of calf contraction and relaxation does maximum pressures occur and. 
If there is an increase in pressure as a result of IPV is it distributed globally or locally 
within the superficial system.
Relationship and contribution of IPV to Photoplethysmography (PPG) findings.
Unfortunately despite the kind assistance of Department of Medical Physics at the 
university Medical School of St.George’s, the instrumentation did not appear to be 
sufficiently sensitive and reliable with respect to the intended procedure and 
measurements taken. The results obtained were not reproducible in the same subjects 
and no meaningful data which could be interpretated reasonably were obtained in six 
out of the required ten subjects. This project was hence abandoned but for 
completeness a brief outline of the methodology of the project is given here.
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4.1.1 Methods and Materials
Our aim was to recruit 10 patients with Sapheno-Femoral Junction (SFJ) 
incompetence, 5 with incompetent perforator veins and 5 with competent perforator 
veins. These patients were recruited from vascular outpatients and waiting lists.
All patients had pre-operative PPG and ultrasound scan and their venous anatomy and 
perforator status documented. The PPGs were undertaken in a standard fashion as 
outlined previously (methods and materials). The scans were all performed by the 
same senior vascular technologist as the randomised trial and the same protocol was 
followed (refer to methods and materials). Subjects with deep venous and small 
saphenous vein incompetence were excluded from this study. All patients were to 
undergo High Saphenous Tie and Strip and multiple avulsions (HST&S) or venous 
ablation by radio-frequency as well as Subfascial Endoscopic Perforator surgery 
(SEPS) depending on their perforator status.
On the day of the operation each patient was interviewed and given a patient 
information sheet to study. If the patients were agreeable a consent form was signed. 
The procedure was undertaken before administration of general anaesthetic in the 
operating theatre. The affected leg was rescanned and the Great Saphenous Vein 
(GSV) cannulated (20G Abocath) at two positions after administration of 1ml of local 
anaesthetic (1% xylocaine). One cannula was placed with in the GSV just above the 
medial malleolus, and the other under direct duplex guidance, directly adjacent to the 
interested perforator vein. Once in place each catheter was fixed to the skin and the 
distance between the catheters noted. The cannula were then connected to a two 
channel transducer and the anaesthetic machine. The system was then flushed with 
heprinised normal saline and zeroed to the level of the sternal notch with the patient
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in the supine position. At this point the patient was administered with 200IU of 
heparin intravenously to prevent the cannula from thombosing.
The anaesthetic machine was set-up as follows to obtain an analogue output from two 
channels:
Setup
Install/service
password
Installation
Analogue
Channel 1 - low resolution PI 
Channel 2- low resolution P2
The output from the anaesthetic machine was connected to the parallel port on the 
ADC-100. The ADC-100 (picolog for windows, 2003, Pico Technologies LTD) is an 
analogue to digital converter with two analogue input channels and programmable 
input voltage range. Specially designed connections were provided by the company to 
connect the ADC-100 output channels to a parallel port on a laptop computer (Sony 
Viao PCG-Z600TEK, Sony Inc., Japan). With the help of Picoscope program and 
picoLog software provided and installed on the laptop data in the form of pressure 
changes could be viewed as an oscilloscope display on a laptop and all data recorded 
in the form of logs for review at a later date. These data included time intervals and 
voltage changes which were calibrated initially to represent changes in pressure in 
mm Hg.
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With the use of a three way tap, the transducer plastic piping was initially connected 
to a sphygmomanometer and the ADC-100 was calibrated for pressures of up to 100 
mmHg. The settings for the converter were as follows:
Sample intervals 10ms
No. of samples 60,000
Voltage range -0.5 2.0 (under options)
The patient was then reconnected to the transducers and asked to lie supine on the 
operating table. The output is observed on the laptop screen and once a stable baseline
pressure was attained the subject was asked to perform foot exercises. The
instructions with respect to these exercises were very specific and were accompanied 
by verbal prompts. The patient was asked to perform full dorsiflexion at the ankle and 
then to return to the resting position. This procedure was performed three times in 
succession whilst recording are taken saved on the laptop. It was important to 
document and make clear which of the two readings was from the perforator and the 
GSV. The patient was then repositioned in a sitting position on the edge of the 
operative bed with the legs dependent. The procedure was then repeated and further 
recordings taken in this position.
This study was assessed and approved by the Local ethics committee.
4.1.2 Results
This procedure was undertaken in six subjects who had consented to take part in the 
study. Recurring problems involved the ineffective damping of the system which did 
not prevent background interference from affecting a steady baseline at the beginning 
of the procedure. Also once a steady state was reached and reading taken, the patterns 
produced by the oscilloscope on the computer screen were not reproducible on
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repeating the exercises. There w ere also no com m on patterns observed w hen the 
reading o f  different subjects w ere compared. Figure 31 and 32 are the graphical 
outputs recorded on one o f  the patients w hich depicts the expected findings during 
exercise.
15 n
Time (Seconds)
PI perforator Press. 
P2 LSV press.
Figure 31 Graphical representation of changes in pressure observed in the foot veins.
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Figure 32 Graphical representation of the difference in the observed pressures.
D ue to tim e constraints it w as not possible to adjust the instrumentation in order to 
improve the accuracy and reproducibility o f  the system  and the project w as  
abandoned.
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5 CHAPTERS
5.1 DISCUSSION
At the end point of this study (1 year following operation), there was a substantial 
difference between the numbers of Incompetent Perforator Veins (IPV) in the two 
groups on DU (Primary outcome). The NSEPSG (HST&S without SEPS) had a far 
higher number of patients and number of IPV at one year (25/32 patients with 46 IPV 
vs. I2/38patients with 19 IPV in the SEPSG). Also the majority of these perforators were 
the same ones seen on the pre-operative DU (37/46 (80%) vs. 5/19 (26%) in SEPSG). 
This dismisses the idea that 80% of IPV are closed at 6 weeks following High 
Saphenous Tie and Strip and multiple avulsions (HST&S) (Campbell & West 1995). 
In our NSEPSG, 40% of IPV (fig. 33) seen on the pre-operative DU were refluxing at
6 weeks and their numbers increased during the rest of the follow-up period. Table 22 
outlines the number of pre-operative perforators which were not refiuxing following 
surgery in the two groups. In the SEPSG this number remains consistently above 92% 
through out the follow up period with no increase from the 6 month scan to the 12 
month scan. In the NSEPSG group however this percentage decreases progressively 
to 36% at I year.
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SEPS (n=62 pre-op)*— NSEPS (n= 58 pre-op)
23 (40%)
No. of sam e  20 
IPV 15
10 -
Same at 1 wkSame at 6wks Same at 6m Same at 1 yr
Follow-up
Figure 33 Graph showing the no. of same IPV in the 2 groups
However, there was no signifieant differenee between the two groups with respect to 
the number of new perforators seen at one year DU (fig. 34). The number of new IPV 
seen on DU increased with time following surgery and represents the progressive 
nature of the disease..
■ ^ S E P S N SE PS
16
14
12
10
No. o f new  _
IP V  ®
6
4
2
0
New at 1 wk New at 6wks New at 6m New at 1 yr
Follow -up
Figure 34 No. of New IPV seen during the follow-up period.
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A note is made here in respect of errors which may have occurred with respect to 
sonography of these subjects. Ideally the radiographer must have been blinded with 
respect to the patients being scanned. Unfortunately in practice this was not possible 
since even if the scar on the medial aspect of the calf was somehow covered up, the 
SEPS clips are easily detectable on DU. With respect to inter and intra-observer 
errors, no steps were taken to assess this however due to the randomised nature of the 
trial and the predetermined protocols, conceptually all errors as a result of this should 
occur equally in both groups. In an internal audit (not published), the radiographer 
was able to detect 95% of all IPV as compared to operative findings. However the 
lack of assessment of these errors does bring about a source of error which is not 
accounted for.
The pain scores appear to be sensitive instruments as demonstrated by the pain scores 
from the patient’s diary and the follow-up VAS for pain. The highest scores were 
noted at the first post-operative day in the diaries with the mean of both groups being
39.2 (SEPSG range 0-80, NSEPSG 0-87, fig. 17). With in 14 days of the operation, the 
pain scores had reduced to 12.9 in the SEPSG and 9.0 in the NSEPSG.
The highest score during the follow-up period was at one week (29.1 in SEPSG, 30.9 
in the NSEPSG). The pain score subsided after that (fig 22, table 7) to 6.3 and 4.3 
respectively at one year. These values are much lower than the pre-operative score 
and represent a statistically significant improvement in the patient perception of pain 
as a result of varicose veins.
There was good correlation between the available I week VAS for pain from the 
patients diaries and I week follow-up appointment (SEPS 23.6/100 29.1/100, 
Pearsons correlation = 0.626, p=0.03, NSEPSG 24.9/100 and 30.9/100, respectively 
Pearsons correlation 0.66, P=0.01) even though the response rate of the 1 week
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follow-up VAS was low (table 3). This adds more weight to the stability of the VAS 
for pain.
The assessment of mobility of the patients followed much the same pattern as that for 
pain, with the highest scores at Iwk post-operatively. The mobility scores for both 
groups had improved at 1 year compared to the preoperative score (table 25).
The patient diaries also assessed the amount of pain relief tablets consumed and 
assistance required during the 14 days following operation. The reduction in the 
number of tablets taken in the NSEPS group was significant when compared to the 
SEPS group. This is because the NSEPS group on average took a higher number of 
tablets on the first operative day than the SEPS group, since both groups have an 
average consumption of less than one tablet at 14 days.
The mean pre-operative VAS for the cosmetic appearances of the trial legs as 
assessed by the subjects themselves were far higher than the scores for pain and 
mobility in both groups. This gives a good insight into the perceived problem with 
respect to patients with varicose veins. The cosmetic improvements at one year in 
both groups were significant and there were no differences between the groups.
The patients in both groups had pre-operative scores in all dimensions of the SF-36 
which were similar to the general population scores the only exception being that of 
physical function score in the SEPSG (table 13). This goes some way to show the 
generally good state of health of patients undergoing varicose vein surgery. It would 
appear that our SEPS sample may have been slightly weighted towards people who 
had a lower perception of their physical function. This is a chance occurrence since 
the process of allocation was randomised.
Again as would be expected the SF-36 scores were lower (i.e. less well) at 1 week 
compared to scores during the rest of the follow-up. The changes over one year are
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shown in table 25. In neither group were these improvements significant, apart from 
the score improvement for bodily pain in the SEPS group (P=0.002). Smith et a l, in 
their study similarly found improvements in SF-36 scores at 6 weeks following 
varicose vein surgery, which were only significant in mental health. The SF-36 is a 
generic questionnaire, which may not be sensitive enough to appreciate the health 
changes as a resulting from varicose vein surgery.
There were significant improvements in the Aberdeen questionnaire scores in each 
group over the 12 month period (P <0.001Table 25). The only significant difference 
between the two groups was observed at week one with the SEPSG mean score of 
23.4 versus 18.2 in the NSEPSG (P<0.05). As would be expected the Aberdeen 
Questionnaire is more sensitive to changes in symptoms brought about by varicose 
vein surgery.
There were significant improvements in the RT90 times (90% of refilling time at 
Photoplethysmography) in both groups at one year. There were no differences 
between the groups with respect to the Photoplethysmography (PPG) times except at 
one year with the NSEPSG having a higher RT90 time. However, the PPG times at 
one year in the SEPSG, although lower than the NSEPSG, were well with in the 
normal limits. Hence the significance of this difference appears not to be of clinical 
importance. There was however a downward trend in the PPG times in the SEPSG 
during the follow-up period and it would be interesting to observe the changes in 
these values at 3 years and 5 years.
In 10 patients, from both groups, the RT 90 time was seen to have reduced at 1 year. 
In 4 of these patients either the 1 year PPG were within normal limits or they had 
reflux on DU whieh could account for the reduced RT90 times. The presence of 
reflux in the remnant below knee Great Saphenous Vein (GSV) in 5 out of the
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remaining 6 patients with markedly reduced and pathological PPG RT90 at 1 year, 
was found not to be significant when compared to the 2 groups as a whole (5/6 vs. 
39/63, Chi Square test P=0.076). Once again it must be noted that no attempt was 
made to clarify inter and intra-observer errors which may have occurred in measuring 
the PPG times.
In conclusion, the two groups were comparable samples with respect to 
demographics, risk factors and classification of varicose veins. SEPS is effective in 
the treatment of IPV and 80% of IPV can recur if they are not addressed at surgery. 
The addition of SEPS to the HST&S does increase the total operating time by 
approximately 16 minutes, and is not assoeiated with increased morbidity (pain, 
mobility restriction, cosmetic effects). Further work is required to assess the strong 
relationship between varicose veins and IPV. If a causative mechanism is elucidated 
then perforator surgery should be part of routine treatment of varicose veins
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FUTURE WORK AND QUESTIONS
Our study has shown that Incompetent Perforator Veins (IPV) recur following High 
Saphenous Tie and Strip and multiple avulsions (HST&S) alone. IPV have already 
been shown to be more commonly associated with recurrent varicose veins than 
primary varicose veins (Rutherford et al 2001). Also IPV occur more commonly in 
primary varicose veins than normal legs (Labropoulos et al. 1999). Whether this 
represents a causation is largely unknown. We plan to add to the increase body of 
evidence implicating IPV in recurrence and primary varicose veins, by rescanning the 
patient groups at 3 years and 5 years. The patterns of reflux in the two groups at these 
points, should shed further light on this subject. We will also assess whether clinical 
recurrence has occurred and what each individual patient feels about the outcome of 
their surgery.
The mechanism by which IPV affect the development of primary varicose veins is 
still largely unknown. Although IPV are more commonly associated with varicose 
veins, whether this is a primary event or re-entry secondary to underlying venous 
hypertension is not known. Our attempt at trying to explain the mechanism of 
pathological action of IPV were unfortunately unsuccessful on this occasion. 
However this work is ongoing and will hopefully reach fruition.
We have shown that IPV remain open following HST&S of the GSV. We believe the 
evidence of association of IPV with varicose veins is strong enough to merit pursue of 
their surgical treatment. Also If reflux of venous blood is the mechanism through 
which pathogenesis of varicose veins occurs, then all reflux disease must be overcome 
(Kistner 1993). In order to achieve this goal, IPV must also be considered and treated. 
Search for IPV should hence be considered routinely in the assessment of varicose 
veins (during DU scanning) and the operation geared towards dealing with IPV as
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well as the other more common areas of pathological reflux (e.g. SFJ). Subfascial 
Endoscopic Perforator Surgery (SEPS) addresses the issue of surgical treatment of 
IPVs convincingly, especially with the development of less invasive surgical 
techniques becoming more and more important in the medical field since the latter 
part of the 20* century. This process has been driven by the need to reduce the insult 
of operations on the body and also patient demand for less invasive procedures and 
more cosmetically acceptable scars. Varicose veins and IPV are no different in this 
respect and developments in the fields are continuing (e.g. Radio-fi-equency ablation 
(Fassiadis 2002, a&b). Laser therapy, foam sclerotherapy etc.). Further developments 
are however on going in order to improve on the down falls of SEPS. This includes 
the clips having come off the perforators and the 2 cm incision needed on the medial 
aspect of the calf, which can be unsightly. As has been shown by this study the 
patient’s perception of the cosmetic appearance of their legs scored highest in the pre­
operative VAS.
Trans-luminal occlusion of Perforators (TRLOP) has further developed minimal 
invasive surgery in to “pin-hole surgery”. This technique has been developed at the 
Whiteley clinic (Kianifard et al. 2002) and involves the introduction of a radio­
frequency catheter into the perforator vein via Seldinger technique (fig 35) and under 
DU guidance. Once in position, the radio-frequency generator is activated and the 
perforator vein is ablated and the complete destruction of the vein confirmed by DU 
post procedure. This appears to be a successful and minimally invasive method of 
dealing with IPV. However, randomised trials, further broad experience with this 
technique and five year follow-up data are still outstanding to establish this as a 
routine surgical tool surgical tool.
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Figure 35 Seldinger teehnique used in the introduction of the TRLOP catheter
As a result of the development of TRLOP, Radio-Frequency Subfascial Endoscopic 
Perforator Surgery (RFS) has developed. Specially designed radio-frequency catheters 
are now being produced (Fig 36) which uses a similar technique to TRLOP to ablate 
IPV.
Figure 36 RFS catheter
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APPENDIX 1
Patient information sheet
Patient Information Sheet 
Varicose Veins and SEPS Operation
You have been diagnosed as suffering from varicose veins. This is caused by the 
valves within the veins themselves not working any more. Usually the valves in the 
veins cause the blood to flow from the foot back to the pelvis whenever you move, 
particularly when you walk. The effect of losing your valves is that the blood now 
gets pumped up your leg whenever you walk, but instead of moving on into the pelvis 
and back to the heart, it falls back down to the ankle.
This backward flow causes varicose veins in some people. In other people it causes 
itching at the ankle called venous eczema. If this gets worse it can go on to cause 
inflammation of the skin, discolouration of the skin and even ulceration.
The most effective treatment for varicose veins or veins in which the valves have 
stopped working is to remove the vein. Under a general anaesthetic, a cut is made in 
the groin. The vein that has lost its valves is then tied so that blood cannot flow into 
it. A wire is then passed down the vein and out through the skin lower down the leg. 
The vein is tied to this wire and then the wire is pulled out, a process called “stripping 
the vein”.
In some patients the valves in the veins which connect the deep and superficial veins 
in the leg, known as perforating veins, may also stop working. It is not known 
whether or not the treatment of these perforating veins by Subfascial Endoscopic 
Perforator vein Surgery (SEPS), at the time of the initial surgery will help to prevent 
your varicose veins recurring. SEPS involves making a small incision on the inside of 
the lower leg and using a telescope to look into the leg to find these veins. Clips are 
then put onto these veins and they are divided. This study is designed to allow us to 
assess whether the treatment of perforating veins with SEPS will help to prevent 
recurrence.
The allocation of patients to either group (operation with and without SEPS), is 
worked out at random. This ensures that no one knows which treatment you will 
receive before entering you into the trial.
The study will follow your progress for I year after your operation and will require 
you to attend for regular appointments at I week, 6 weeks, 6 months and I year. On 
each occasion you will have a number of painless tests performed:
The veins in your leg will be assessed by a Duplex ultrasound scan 
A photograph of your leg will be taken so that the cosmetic result can be assessed
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Improvement in function will be measured using a Photoplethysmography machine
which measures the time taken for blood to refill your leg
There will be 2 short questionnaires about your health for you to complete
You will be asked to walk a distance of 50 metres whilst being watched and timed
These tests will also be performed before the operation so that we can assess any 
changes.
Your decision to participate in this study is entirely voluntary. Should you wish to 
participate in the trial you will be asked to sign a consent form. However at any stage 
you are free to withdraw from the trial and this will not affect your current or future 
treatment. With your permission, your GP will be notified of your entry into the trial.
Information about you and your treatment will be recorded and held on a computer 
database in accordance with the governing regulations. For verification of facts 
recorded as part of the trial we may need access to your hospital notes. Any 
information which is retrieved by this method will be subject to the same regulations 
as the trial data.
We would like to invite you to join this study. You will have the opportunity to 
discuss the procedure with one of the investigators, either Mr. Mark Whiteley, 
Consultant vascular surgeon, or Mr Babak Kianifard, research fellow in vascular 
surgery.
If you do not wish to be part of this study you will have the same surgery that has 
been
planned, and will be seen again in clinic after six weeks.
If you do wish to contact either one of the investigators about any aspect of this study 
the contact numbers are below:
Mr. Mark Whiteley 01483571122 Ext. 4424 
Mr Babak Kianifard 01483 571122 Ext. 4011
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Consent form
Patient Consent Form
A randomised controlled trial investigating the role of Subfascial Endoscopic 
Perforator vein Surgery (SEPS) in the prevention of recurrence in primary varicose 
veins.
Name of Consultant enrolling the patient:
Patient's surname: 
forename(s):
Date of Birth: / /
Gender: Male □ Female □
The patient should complete the remaining section of the form:
(please circle the relevant answer to each question)
Have you read the patient information sheet? Yes No
Have you had the opportunity to ask questions
and discuss the study? Yes No
Have you received satisfactory answers to
all your questions? Yes No
Have you received enough information about the study? Yes No
Who have you spoken to?
(please write their name)
Do you understand that you are free to withdraw from 
the study at any time, without having to give a reason, 
without affecting your future medical care? Yes No
Do you give permission for your General Practitioner (GP)
to be notified of your participation in this trial? Yes No
Do you agree to take part in the study? Yes No
(if'yes' please sign below)
Signature:.................................................................................................
Nam e:.......................................................................................................
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P r e - o p e r a t i v e  p r o - f o r m a
(IN BLOCK CAPITALS) 
Pro-forma Today's date: 
SEPS RESEARCH PROJECT
PRIMARY 
SEPS □
LEFTD
NAME:
Male n
ADDRESS:
□
RIGHTO
Female n
RECURRENCE □
NO SEPSO BILATERALO
Age: D.O.B.:
PHONE NO.
SYMPTOMS & HISTORY:
DURATION:
Previous venous surgery (details including dates): 
PM/SHX:
PREVIOUS DVT □ Details:
MEDICATION:
RISK FACTORS:
OCCUPATION:
Hours standing at work/normal day:
1-2 hours □ 3-4 hours □ 5-6 hours □
NUMBER OF PREGNANCIES:
BMI: HEIGHT:
FAMILY HISTORY:
WEIGHT:
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Pre-operative pro-forma
CEAP CLASSIFICATION:
R
Clinical
None □ □
Telangiectases, reticular, □ □
Mai. Rare □ □
Varicose Veins □ □
Oedema (without skin changes) □ □
Skin changes □ □
Healed Ulcer □ □
Active Ulcer □ □
Aetiology
Primary □ □
Secondary □ □
Congenital □ □
If congenital on what basis:
Anatomical
Superficial □ □
Perforating □ □
Deep □ □
Pathophysiological
Reflux □ □
Obstruction □ □
Reflux + Obstruction □ □
CEAP Class
EXCLUSION CRITERIA:
Immobility □
Previous DVT □
Other:
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Pre-operative pro-forma
Visual Analogue Score Sheet
To help people say how they are feeling we have drawn a scale with the extreme 
feelings described at each end of the scale.
We would like you to indicate how you are feeling by drawing a cross in the 
appropriate position on the line.
PAIN
No Pain 
At All
The Most Severe 
Pain I’ve Ever Felt
MOBILITY
Full Mobility 
Without Restriction
I am Unable to 
Move At All
COSMETIC VIEW OF LEG
I am perfectly happy 
with the Cosmetic 
appearance of my Leg
My leg could not 
look worse 
than it does now
Visual Analogue Scores
Pain % Mobility____ % Cosmetic View %
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Pre-operative pro-forma
Duplex US
R L
Comp Reflux Not Seen Comp Reflux Not Seen
Sup
CFV □ □ □ □ □ □
SFV □ □ □ □ □ □
PopV □ □ □ □ □ □
PTV □ □ □ □ □ □
PER □ □ □ □ □ □
Gastroc □ □ □ □ □ □
L-S System
SFJ □ □ □ □ □ □
GSV(upper %) □ □ □ □ □ □
GSV(mid %) □ □ □ □ □ □
GSV(lower V2) □ □ □ □ □ □
S-S System
SPJ □ □ □ □ □ □
SSV(upperl/3) □ □ □ □ □ □
SSV(midl/3) □ □ □ □ □ □
SSV(lowerl/3) □ □ □ □ □ □
Post. Arch V □ □ □ □ □ □
Giacomini □ □ □ □ □ □
GSV-SSV CommV □ □ □ □ □ □
Other veins only □ □
Perforators
R L
How many? Not Seen How many? Not Seen
Thigh
CSV
Post. Arch V □ □ □
SSV □ □ □
Size From To Size
1. mm mm
2. mm mm
3. ___mm mm
4. mm mm
5. mm mm
6. mm mm
 From To
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Pre-operative pro-forma
PHOTOPLETHYSMOGRAPHY
Refill Time  sec
% Refill Tim e____sec
T90  sec
Photography
Cosmetic Score 1 2
Gait Observation
Normal □
Mild Limp, Normal Speed □
Moderate Limp, Normal Speed □
Major Limp, Impaired Speed □
Walking with 1 stick □
Walking with other assistance □
Time to walk 30 metres: min sec
Quality of Life Questionnaires 
SF-36 Score _
AQ Score _
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P O S T - O P E R A T I V E  D I A R Y
NAME Hospital No.: Date of Operation:
Please fill in the as instructed on a daily bases until 2 weeks post operatively. 
POST-OPERATIVE DAY
PAE4
No Pain 
At All
The Most Severe 
Pain I’ve Ever Felt
MOBILITY
Full Mobility 
No Restriction
I am Unable to 
Move at All
(Doctors use only 
Pain killers taken: 
Name:
Pain % Mobility %)
Number:
Assistance required during the day: 
I.
2 .
3.
4.
5.
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APPENDIX 2
S t u d y  A p p r a i s a l  Q u e s t i o n n a i r e
Study:
Type of study:
+1 -1
Clearly Stated Aim □ □
Justified size of sample (Power) □ □
Identified whether their measurements are valid and reliable □ □
Clearly stated their statistical methods □ □
Explained events (missing data, bias) □ □
Interpreted Their findings correctly (conclusions) □ □
Discussed interesting findings (outliers, comments) □ □
Reported comparison with the rest of the literature □ □
Clearly stated implications (are they relevant) □ □
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Assessing Cohort studies
study:
Participants:
Relevant population under exam.?
Design:
Aims clearly stated?
Is the design appropriate for the aim?
How are they recruited? Correctly?
Did it have a control group?
Did it require one?
Was the sample size justified?
Was the intervention accurately measured? (reliability) 
Was the FU satisfactory?
All data accounted for (Missing data?)
Was the FU long enough for detection of imp. events? 
Were relevant outcomes ignored? (validity)
Results:
Are stats described?
Do the numbers add up?
Were basic data described?
Was the statistical significance assessed?
The Findings:
Did any untoward events occur during the study?
What do the main findings mean? Explained?
Any other factors influenced the outcome?
Any important findings overlooked?
How are the null findings interpreted?
Are the results compared with others in the field?
What are the implications for your study?
+1 -1
□ □
□ □
□ □
□ □
□ □
□ □
□ □
□ □
□ □
□ □
□ □
□ □
□ □
□ □
□ □
□ □
+1 -1
□ □
□ □
□ □
□ □
□ □
□ □
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A s s e s s i n g  C a s e  C o n t r o l  S t u d i e s  
Study:
General: ±1____ A
How were cases obtained? Correctly? □ □
Is the control group appropriate? □ □
Were data collected in the same way in the 2 grps.? □ □
Design:
Are the aims clearly stated? □ □
Is the method appropriate for the aim? □ □
Was the size of the sample justified? □ □
Valid? □ □
Reliable? □ □
Analysis:
Are the stats Described? □ □
Is it likely that an untoward event occurred? □ □
Do the no. add up? □ □
How was the data collected? Reliable? □ □
The Findings:
What do the main findings mean? Explained? □ □
Has bias occurred? Where? □ □
Is it possible confounding may have occurred? □ □
How are the null findings interpreted? □ □
Are important effects overlooked? □ □
Are the results compared with others in the field? □ □
What are the implications for your study?
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Assessing Clinical Trials
study:
General: + i_____^
Random allocation? □ □
Correctly randomised? □ □
Missing data? □ □
Missing data Explained? □ □
Was assessment blinded? □ □
Design:
Are aims clearly stated? □ □
Was size justified? □ □
Validity? □ □
Reliability? □ □
Could lack of blinding introduce bias? □ □
Results:
Are stats described? □ □
Was stat signif. Assessed? □ □
Were the basic data described? □ □
Do the numbers add up? □ □
Were treatment groups similar? □ □
Treatment as per intention to treat? □ □
Were the side effects recorded? □ □
The Findings:
What do the main findings mean? Explained? □ □
Any other factors influenced the outcome? □ □
Any important findings overlooked? □ □
How are the null findings interpreted? □ □
Are the results compared with others in the field? □ □
What are the implications for your study?
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Abstract
Objectives:
The aim of the review was to evaluate the effectiveness of Subfascial Endoscopic 
Perforator Surgery (SEPS) in addition to conventional surgery (High Saphenous Tie 
and Stripping (HST&S)) in the surgical treatment of primary non-ulcerated varicose 
veins. A second search was made to look at the efficacy of ultrasound in the 
assessment of incompetent perforating veins.
Search strategy:
A search was made using four major data bases, with the use of pre-defmed criteria. 
Two separate searches were made, the first looking at the surgical procedure on the 
affected population, the other concentrating on duplex ultrasound as the outcome 
measure following surgery.
Selection criteria:
There is a lack of material with respect to the questions being asked. No randomised 
control trials were found. All relevant papers other than case series were considered 
and evaluated.
Data collection and analysis:
List of all papers were then scrutinised and irrelevant papers excluded. All other 
papers were then studied and assessed separately using a simple study appraisal form 
(appendix 2). Due to the small number of papers and the diverse methods of 
assessment and populations studied within them, each paper which was included was 
individually read and summarised.
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Main results:
With respect to the intervention (SEPS) and the population involved (primary non­
ulcerated primary varicose veins), there were no suitable papers which tackled the 
outcome following SEPS. With respect to the efficacy of ultrasound two papers were 
of a high enough quality to be included.
Conclusions:
At present there is no correctly conducted study which looks at the use of SEPS in the 
treatment of primary varicose veins.
Objectives and Review Questions
The aim of this review is to establish the level of evidence available to support or 
disprove the efficacy of SEPS in conjunction with HST&S in improving the outcome 
and recurrence of varicose veins.
Question: In patients undergoing surgery for primary non-ulcerated varicose veins, to 
what extent is post-operative detected reflux altered by addition of SEPS.
Study Selection Criteria
Population Primary varicose veins
Intervention SEPS
Outcome Ultra sound detected reflux within 1 year
Study design Randomised control trial
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Inclusion criteria:
Inclusion criteria
Population Primary non-ulcerated
Varicose veins
Intervention Subfascial endoscopic perforator
Surgery
Outcome Duplex detected reflux
Study Design RCT, observational studies
Exclusion criteria
Recurrent, ulcerated 
varicose veins
Other procedures
Case report, expert 
opinion, technique papers, 
bench research.
Tvpe of narticinants and intervention
The group of patients interested in were those who were having their first operation 
for CSV incompetence. This excludes all those patients with ulceration, recurrence, 
SSV reflux and deep venous reflux.
The interested intervention carried out on these patients is SEPS. This may be carried 
out in conjunction with the accepted treatment for GSV reflux, HST&S. All other 
interventions were disregarded.
Tvpes of outcome measures
The outcome measure was reflux as detected by duplex ultrasound (DU). A separate 
review was carried out with respect to the efficacy of duplex ultrasound with this 
respect.
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Types o f  papers
Following the search strategy on the different search engines, all the lists were 
collated and scanned. All those papers which appeared unrelated were discounted at 
this point. All other papers were read individually and assessed by using a study 
appraisal questionnaire.
A search was made to include all papers relevant to surgery for primary non-ulcerated 
varicose veins. There were no randomised control trials related to the type of surgery 
involved. All papers observational papers (cohort, case-control studies, cross- 
sectional studies, before and after studies and case series) were considered for 
appraisal. All papers concerned with case reports, bench research and expert opinions 
were disregarded.
Search Strategy Including Search Terms and Resources to be Searched
Search:
Electronic Databases:
National Research Register
CINAHL (Cumulative Index to Nursing and Allied Health Literature, 1982 to present) 
EMBASE (1974 to present)
MEDLINE (1951 to present)
Cochrane library (Central Register of Controlled Trials (CENTRAL), Database of 
Systematic Reviews, Database of Abstracts of Reviews of Effects, Database of 
Methodology Reviews, Methodology Register(CMR), Health technology assessment 
database (HTA), NHS Economic evaluation database (NHS EED)
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Search Term
The terms used are outlined in the table 24 (Intervention and population) and 2 (DU) 
below. Each citation was studied and excluded if not relevant. All remaining papers 
were then read fully and appraised.
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Table 23 MEDLINE (population and Intervention) search criteria.
Info added
No. Database Search term Info added since Results
Medline- 
1951 to
1 date (VARICOSE AD J VEINS).MJ. Unrestricted 7182
Medline-
1951 to
2 date (VENOUS ADJ INSUFFICIENCY).MJ. unrestricted 2473
Medline-
1951 to
3 date VENOUS ADJ REFLUX unrestricted 438
Medline-
1951 to
4 date PERFORATOR ADJ VEINS unrestricted 96
Medline-
1951 to
5 date 1 OR 2 OR 3 OR 4 unrestricted 9586
Medline- unrestricted
1951 to SUBFASCIAL ADJ ENDOSCOPIC
6 date ADJ PERFORATOR ADJ SURGERY 38
Medline- ENDOSCOPY.W..MJ. AND unrestricted
1951 to VASCULAR-SURGICAL-
7 date PROCEDURES.MJ. 87
Medline- unrestricted
1951 to
8 date SEPS I 7 4 5
Medline- unrestricted
1951 to PERFORATOR ADJ VEIN ADJ
9 date SURGERY 20
Medline- unrestricted
I95I to
10 date 6 OR 7 OR 8 OR 9 1836
Medline- unrestricted
1951 to
11 date 5 AND 10 72
Medline- unrestricted
1951 to
12 date DEEP OR ULCER 175304
Medline-
1951 to
13 date 11 NOT 12 unrestricted 17
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Table 24 EMBASE (Duplex ultrasound) search criteria
No. Database Search term
EMBASE - 
1974 to date
EMBASE - 
1974 to date
EMBASE - 
1974 to date
EMBASE - 
1974 to date
duplex ADJ ultrasound 
colour ADJ duplex 
colour ADJ duplex 
1 0 R 2  0R 3
10
EMBASE -
1974 to date varicose ADJ veins 
EMBASE -
1974 to date venous ADJ reflux 
EMBASE -
1974 to date 6 OR 7 
EMBASE -
1974 to date 8 AND 5 
EMBASE -
1974 to date deep OR ulcer 
EMBASE -
1974 to date 9 NOT 10
Info added Since 
unrestricted
unrestricted
unrestricted
unrestricted
unrestricted
unrestricted
unrestricted
unrestricted
unrestricted
unrestricted
Results
1268
706
706
1852
2413
605
2888
131
136567
56
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Study Quality Assessment Checklists and Procedures
After discarding all non relevant paper, each paper was read and scored using the 
appraisal questionnaire. Those that scored 50% were summarised and included in this 
review. All other papers were discarded.
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Data Extraction Strategy
Due to the lack of suitable papers, the studies selected were summarised individually. 
Description of the Studies
Antoch-G, Pourhassan-S, Hansen-0, Stock-W2002 Comparison o f colour Doppler 
ultrasonography, ascending phlebography and clinical examination in the diagnosis 
o f incompetent calf perforating veins. Br J  Surg 89:192-3
The main objective of this paper was to compare the ability of ultrasound, ascending 
phlebography and clinical examination in defining perforator vein incompetence. 
Patient and Methods
Sixty three legs in 50 patients were entered into the study. This appears to be large 
enough number for this comparison study, however no reason or explanation given 
for this number of patients. Also the exact source and recruitment process is not 
described. Since all patients included were classified in the same class of chronic 
venous insufficiency, they do make a good comparison group.
No time period given for the duration of study and date, however the paper was 
published in 2001 and is up to date.
All participants were examined, had ascending phlebography and colour duplex 
ultrasound. This was followed by confirmation of these findings at surgery (SEPS), 
carried out by surgeons who were blinded to previous investigations. However 
although enough information is given about assessment of IPV during SEPS, there is 
not enough information with regards to the assessors themselves and their experience 
with SEPS.
McNemara’s test was used to analyse differences in values of specificity and 
sensitivity for matched pair proportions. This is an appropriate test for comparing 
proportions.
Results
Ultrasound is significantly more sensitive (mean 80%) than ascending phlebography 
(66%) in assessing IPV. Clinical examination was also more sensitive (79%) than 
ascending phlebography. There was no significant difference between ultrasound and 
ascending phlebography with respect to specificity. Sensitivity was improved to 87% 
by combining clinical examination and colour duplex ultrasound.
No withdrawals mentioned.
No morbidity or complications mentioned.
Discussion.
Ultra sound is superior to ascending phlebography in imaging cockett perforators, and 
the addition of phlebography has no further advantage over ultrasound and clinical 
examination.
Comparisons were made with two other similar papers and similarities and 
differences discussed.
Use of ascending phlebography should be limited to patients for whom ultrasound is 
not available or where its results are questionable.
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Phillips-G-W-L, Paige-J, Molan-M-P 1995 A comparison o f colour duplex ultrasound 
with venography and varicography in the assessment o f varicose veins. Clinical 
Radiol 50(l):20-25
The aim is to prospectively compare Ultrasound (US) findings and compare them 
against the more established ascending plus varicography (V), in patients with 
varicose veins.
Patients and Methods.
Over a 9 month period, 68 (93 legs) consecutive patients referred for pre-operative 
assessment of varicose veins, were recruited. Forty nine of the 93 legs represented 
recurrent varicose veins.
A full description of the three techniques is given along with the fact that US and V-V 
were performed by two different investigators who were blinded with regards to the 
other investigation.
The findings were confirmed at surgery. However this was based on the finding of the 
investigations (US and V). The false negative rate also can not be assessed by surgery. 
A big assumption by the authors is that the total number of abnormal communications 
seen by V or US to represent 100% of the abnormalities present.
Nine cases did not proceed to surgery due to deep venous incompetence.
The remaining 84 underwent the appropriate interventions.
Results
No false positive cases identified. Incompetent calf perforators were present in 62 legs 
(74%).
V and ultrasound had high detection rates for sapheno-femoral and sapheno-popliteal 
junction disease with 90% being demonstrated by either technique. Varicography was 
found to be superior in assessment of incompetent calf perforators with 83% being 
demonstrated by V and 60% by US.
Discussion
Comparison is made with different papers.
Accuracy of US in identifying IPV is significantly less than that of V. However 10% 
of IPV missed on V were seen on US.
Suggest that US alone is second best, and all patients should have all three modalities 
of investigation before surgery.
The authors do mention that all 9 cases with post-thrombotic changes which 
prohibited surgery, were diagnosed by ascending venography and 2 of these were 
missed by US. Also another 2 cases which appeared normal on venography were 
abnormal on US. This does raise the question of the accuracy of the investigator 
carrying out the US or the accuracy of machine being used. Ultra sound is now the 
accepted standard for diagnosis of post-thrombotic changes seen within the deep 
veins. This study is more than 10 years old and the efficacy of modem machines have 
advanced greatly over this period. This questions the relevance to the current 
situation.
Results
Despite an extensive search of literature no adequate studies exist that investigate the 
place of SEPS in the treatment of primary non-ulcerated varicose veins. However 
searching through the different studies, SEPS is being carried out in a large number of 
international institutions.
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With respect to ultrasound, the most up to date paper reviewed showed duplex 
ultrasound to be superior to phlebography in assessing perforator veins. The other 
paper reviewed however disputes this. The later paper however is most probably out 
of date now, due to the progression of accuracy of ultrasound since publication of this 
paper (ten years ago).
Conclusions
There is insufficient evidence at present to assess the place of SEPS in the treatment 
of primary varicose veins.
Ultrasound appears to be an accurate form of investigation of IPV.
As the background to this thesis outlines, the place of perforator surgery in the 
treatment of primary non ulcerated patients suffering with varicose veins has not been 
established. There are presently no published randomised trials which have assessed 
the impact of SEPS on the treatment of such patients, and the long term fate of 
perforators in treated varicose veins is still unknown. Our aim was to assess the effect 
of SEPS, as part of randomised clinical trial, and to observe the fate of IPV with in 
one year following surgery aimed directly at the perforators (Subfascial endoscpic 
perforator surgery group, SEPSG) as compared to HST&S alone (Non SEPS Group, 
NSEPSG). DU was used to assess all patients and the primary outcome measure was 
the incidence of pathological venous reflux and IPV within a one year period. As part 
of secondary outcome measure PPG, quality of life questionnaires, visual analogue 
scores, surgical data and post-operative patient diaries were used to observe any 
appreciable differences in the two groups and to document the additional effect of 
SEPS on the patient’s recovery.
In conjunction with the above, we had hoped to directly assess the contribution of IPV 
to venous hypertension in chronic venous disease. It was hoped that by direct 
cannulation of the perforator veins and observation of calibrated pressure changes 
adjacent to both incompetent and competent perforator veins, an idea of the 
contribution of IPV to venous hypertension may be surmised. However, in practice 
this technique did not prove to be fruitful due to the difficulties in instrumentation and 
limited reproducibility of the technique.
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Jutley-R-S, Cadle-I, Cross-K-S. 2001 Preoperative assessment o f primary varicose veins: a duplex 
study o f venous incompetence. European journal o f vascular and endovascular surgery 21:370-3 Paper 
on the usefulness o f pre-operative duplex.
Wuppermann-T, Dittrich-0. 2001 Ultrasound study before surgery o f varicose veins.
VASA 30:3-8 Review article.
Labropoulos-N, Mansour-M-A, Kang-S-S, Gloviczki-P, Baker-W-H. 1999 New insights into perforator 
vein incompetence. European journal o f vascular and endovascular surgery 18:228-34 Paper showing 
the no and diameter of ipv increases with more severe CVl.
Wills-V, Moylan-D, Chambers-J. 1998 The use o f routine duplex scanning in the assessment of 
varicose veins. The Australian and New Zealand journal o f surgery 68:41-4 Confirms use o f pre-op 
duplex vs. examination and hand held Doppler.
Kerwat-R, Shandall-A. 1997 The place o f duplex scanning for varicose veins and common venous 
problems. Annals o f the Royal College o f Surgeons o f England 79:308 Comment.
Phillips-G-W, Cheng-L-S. 1996 The value o f ultrasound in the assessment o f incompetent perforating 
veins. Australasian radiology 40:15-8 Did not seore >50%.
Englund-R.1996 Duplex scanning for recurrent varicose veins. The Australian and New Zealand 
journal of surgery 66:618-20 Recurrent varicose veins and patterns o f reflux.
Bergan-J-J. 1996 New technology and recurrent varicose veins. Lancet 348:210-1 
Comment
Khaira-H-S, Pamell-A, Crowson-M-C. 1996 Colour flow duplex in the assessment o f recurrent 
varicose veins. Annals o f the Royal College o f Surgeons o f England 78:139-41 Patterns o f reflux in 
reeurrence.
Tong-Y, Royle-J. 1995 Recurrent varicose veins following high ligation o f long saphenous vein: a 
duplex ultrasound study. Cardiovascular surgery 3:485-7 
Did not score >50%.
Rabe-E. 1994 Evaluation of the insufficient perforant vein using colour-coded duplex ultrasound. 
Zeitschrift fur Lymphologie. Journal o f lymphology 18 (2), P: 31-3 
Paper looking at the classification of IPV.
Farrah-J, Shami-S-K. 2001 Patterns of incompetence in patients with recurrent varicose veins: A 
duplex ultrasound study. Phlebology 16:34-37
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Recurrent varicosed veins, and pattern of reflux.
Yamaki-T, Nozaki-M, Sasaki-K. 2000 Quantitative assessment o f superficial venous insufficiency 
using duplex ultrasound and air plethysmography. Dermatologie Surgery 26:644-648 Not relevant.
De-Maeseneer-M-G, Ongena-K-P, Van-den-Brande-F, Van-Schil-P-E, De-Hert-S-G, Eyskens-E-J. 
1997 Duplex ultrasound assessment o f neovascularization after sapheno- femoral or sapheno-popliteal 
junction ligation. Phlebology 12:64-68 
Paper looking at recurrence following HST.
Johnson-B-F, Strandness-D-E-Jr. 1997 Ultrasound and venous valvular reflux. Journal o f Vascular 
Investigation 3:108-113 Technique.
Evans-C-J, Leng-G-C, Stonebridge-P, Lee-A-J, Allan-P-L, Fowkes-F-G-R. 1995 Reproducibility o f 
duplex ultrasound in the measurement o f venous reflux.
Phlebology 10:149-154 Did not score >50%. Two people trained to scan in 8 weeks validation? The 
other surgeon who was scanning.
Darke SG, Vetrivel S, Foy DMA, Smith S, Baker S 1997 A comparison o f duplex scanning and 
continuous wave doppler in the assessment o f primary and uncomplicated varicose veins European 
Journal o f Vascular & Endovascular Surgery 14(6) Continuous wave Doppler.
Valentin LI, Valentin WH, Mercado S, Rosado CJ 1993 Venous reflux localization: comparative study 
of venography and duplex scanning. Phlebology8:124-127.
Did not score >50%.
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